Category,GO BP Term,Hepatocytes,.,Patient 2177,..,Patient 2280,...,Patient 2556,....,Patient 2766,.....,Patient 3196,......,Patient 3477,.......,,P-Value,Gene Count,P-Value,Gene Count,P-Value,Gene Count,P-Value,Gene Count,P-Value,Gene Count,P-Value,Gene Count,P-Value,Gene CountGOTERM_BP_5,protein modification process,8.30E-07,774,9.70E-08,769,2.00E-17,939,2.10E-10,702,2.10E-10,879,1.90E-09,803,5.10E-09,767GOTERM_BP_5,cellular protein metabolic process,2.30E-14,1279,8.20E-15,1262,5.70E-27,1512,1.50E-17,1137,2.30E-20,1440,1.80E-16,1307,2.20E-19,1268GOTERM_BP_5,phosphorylation,1.90E-07,449,3.00E-07,441,7.00E-12,528,5.10E-13,423,3.50E-09,502,6.20E-08,457,7.20E-09,444GOTERM_BP_5,regulation of programmed cell death,1.10E-02,417,6.00E-04,423,5.90E-09,521,2.80E-04,378,1.30E-03,471,4.00E-03,427,9.00E-04,415GOTERM_BP_5,regulation of apoptosis,1.30E-02,412,6.10E-04,419,1.00E-08,515,3.30E-04,374,1.20E-03,467,4.00E-03,423,9.30E-04,411GOTERM_BP_5,regulation of protein metabolic process,5.00E-05,304,9.70E-09,319,1.10E-07,357,1.00E-06,277,3.00E-05,335,1.90E-07,321,1.50E-06,304GOTERM_BP_5,regulation of signal transduction,2.30E-03,457,1.80E-02,439,1.00E-04,532,4.20E-04,405,2.30E-02,493,1.30E-03,465,7.30E-03,437GOTERM_BP_5,regulation of cellular protein metabolic process,6.60E-06,272,3.50E-08,279,3.00E-07,312,1.10E-06,244,6.70E-05,292,1.60E-07,283,1.30E-06,268GOTERM_BP_5,carboxylic acid metabolic process,1.30E-15,355,2.40E-17,355,4.10E-13,385,2.20E-15,317,1.60E-12,374,3.80E-15,357,1.90E-16,349GOTERM_BP_5,intracellular signaling cascade,2.90E-02,627,2.30E-03,632,2.30E-07,769,4.90E-04,566,8.40E-03,704,7.90E-02,627,2.70E-02,607GOTERM_BP_5,negative regulation of protein modification process,8.90E-05,78,8.10E-06,80,8.30E-06,89,1.50E-06,75,3.90E-06,88,3.40E-05,80,2.00E-05,78GOTERM_BP_5,negative regulation of programmed cell death,3.60E-02,188,1.30E-02,189,2.80E-05,234,1.00E-01,159,6.40E-02,205,3.00E-02,191,4.10E-03,190GOTERM_BP_5,positive regulation of cell death,1.40E-01,218,2.60E-03,232,1.90E-06,285,4.00E-03,205,7.00E-03,256,3.10E-02,229,4.80E-02,217GOTERM_BP_5,regulation of kinase activity,2.20E-02,189,7.10E-03,190,3.20E-03,221,7.00E-02,160,1.10E-01,201,1.10E-02,194,8.80E-02,177GOTERM_BP_5,regulation of protein modification process,2.30E-03,165,1.30E-05,174,4.30E-04,190,6.50E-06,158,1.90E-04,187,6.70E-04,170,3.30E-04,165GOTERM_BP_5,intracellular protein transport,3.50E-06,221,6.90E-09,229,2.60E-10,263,3.80E-09,208,3.80E-09,253,1.00E-07,230,2.40E-07,220GOTERM_BP_5,positive regulation of programmed cell death,1.40E-01,217,2.60E-03,231,1.70E-06,284,4.10E-03,204,6.80E-03,255,3.10E-02,228,4.90E-02,216GOTERM_BP_5,regulation of phosphate metabolic process,3.70E-02,250,1.20E-02,251,1.80E-02,288,1.00E-01,212,1.40E-01,269,3.80E-02,253,1.30E-01,235GOTERM_BP_5,regulation of phosphorus metabolic process,3.70E-02,250,1.20E-02,251,1.80E-02,288,1.00E-01,212,1.40E-01,269,3.80E-02,253,1.30E-01,235GOTERM_BP_5,negative regulation of apoptosis,3.20E-02,186,1.50E-02,186,4.50E-05,230,9.90E-02,157,5.50E-02,203,2.70E-02,189,4.80E-03,187GOTERM_BP_5,negative regulation of cell death,4.00E-02,188,1.40E-02,189,3.70E-05,234,1.10E-01,159,7.20E-02,205,3.40E-02,191,4.70E-03,190GOTERM_BP_5,positive regulation of apoptosis,1.80E-01,214,3.10E-03,229,3.00E-06,281,6.70E-03,201,9.70E-03,252,4.30E-02,225,5.50E-02,214GOTERM_BP_5,negative regulation of protein metabolic process,9.20E-04,111,5.60E-06,118,1.70E-07,137,7.40E-05,103,1.00E-04,125,9.40E-06,120,1.00E-04,112GOTERM_BP_5,protein kinase cascade,1.90E-02,196,1.80E-02,193,2.00E-04,236,2.50E-02,170,7.90E-02,210,1.60E-02,199,8.30E-03,193GOTERM_BP_5,negative regulation of cellular protein metabolic process,6.30E-04,108,1.30E-05,113,4.80E-08,134,1.70E-05,102,9.40E-05,121,5.00E-06,117,3.60E-05,110GOTERM_BP_5,regulation of small GTPase mediated signal transduction,9.30E-02,131,6.20E-01,116,6.50E-03,158,1.80E-01,111,2.40E-01,140,1.30E-01,131,4.70E-01,117GOTERM_BP_5,mitosis,2.70E-01,110,2.70E-04,129,6.20E-05,149,2.60E-02,105,1.00E-03,140,4.60E-03,126,4.60E-03,121GOTERM_BP_5,regulation of ubiquitin-protein ligase activity,4.10E-04,53,1.50E-06,58,3.10E-05,61,2.80E-06,53,4.40E-04,57,1.50E-05,57,2.10E-05,55GOTERM_BP_5,M phase of mitotic cell cycle,3.60E-01,110,4.60E-04,130,7.90E-05,151,3.20E-02,106,1.20E-03,142,7.10E-03,127,6.80E-03,122GOTERM_BP_5,positive regulation of protein metabolic process,1.70E-03,139,1.60E-03,137,5.90E-03,153,1.60E-05,132,1.20E-03,153,2.20E-04,145,1.70E-04,140GOTERM_BP_5,protein oligomerization,4.20E-03,101,7.70E-05,107,1.10E-04,120,3.90E-04,94,1.20E-04,117,3.50E-04,107,8.40E-06,109GOTERM_BP_5,protein transport,5.00E-07,427,8.70E-08,425,2.20E-07,483,4.00E-08,382,5.70E-07,468,7.00E-07,431,1.10E-05,406GOTERM_BP_5,positive regulation of ligase activity,1.90E-04,51,4.80E-06,54,7.00E-06,59,1.30E-06,51,1.60E-04,55,5.00E-06,55,2.40E-05,52GOTERM_BP_5,negative regulation of cell proliferation,6.70E-01,168,8.10E-01,161,1.90E-01,206,7.80E-01,141,6.20E-01,189,8.20E-01,166,8.10E-01,158GOTERM_BP_5,anti-apoptosis,2.30E-02,113,2.50E-02,111,4.50E-05,141,1.30E-01,93,2.10E-01,116,2.60E-02,114,5.30E-02,107GOTERM_BP_5,M phase,5.40E-01,156,7.40E-03,176,9.70E-04,208,8.80E-02,147,1.20E-02,195,9.20E-02,171,1.00E-01,163GOTERM_BP_5,RNA processing,6.20E-09,325,2.30E-07,313,1.20E-08,362,1.20E-03,258,1.50E-11,365,5.90E-08,324,7.90E-10,320GOTERM_BP_5,vasculature development,1.90E-01,127,8.00E-02,129,3.70E-02,152,2.00E-01,110,1.50E-01,142,7.60E-02,133,3.10E-01,120GOTERM_BP_5,positive regulation of cellular protein metabolic process,3.50E-03,132,3.50E-03,130,9.10E-03,146,5.90E-05,125,2.00E-03,146,7.80E-04,137,6.80E-04,132GOTERM_BP_5,positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,2.10E-04,48,1.50E-05,50,4.70E-05,54,5.80E-06,47,3.50E-04,51,1.50E-05,51,7.50E-05,48GOTERM_BP_5,negative regulation of ligase activity,1.20E-04,48,2.40E-06,51,6.60E-06,55,9.00E-07,48,6.70E-05,52,7.30E-06,51,4.40E-06,50GOTERM_BP_5,induction of programmed cell death,4.60E-01,154,6.30E-02,164,8.60E-05,209,1.10E-02,152,3.30E-02,187,6.00E-02,169,2.50E-01,154GOTERM_BP_5,posttranscriptional regulation of gene expression,1.40E-02,117,3.50E-05,128,2.50E-05,145,3.60E-02,100,1.20E-02,129,3.10E-06,135,3.80E-04,122GOTERM_BP_5,positive regulation of transferase activity,1.50E-01,123,5.70E-02,125,2.50E-02,147,1.40E-01,107,1.80E-01,135,8.50E-02,127,4.00E-01,113GOTERM_BP_5,mRNA metabolic process,7.00E-07,222,1.20E-08,226,1.10E-06,247,6.50E-03,175,6.50E-07,242,4.90E-07,225,5.30E-06,212GOTERM_BP_5,negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,1.00E-04,47,6.20E-06,49,4.10E-06,54,7.90E-07,47,4.90E-05,51,5.50E-06,50,3.50E-06,49GOTERM_BP_5,fatty acid metabolic process,1.60E-05,124,3.00E-08,131,8.80E-05,135,2.10E-07,117,2.30E-05,134,5.20E-06,127,7.50E-06,122GOTERM_BP_5,blood vessel development,1.60E-01,125,8.20E-02,126,4.40E-02,148,2.10E-01,107,2.10E-01,137,9.60E-02,129,3.20E-01,117GOTERM_BP_5,protein targeting,3.00E-04,128,1.10E-05,132,1.30E-06,152,8.10E-05,116,2.40E-04,140,2.40E-03,125,1.40E-04,126GOTERM_BP_5,actin filament organization,9.90E-01,25,7.60E-01,32,7.40E-01,38,6.60E-01,29,5.50E-01,39,2.40E-01,39,5.30E-01,34GOTERM_BP_5,protein catabolic process,5.70E-04,335,2.20E-06,346,4.50E-07,399,1.70E-05,304,2.10E-05,379,8.90E-05,345,2.30E-06,341GOTERM_BP_5,proteolysis,5.70E-03,539,5.10E-05,551,3.80E-04,627,6.00E-04,479,8.40E-04,606,8.80E-04,555,3.60E-04,535GOTERM_BP_5,carboxylic acid catabolic process,2.60E-07,80,1.90E-11,87,1.20E-07,88,7.30E-10,78,3.70E-06,83,1.40E-10,87,3.50E-10,84GOTERM_BP_5,regulation of protein catabolic process,5.00E-02,32,2.00E-02,33,4.40E-03,39,9.40E-03,31,1.30E-01,33,1.70E-02,34,3.20E-03,35GOTERM_BP_5,striated muscle cell development,8.70E-01,22,4.60E-01,26,5.90E-01,29,9.10E-01,18,4.40E-02,35,6.50E-01,25,8.80E-01,21GOTERM_BP_5,cellular protein catabolic process,3.60E-04,327,7.30E-07,339,1.70E-07,390,2.00E-05,295,5.10E-06,372,4.90E-05,337,1.20E-06,333GOTERM_BP_5,mRNA processing,6.20E-07,196,9.80E-09,200,7.60E-07,218,1.10E-02,152,2.10E-07,215,1.90E-06,196,8.30E-06,186GOTERM_BP_5,nucleoside phosphate metabolic process,5.80E-06,177,7.60E-03,158,8.40E-03,181,1.20E-03,146,3.80E-02,171,1.60E-02,160,4.90E-03,157GOTERM_BP_5,RNA metabolic process,3.30E-07,518,1.30E-06,506,4.30E-08,590,6.80E-03,418,1.10E-08,578,3.50E-06,517,4.80E-08,508GOTERM_BP_5,enzyme linked receptor protein signaling pathway,2.30E-01,170,1.20E-01,171,5.70E-04,217,2.60E-01,146,9.10E-02,194,2.00E-02,184,5.00E-03,181GOTERM_BP_5,positive regulation of cell communication,5.00E-01,157,4.20E-01,156,2.40E-01,187,4.60E-02,150,3.70E-01,178,1.60E-01,168,4.40E-01,153GOTERM_BP_5,blood vessel morphogenesis,1.70E-01,108,9.20E-02,109,8.90E-02,126,2.50E-01,92,1.90E-01,119,1.50E-01,110,3.80E-01,100GOTERM_BP_5,cellular protein complex assembly,2.70E-01,82,5.10E-02,87,9.30E-02,98,1.80E-01,73,2.10E-04,109,8.00E-02,88,4.70E-02,86GOTERM_BP_5,modification-dependent macromolecule catabolic process,2.10E-04,314,1.20E-06,323,2.40E-07,372,2.10E-05,282,2.80E-06,357,3.50E-05,323,2.30E-06,317GOTERM_BP_5,regulation of intracellular transport,3.20E-01,37,5.40E-01,34,3.30E-01,42,7.10E-01,28,8.30E-01,35,4.50E-01,36,3.10E-01,36GOTERM_BP_5,negative regulation of phosphate metabolic process,2.40E-02,31,3.60E-02,30,2.50E-01,30,1.90E-01,24,1.10E-01,31,1.60E-01,28,3.20E-01,25GOTERM_BP_5,negative regulation of phosphorus metabolic process,2.40E-02,31,3.60E-02,30,2.50E-01,30,1.90E-01,24,1.10E-01,31,1.60E-01,28,3.20E-01,25GOTERM_BP_5,negative regulation of macromolecule metabolic process,1.20E-01,364,1.10E-01,358,6.30E-04,443,2.10E-02,326,2.60E-01,397,6.50E-02,373,1.50E-01,350GOTERM_BP_5,regulation of GTPase activity,1.20E-02,72,1.60E-01,64,1.70E-02,80,3.20E-01,54,3.80E-01,68,8.50E-02,68,6.40E-02,66GOTERM_BP_5,positive regulation of signal transduction,6.40E-01,138,5.70E-01,137,3.20E-01,166,1.80E-01,129,5.50E-01,156,2.00E-01,150,6.00E-01,134GOTERM_BP_5,glucose metabolic process,2.70E-04,95,1.20E-04,95,1.30E-03,103,1.20E-04,86,3.10E-04,103,1.00E-02,89,3.70E-04,92GOTERM_BP_5,muscle organ development,8.40E-01,94,5.20E-01,99,7.70E-01,111,5.10E-01,87,1.30E-01,121,2.70E-01,107,8.90E-01,89GOTERM_BP_5,in utero embryonic development,4.80E-01,85,2.80E-01,87,2.60E-02,110,6.80E-01,70,2.90E-01,98,8.20E-02,95,2.60E-01,86GOTERM_BP_5,positive regulation of protein modification process,8.70E-03,106,1.00E-02,104,2.10E-02,117,7.40E-05,103,9.30E-03,116,6.30E-03,108,2.30E-03,106GOTERM_BP_5,negative regulation of cellular metabolic process,1.10E-01,358,2.10E-01,346,1.40E-03,432,3.60E-02,317,3.30E-01,387,1.30E-01,361,1.80E-01,342GOTERM_BP_5,cellular lipid catabolic process,3.70E-04,52,1.10E-05,55,1.70E-04,58,7.70E-06,51,1.90E-03,54,5.50E-04,52,7.00E-04,50GOTERM_BP_5,hexose metabolic process,4.60E-04,115,3.30E-04,114,9.40E-03,122,5.00E-03,97,1.50E-03,123,1.20E-02,109,7.20E-04,111GOTERM_BP_5,striated muscle cell differentiation,9.60E-01,35,7.60E-01,39,7.00E-01,47,9.80E-01,28,1.40E-01,53,9.20E-01,37,8.40E-01,37GOTERM_BP_5,RNA splicing,6.20E-07,176,3.70E-08,178,7.20E-08,199,1.80E-02,134,5.00E-08,195,3.30E-06,175,2.60E-06,169GOTERM_BP_5,protein import,3.10E-03,79,1.70E-03,79,7.00E-05,94,1.10E-03,72,3.10E-03,86,8.70E-02,72,1.60E-03,78GOTERM_BP_5,regulation of translation,5.60E-03,81,5.20E-03,80,8.60E-04,94,8.50E-02,65,7.80E-02,82,8.00E-05,89,8.10E-03,78GOTERM_BP_5,fatty acid catabolic process,2.10E-03,27,1.10E-07,33,5.70E-05,32,2.20E-08,32,2.50E-05,32,2.00E-06,32,8.40E-05,29GOTERM_BP_5,dephosphorylation,7.00E-01,71,5.60E-01,72,4.00E-02,96,7.50E-01,60,3.60E-01,85,1.80E-01,81,5.50E-01,71GOTERM_BP_5,protein heterooligomerization,1.10E-03,37,1.70E-01,29,2.10E-02,37,1.10E-01,27,5.20E-03,38,3.30E-02,33,1.50E-02,33GOTERM_BP_5,negative regulation of signal transduction,2.80E-02,120,1.50E-02,120,3.50E-02,135,5.00E-03,110,2.90E-02,132,4.30E-02,120,5.60E-03,121GOTERM_BP_5,regulation of T cell activation,1.00E+00,43,9.00E-01,49,3.70E-01,67,6.50E-01,47,9.90E-01,50,8.00E-01,53,7.70E-01,51GOTERM_BP_5,cation transport,3.30E-01,268,7.60E-01,250,8.20E-01,292,6.10E-01,223,5.40E-01,292,8.20E-01,256,7.00E-01,248GOTERM_BP_5,heart development,7.10E-01,99,5.20E-01,101,6.90E-01,115,4.90E-01,89,1.30E-01,123,1.90E-01,111,2.70E-01,104GOTERM_BP_5,negative regulation of cell communication,4.40E-02,132,1.80E-02,133,5.30E-02,149,5.10E-03,122,2.90E-02,147,3.90E-02,134,6.50E-03,134GOTERM_BP_5,regulation of nucleocytoplasmic transport,3.90E-01,30,7.40E-01,26,4.00E-01,34,9.10E-01,20,8.60E-01,28,6.30E-01,28,5.00E-01,28GOTERM_BP_5,response to nutrient,4.80E-01,68,2.50E-02,78,1.10E-01,85,4.80E-02,68,3.30E-01,78,1.80E-01,74,2.70E-01,69GOTERM_BP_5,monosaccharide catabolic process,7.80E-02,41,2.00E-01,38,1.20E-01,45,3.30E-02,38,1.50E-02,48,1.40E-01,40,7.30E-02,40GOTERM_BP_5,pyridine nucleotide metabolic process,1.20E-04,33,9.00E-04,31,7.80E-03,32,1.40E-01,22,2.40E-02,30,4.80E-02,27,1.80E-03,30GOTERM_BP_5,positive regulation of cell proliferation,4.30E-01,199,7.50E-01,187,3.40E-01,231,2.60E-01,176,9.40E-01,204,6.10E-01,197,7.10E-01,185GOTERM_BP_5,metal ion transport,5.50E-01,220,8.40E-01,207,7.60E-01,247,8.20E-01,181,7.10E-01,241,8.60E-01,213,7.40E-01,207GOTERM_BP_5,cell redox homeostasis,3.30E-03,42,9.20E-04,43,7.60E-04,48,5.80E-03,37,3.20E-02,42,8.60E-04,44,1.40E-03,42GOTERM_BP_5,muscle cell development,9.10E-01,23,5.50E-01,27,7.90E-01,29,9.30E-01,19,9.10E-02,36,7.30E-01,26,9.10E-01,22GOTERM_BP_5,spermatogenesis,5.90E-01,145,1.40E-01,154,7.60E-01,163,5.30E-01,126,7.20E-01,159,9.30E-01,136,3.70E-01,145GOTERM_BP_5,regulation of inflammatory response,7.80E-01,34,6.60E-01,35,2.30E-01,46,1.40E-01,37,5.50E-01,41,5.10E-02,45,6.10E-01,35GOTERM_BP_5,protein homooligomerization,8.70E-02,53,5.20E-03,58,1.90E-03,67,1.20E-02,51,1.30E-03,66,6.70E-03,59,4.20E-04,61GOTERM_BP_5,regulation of cell morphogenesis,5.30E-01,63,2.00E-01,67,9.50E-03,86,3.30E-02,65,2.70E-01,74,1.20E-01,71,1.20E-01,68GOTERM_BP_5,hexose catabolic process,7.70E-02,40,2.00E-01,37,1.10E-01,44,3.40E-02,37,2.40E-02,46,2.00E-01,38,1.10E-01,38GOTERM_BP_5,lipid modification,4.20E-03,45,9.80E-06,51,6.70E-04,52,3.00E-05,46,6.20E-04,51,2.20E-04,49,1.80E-03,45GOTERM_BP_5,angiogenesis,1.40E-01,78,7.20E-02,79,3.40E-02,93,3.40E-01,64,1.40E-01,86,1.40E-01,79,3.70E-01,71GOTERM_BP_5,cellular amine metabolic process,7.20E-06,183,4.10E-05,177,6.70E-05,200,1.10E-04,157,1.10E-04,194,1.20E-05,184,4.30E-06,179GOTERM_BP_5,steroid metabolic process,1.00E-01,106,1.00E-03,117,1.60E-03,132,2.60E-03,103,1.10E-02,124,2.50E-03,118,2.70E-04,118GOTERM_BP_5,response to estrogen stimulus,7.90E-01,47,3.60E-01,52,3.20E-01,61,5.90E-02,52,7.10E-01,54,5.60E-01,51,6.10E-01,48GOTERM_BP_5,positive regulation of cell differentiation,8.50E-01,102,7.40E-01,103,3.70E-03,146,1.20E-01,103,7.20E-01,118,3.50E-01,114,2.50E-01,111GOTERM_BP_5,positive regulation of hydrolase activity,9.00E-02,95,3.10E-02,97,1.10E-01,107,1.50E-01,81,2.70E-01,100,9.40E-02,96,3.40E-01,86GOTERM_BP_5,fatty acid oxidation,4.60E-03,28,1.30E-07,35,6.80E-05,34,1.30E-07,33,1.30E-04,33,1.10E-05,33,1.60E-05,32GOTERM_BP_5,lipid oxidation,4.60E-03,28,1.30E-07,35,6.80E-05,34,1.30E-07,33,1.30E-04,33,1.10E-05,33,1.60E-05,32GOTERM_BP_5,nucleocytoplasmic transport,2.90E-02,87,2.50E-01,78,5.50E-03,102,6.80E-03,80,4.90E-02,94,2.70E-01,80,4.80E-02,83GOTERM_BP_5,regulation of intracellular protein transport,4.50E-01,27,9.20E-01,21,6.50E-01,29,9.60E-01,17,8.90E-01,25,7.90E-01,24,6.80E-01,24GOTERM_BP_5,cellular carbohydrate catabolic process,8.40E-02,48,9.40E-02,47,5.60E-02,55,1.40E-02,46,1.70E-02,56,1.00E-01,48,4.60E-02,48GOTERM_BP_5,T cell activation,9.90E-01,49,9.00E-01,53,9.00E-01,63,9.40E-01,44,9.80E-01,56,9.70E-01,51,9.80E-01,48GOTERM_BP_5,oxidoreduction coenzyme metabolic process,1.20E-05,41,8.50E-05,39,1.80E-03,40,6.50E-02,28,5.20E-03,38,8.20E-03,35,4.90E-04,37GOTERM_BP_5,positive regulation of cytoskeleton organization,8.70E-01,19,4.30E-01,23,8.80E-01,22,1.00E-01,24,7.50E-01,23,6.20E-01,22,6.20E-01,21GOTERM_BP_5,organ morphogenesis,9.40E-01,250,9.70E-01,241,1.00E+00,#N/A,9.50E-01,212,9.70E-01,277,9.50E-01,253,9.90E-01,230GOTERM_BP_5,nuclear transport,4.10E-02,87,3.10E-01,78,9.40E-03,102,1.00E-02,80,7.00E-02,94,3.30E-01,80,6.60E-02,83GOTERM_BP_5,regulation of cell migration,7.00E-01,78,1.40E-01,87,6.90E-02,103,6.90E-01,67,7.10E-01,87,7.00E-01,79,8.50E-01,72GOTERM_BP_5,negative regulation of transport,9.30E-01,57,7.60E-01,60,4.30E-01,76,6.60E-01,54,8.80E-01,66,5.10E-01,66,7.10E-01,60GOTERM_BP_5,protein localization in organelle,3.00E-03,87,7.00E-03,84,2.00E-03,98,5.30E-03,76,2.80E-03,95,7.70E-02,80,1.00E-02,82GOTERM_BP_5,regulation of protein kinase cascade,8.30E-02,130,1.10E-02,135,2.70E-02,152,1.20E-03,126,5.90E-02,145,4.80E-03,141,4.90E-02,128GOTERM_BP_5,negative regulation of cell motion,1.20E-01,36,8.90E-01,26,9.20E-02,41,7.90E-01,24,7.60E-01,32,7.50E-01,29,5.20E-01,30GOTERM_BP_5,regulation of angiogenesis,2.50E-01,34,3.70E-01,32,3.80E-01,37,2.30E-01,30,6.70E-01,33,5.70E-01,31,4.20E-01,31GOTERM_BP_5,actomyosin structure organization,1.00E+00,#N/A,8.30E-01,12,6.10E-01,16,1.00E+00,#N/A,1.50E-01,19,6.30E-01,14,1.00E+00,#N/AGOTERM_BP_5,mitochondrial transport,3.70E-04,48,8.30E-05,49,2.60E-04,53,5.40E-03,40,6.20E-04,51,2.20E-04,49,7.70E-03,43GOTERM_BP_5,cellular amino acid metabolic process,1.80E-05,139,3.40E-05,136,1.50E-04,151,8.70E-05,121,3.00E-04,146,2.00E-06,144,1.90E-06,139GOTERM_BP_5,negative regulation of cell cycle,1.20E-01,45,3.30E-01,41,2.20E-01,49,9.30E-01,28,2.00E-01,48,3.50E-01,42,2.80E-01,41GOTERM_BP_5,regulation of adaptive immune response,7.00E-01,26,9.60E-01,21,6.10E-01,31,7.30E-01,22,9.50E-01,25,9.90E-01,20,9.90E-01,19GOTERM_BP_5,cell morphogenesis,8.00E-01,162,6.20E-01,164,1.00E-01,207,5.00E-01,146,6.80E-01,185,5.50E-01,171,5.40E-01,163GOTERM_BP_5,endocytosis,9.20E-01,95,8.80E-01,95,5.10E-01,121,4.30E-01,92,9.00E-01,108,7.90E-01,101,9.30E-01,91GOTERM_BP_5,muscle fiber development,7.50E-01,16,6.00E-01,17,5.80E-01,20,7.20E-01,14,3.60E-01,21,7.80E-01,16,6.90E-01,16GOTERM_BP_5,regulation of establishment of protein localization,6.90E-01,56,8.50E-01,52,8.40E-01,62,9.50E-01,42,9.40E-01,57,7.90E-01,55,9.20E-01,49GOTERM_BP_5,lymphocyte proliferation,8.50E-01,18,7.30E-01,19,8.50E-01,21,9.60E-01,13,9.30E-01,19,9.80E-01,15,9.80E-01,14GOTERM_BP_5,ER to Golgi vesicle-mediated transport,4.20E-04,32,2.50E-03,30,1.00E-03,34,1.00E-02,26,4.80E-02,29,1.70E-03,31,4.80E-03,29GOTERM_BP_5,"di-, tri-valent inorganic cation transport",8.10E-01,79,5.10E-01,83,9.00E-01,89,7.30E-01,69,4.60E-01,95,8.50E-01,79,7.70E-01,77GOTERM_BP_5,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7.50E-01,25,9.70E-01,20,6.50E-01,30,7.80E-01,21,9.60E-01,24,9.90E-01,19,9.90E-01,18GOTERM_BP_5,regulation of actin filament depolymerization,5.40E-01,14,5.00E-01,14,3.80E-01,17,5.70E-01,12,1.00E-01,19,4.10E-01,15,4.70E-01,14GOTERM_BP_5,ion homeostasis,6.90E-01,190,7.70E-01,184,8.70E-01,213,7.50E-01,161,7.00E-01,212,9.10E-01,184,7.70E-01,181GOTERM_BP_5,Golgi vesicle transport,5.30E-04,82,3.10E-05,85,7.00E-05,94,1.60E-04,75,5.30E-04,89,1.30E-05,88,2.60E-04,81GOTERM_BP_5,regulation of protein transport,6.70E-01,53,9.20E-01,47,8.90E-01,57,9.70E-01,38,9.70E-01,52,8.80E-01,50,9.20E-01,46GOTERM_BP_5,negative regulation of protein complex disassembly,4.80E-01,21,1.40E-01,24,2.50E-01,26,5.20E-01,18,3.20E-02,29,2.80E-01,23,2.90E-01,22GOTERM_BP_5,regulation of cyclin-dependent protein kinase activity,2.90E-01,29,1.70E-01,30,1.30E-01,35,3.30E-01,25,6.10E-01,29,3.30E-01,29,1.50E-01,30GOTERM_BP_5,negative regulation of transferase activity,4.80E-02,55,5.20E-02,54,9.90E-02,60,3.70E-01,42,4.30E-01,53,9.10E-02,54,2.20E-01,49GOTERM_BP_5,kidney development,7.90E-01,43,8.00E-01,42,5.60E-01,53,6.20E-01,39,9.50E-01,44,8.70E-01,42,8.60E-01,40GOTERM_BP_5,organ regeneration,1.00E-01,17,5.90E-01,13,6.00E-01,15,3.50E-01,13,8.10E-01,13,6.50E-01,13,8.20E-01,11GOTERM_BP_5,response to monosaccharide stimulus,8.60E-01,20,4.20E-01,24,2.00E-01,30,9.50E-02,25,1.40E-01,30,1.90E-01,27,6.10E-01,22GOTERM_BP_5,regulation of insulin secretion,5.50E-01,20,3.80E-01,21,2.90E-01,25,2.30E-01,20,5.80E-01,22,1.50E-01,24,5.90E-01,19GOTERM_BP_5,establishment of vesicle localization,8.70E-02,21,1.50E-02,23,3.00E-01,21,2.30E-01,17,1.40E-01,22,1.70E-01,20,3.10E-01,18GOTERM_BP_5,hemopoiesis,9.80E-01,98,9.40E-01,99,8.80E-01,121,9.70E-01,83,9.90E-01,108,1.00E+00,95,1.00E+00,86GOTERM_BP_5,bone development,8.90E-01,53,6.10E-01,57,2.00E-01,73,6.00E-01,50,5.30E-01,66,6.00E-01,59,8.00E-01,53GOTERM_BP_5,regulation of lymphocyte proliferation,9.80E-01,31,9.90E-01,29,7.20E-01,44,9.50E-01,28,9.90E-01,34,7.60E-01,38,8.30E-01,35GOTERM_BP_5,interphase,1.10E-01,58,1.40E-02,62,1.60E-02,70,3.10E-02,54,2.40E-01,61,3.70E-01,54,4.10E-01,51GOTERM_BP_5,response to lipopolysaccharide,3.10E-01,40,1.30E-02,47,1.60E-03,56,1.10E-01,38,8.80E-02,48,1.00E-01,44,4.60E-03,48GOTERM_BP_5,neuron projection development,1.40E-01,131,8.90E-02,131,7.30E-03,160,8.80E-02,116,2.40E-01,142,1.60E-01,132,1.70E-01,126GOTERM_BP_5,cell part morphogenesis,7.30E-02,134,8.90E-02,131,2.00E-02,157,2.40E-01,111,2.90E-01,141,1.90E-01,131,1.40E-01,127GOTERM_BP_5,"nucleobase, nucleoside and nucleotide biosynthetic process",9.90E-04,114,7.50E-02,101,1.40E-01,114,9.00E-03,96,7.90E-02,113,9.50E-02,103,4.80E-02,101GOTERM_BP_5,"nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process",9.90E-04,114,7.50E-02,101,1.40E-01,114,9.00E-03,96,7.90E-02,113,9.50E-02,103,4.80E-02,101GOTERM_BP_5,striated muscle contraction,9.90E-01,15,9.60E-01,17,1.00E+00,#N/A,7.40E-01,18,7.90E-01,23,9.10E-01,19,9.90E-01,15GOTERM_BP_5,positive regulation of cell activation,1.00E+00,40,1.00E+00,38,8.30E-01,57,9.50E-01,38,1.00E+00,43,9.00E-01,48,9.60E-01,43GOTERM_BP_5,cytoskeleton-dependent intracellular transport,7.20E-01,24,6.70E-01,24,4.80E-01,30,9.70E-01,16,6.00E-01,28,6.50E-01,25,9.90E-01,17GOTERM_BP_5,hemopoietic or lymphoid organ development,9.60E-01,110,9.00E-01,112,8.40E-01,135,9.70E-01,92,9.90E-01,121,9.90E-01,107,1.00E+00,97GOTERM_BP_5,neurogenesis,3.90E-01,289,1.90E-01,291,1.30E-02,355,1.90E-01,256,3.50E-01,323,2.40E-01,298,3.90E-01,279GOTERM_BP_5,regulation of endothelial cell proliferation,6.00E-02,21,9.00E-03,23,7.20E-02,23,1.00E-01,18,9.90E-02,22,7.00E-02,21,8.30E-02,20GOTERM_BP_5,spindle organization,1.00E-01,27,1.90E-03,32,1.00E-03,36,6.60E-03,28,1.40E-03,35,1.90E-02,30,1.80E-02,29GOTERM_BP_5,purine nucleotide biosynthetic process,2.80E-02,83,3.20E-01,73,2.60E-01,86,8.10E-03,76,1.40E-01,86,1.80E-01,78,2.10E-01,74GOTERM_BP_5,regulation of lymphocyte activation,1.00E+00,55,9.80E-01,58,5.00E-01,82,8.30E-01,56,1.00E+00,62,8.60E-01,66,9.10E-01,61GOTERM_BP_5,negative regulation of neuron apoptosis,3.60E-02,32,1.40E-01,29,5.20E-02,35,8.70E-02,27,9.70E-02,33,1.90E-01,29,4.00E-02,31GOTERM_BP_5,negative regulation of actin filament depolymerization,6.30E-01,12,4.40E-01,13,4.30E-01,15,5.40E-01,11,1.20E-01,17,5.00E-01,13,5.70E-01,12GOTERM_BP_5,negative regulation of cell migration,3.40E-01,30,8.50E-01,24,1.20E-01,37,9.00E-01,20,8.30E-01,28,8.40E-01,25,6.60E-01,26GOTERM_BP_5,acetyl-CoA metabolic process,2.10E-03,24,1.60E-03,24,5.60E-04,27,6.10E-03,21,5.70E-05,28,2.70E-03,24,3.10E-04,25GOTERM_BP_5,regulation of cytoskeleton organization,9.40E-01,57,4.70E-01,65,7.80E-01,71,5.50E-01,56,6.50E-01,71,7.40E-01,63,7.30E-01,60GOTERM_BP_5,interphase of mitotic cell cycle,8.80E-02,57,5.90E-03,62,3.00E-02,67,2.60E-02,53,2.60E-01,59,2.70E-01,54,3.80E-01,50GOTERM_BP_5,protein import into nucleus,1.00E-01,48,2.90E-01,44,4.60E-02,56,4.80E-02,44,1.30E-01,52,7.20E-01,40,8.70E-02,47GOTERM_BP_5,muscle tissue development,9.80E-01,49,8.80E-01,53,8.80E-01,63,5.90E-01,51,1.20E-01,74,3.90E-01,63,8.80E-01,52GOTERM_BP_5,regulation of DNA metabolic process,5.30E-01,55,4.60E-01,55,3.60E-02,73,2.70E-01,51,4.70E-01,62,8.80E-01,50,9.20E-01,46GOTERM_BP_5,cellular response to nutrient levels,2.10E-02,29,7.10E-03,30,2.20E-01,28,1.30E-01,23,2.70E-02,31,6.80E-01,21,2.30E-01,24GOTERM_BP_5,positive regulation of lymphocyte activation,9.80E-01,37,9.80E-01,36,5.30E-01,54,8.90E-01,35,1.00E+00,39,7.90E-01,44,8.80E-01,40GOTERM_BP_5,regulation of striated muscle tissue development,4.80E-02,31,1.70E-01,28,2.60E-01,31,2.60E-01,24,4.90E-01,28,3.30E-01,27,1.50E-01,28GOTERM_BP_5,cellular response to insulin stimulus,2.10E-01,37,1.70E-01,37,1.80E-02,47,4.50E-02,36,3.50E-01,39,7.50E-02,40,2.70E-01,35GOTERM_BP_5,G1/S transition of mitotic cell cycle,8.90E-02,33,7.00E-02,33,2.90E-01,34,1.50E-01,28,3.00E-01,33,4.30E-01,29,7.10E-01,25GOTERM_BP_5,response to hydrogen peroxide,9.10E-01,23,3.40E-01,29,7.90E-01,29,7.30E-01,22,8.60E-01,27,6.40E-01,27,8.60E-01,23GOTERM_BP_5,regulation of DNA replication,8.30E-01,27,1.10E-01,35,7.00E-02,41,3.60E-01,28,4.20E-01,35,8.60E-01,27,8.30E-01,26GOTERM_BP_5,respiratory tube development,2.00E-01,54,2.00E-01,53,3.60E-02,66,1.10E-01,49,1.60E-02,66,9.30E-02,57,1.20E-01,54GOTERM_BP_5,morphogenesis of an epithelium,8.80E-02,56,4.50E-01,49,3.80E-01,58,3.80E-01,44,4.80E-01,55,6.50E-01,48,3.90E-01,49GOTERM_BP_5,positive regulation of transport,1.40E-01,115,6.10E-01,103,7.50E-01,118,8.60E-02,102,8.30E-01,112,6.20E-01,106,6.20E-01,101GOTERM_BP_5,regulation of mononuclear cell proliferation,9.90E-01,31,9.90E-01,29,7.60E-01,44,9.60E-01,28,1.00E+00,34,7.90E-01,38,8.60E-01,35GOTERM_BP_5,regulation of leukocyte proliferation,9.90E-01,31,9.90E-01,29,7.60E-01,44,9.60E-01,28,1.00E+00,34,7.90E-01,38,8.60E-01,35GOTERM_BP_5,positive regulation of leukocyte activation,1.00E+00,38,1.00E+00,37,7.90E-01,55,9.30E-01,37,1.00E+00,42,8.50E-01,47,9.40E-01,42GOTERM_BP_5,amine catabolic process,2.60E-05,56,3.70E-05,55,5.40E-04,58,1.50E-04,49,4.50E-03,54,4.20E-05,56,7.60E-07,58GOTERM_BP_5,gut development,1.20E-01,22,7.70E-01,16,2.60E-01,23,2.60E-01,18,6.90E-01,19,4.70E-01,19,4.90E-01,18GOTERM_BP_5,positive regulation of macromolecule metabolic process,7.70E-01,396,2.90E-01,407,5.80E-02,490,2.60E-01,358,7.30E-01,445,5.60E-01,410,3.00E-01,400GOTERM_BP_5,protein maturation,1.40E-01,65,1.50E-02,70,9.70E-02,75,1.80E-01,56,4.70E-02,75,3.40E-02,70,1.10E-01,64GOTERM_BP_5,purine ribonucleotide metabolic process,5.60E-02,76,5.40E-01,65,4.70E-01,77,5.00E-02,67,2.10E-01,79,2.30E-01,72,2.70E-01,68GOTERM_BP_5,response to insulin stimulus,4.80E-01,49,3.40E-01,50,7.60E-02,63,8.00E-02,49,4.40E-01,55,1.80E-01,54,5.10E-01,47GOTERM_BP_5,negative regulation of intracellular transport,6.50E-01,11,7.70E-01,10,7.40E-01,12,1.00E+00,#N/A,5.20E-01,13,8.10E-01,10,5.90E-01,11GOTERM_BP_5,negative regulation of mitotic cell cycle,3.20E-01,13,4.50E-01,12,2.60E-01,15,1.00E+00,#N/A,2.10E-01,15,5.10E-01,12,1.50E-01,14GOTERM_BP_5,phospholipid catabolic process,3.90E-02,16,2.90E-01,13,2.40E-02,18,1.30E-01,13,2.10E-01,15,3.40E-01,13,1.50E-01,14GOTERM_BP_5,actin filament capping,6.50E-01,11,6.20E-01,11,5.80E-01,13,4.00E-01,11,2.10E-01,15,6.70E-01,11,5.90E-01,11GOTERM_BP_5,lung alveolus development,3.20E-01,13,6.20E-01,11,4.10E-01,14,1.30E-01,13,3.50E-01,14,3.40E-01,13,2.70E-01,13GOTERM_BP_5,osteoblast differentiation,1.30E-01,25,2.70E-01,23,3.90E-02,30,6.80E-01,17,4.60E-01,24,1.50E-01,25,2.50E-02,27GOTERM_BP_5,negative regulation of T cell activation,7.70E-01,19,6.20E-01,20,7.40E-02,29,4.40E-01,19,7.00E-01,22,5.80E-01,21,4.60E-01,21GOTERM_BP_5,positive regulation of endocytosis,6.70E-01,14,9.70E-01,10,6.90E-01,16,6.80E-01,12,9.20E-01,13,7.00E-01,14,1.00E+00,#N/AGOTERM_BP_5,porphyrin metabolic process,5.40E-03,22,1.20E-02,21,3.70E-02,22,1.50E-01,16,9.20E-03,23,6.50E-03,22,9.10E-04,23GOTERM_BP_5,regulation of cell shape,6.10E-01,26,7.60E-01,24,4.90E-01,31,3.30E-01,25,7.10E-01,28,4.30E-01,28,3.00E-01,28GOTERM_BP_5,lung development,2.30E-01,52,1.80E-01,52,4.00E-02,64,9.90E-02,48,1.80E-02,64,7.70E-02,56,6.90E-02,54GOTERM_BP_5,T cell differentiation,1.00E+00,20,8.80E-01,27,8.90E-01,32,9.80E-01,20,9.90E-01,27,9.70E-01,25,9.40E-01,25GOTERM_BP_5,negative regulation of organelle organization,6.10E-01,39,3.70E-01,41,1.90E-01,50,2.30E-01,38,8.20E-02,51,1.70E-01,45,1.80E-01,43GOTERM_BP_5,cell projection morphogenesis,1.30E-01,126,1.60E-01,123,5.70E-02,147,3.50E-01,104,4.30E-01,132,3.40E-01,122,2.30E-01,119GOTERM_BP_5,response to UV,4.40E-01,30,1.40E-01,33,1.30E-02,42,5.50E-01,25,2.70E-01,35,3.70E-01,31,1.70E-01,32GOTERM_BP_5,cellular chemical homeostasis,7.00E-01,176,5.80E-01,176,7.50E-01,202,7.70E-01,149,6.60E-01,198,8.40E-01,174,5.80E-01,173GOTERM_BP_5,liver development,5.60E-01,26,2.10E-01,29,5.40E-01,30,2.00E-01,26,1.60E-01,33,8.00E-02,32,4.60E-01,26GOTERM_BP_5,positive regulation of T cell activation,9.70E-01,29,9.10E-01,31,4.90E-01,43,7.10E-01,30,9.90E-01,31,6.70E-01,36,7.70E-01,33GOTERM_BP_5,skeletal muscle fiber development,7.40E-01,13,7.10E-01,13,8.50E-01,14,6.30E-01,12,5.40E-01,16,7.70E-01,13,8.10E-01,12GOTERM_BP_5,actin filament bundle formation,1.00E+00,#N/A,1.00E+00,#N/A,6.60E-01,12,5.00E-01,10,6.00E-01,12,6.00E-01,11,5.10E-01,11GOTERM_BP_5,digestive tract morphogenesis,7.30E-01,10,7.10E-01,10,3.20E-01,14,5.00E-01,10,7.50E-01,11,4.20E-01,12,3.40E-01,12GOTERM_BP_5,endoplasmic reticulum unfolded protein response,5.90E-02,15,1.10E-01,14,1.80E-01,15,1.90E-01,12,1.40E-01,15,6.60E-02,15,1.00E-01,14GOTERM_BP_5,myofibril assembly,1.00E+00,#N/A,7.10E-01,10,8.00E-01,11,1.00E+00,#N/A,6.50E-02,16,7.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,cellular response to unfolded protein,5.90E-02,15,1.10E-01,14,1.80E-01,15,1.90E-01,12,1.40E-01,15,6.60E-02,15,1.00E-01,14GOTERM_BP_5,integrin-mediated signaling pathway,7.30E-01,32,8.30E-01,30,4.60E-01,40,5.90E-01,29,9.00E-01,33,5.00E-01,35,8.00E-01,30GOTERM_BP_5,lymphocyte mediated immunity,9.40E-01,28,3.10E-01,36,6.50E-01,38,5.90E-01,29,7.90E-01,35,5.00E-01,35,9.10E-01,28GOTERM_BP_5,protein folding,1.30E-03,105,2.00E-04,107,5.70E-04,119,1.40E-03,93,5.70E-05,120,1.40E-03,106,8.60E-03,98GOTERM_BP_5,neuron projection morphogenesis,1.10E-01,111,1.80E-01,107,2.10E-02,132,3.40E-01,91,4.90E-01,114,3.70E-01,106,2.30E-01,104GOTERM_BP_5,regulation of metal ion transport,7.30E-01,37,7.60E-01,36,8.50E-01,41,6.20E-01,33,9.20E-01,38,8.30E-01,36,6.30E-01,37GOTERM_BP_5,striated muscle tissue development,9.60E-01,48,8.90E-01,50,1.00E+00,#N/A,6.30E-01,48,1.90E-01,69,4.60E-01,59,8.10E-01,51GOTERM_BP_5,"protein import into nucleus, translocation",3.10E-01,19,4.00E-01,18,2.50E-01,22,4.00E-01,16,5.60E-01,19,9.00E-01,14,5.00E-01,17GOTERM_BP_5,protein targeting to mitochondrion,4.90E-04,27,1.70E-05,29,1.40E-04,30,1.00E-02,22,1.20E-03,28,6.40E-04,27,2.90E-03,25GOTERM_BP_5,endosome transport,8.50E-01,25,4.40E-01,29,6.10E-01,32,7.10E-01,23,5.10E-01,32,4.20E-01,30,6.00E-01,27GOTERM_BP_5,ribonucleotide biosynthetic process,3.70E-02,70,3.60E-01,61,4.30E-01,70,2.10E-02,63,1.30E-01,73,1.40E-01,67,2.40E-01,62GOTERM_BP_5,regulation of leukocyte activation,1.00E+00,59,1.00E+00,62,8.20E-01,86,9.20E-01,60,1.00E+00,69,9.20E-01,72,9.60E-01,66GOTERM_BP_5,biopolymer methylation,5.10E-01,34,9.30E-02,39,2.60E-02,47,2.00E-01,33,2.40E-02,46,1.40E-01,39,2.60E-02,41GOTERM_BP_5,coenzyme biosynthetic process,1.40E-04,49,1.10E-02,43,1.40E-02,48,2.70E-01,32,6.90E-02,44,1.10E-02,44,2.60E-02,41GOTERM_BP_5,cellular carbohydrate biosynthetic process,3.70E-04,48,5.60E-03,44,2.60E-02,47,1.90E-02,38,1.30E-02,47,2.70E-03,46,4.50E-02,40GOTERM_BP_5,blood coagulation,9.60E-01,41,5.70E-01,48,2.80E-01,60,7.70E-02,50,8.90E-01,49,6.80E-01,48,5.80E-01,47GOTERM_BP_5,positive regulation of cellular metabolic process,7.70E-01,407,3.60E-01,415,4.90E-02,504,2.90E-01,366,7.70E-01,455,6.10E-01,419,3.40E-01,409GOTERM_BP_5,positive regulation of protein catabolic process,3.30E-02,19,6.30E-02,18,1.40E-01,19,1.60E-02,18,1.00E-01,19,1.50E-02,20,2.60E-03,21GOTERM_BP_5,tissue morphogenesis,4.70E-01,87,7.80E-01,80,5.90E-01,98,6.50E-01,72,6.40E-01,94,6.00E-01,86,7.60E-01,79GOTERM_BP_5,spermatid differentiation,8.80E-01,24,6.00E-01,27,8.30E-01,29,9.40E-01,19,3.50E-01,33,8.40E-01,25,4.50E-01,28GOTERM_BP_5,purine nucleotide catabolic process,4.30E-02,22,3.40E-01,18,1.90E-01,22,1.40E-01,18,2.30E-01,21,9.90E-02,21,6.00E-02,21GOTERM_BP_5,germ cell development,7.40E-01,46,6.80E-01,46,8.60E-01,51,8.20E-01,38,4.00E-01,56,8.40E-01,45,8.20E-01,43GOTERM_BP_5,cellular amino acid catabolic process,2.10E-04,48,4.60E-05,49,9.20E-04,51,8.00E-04,42,1.70E-02,46,4.40E-05,50,8.70E-06,50GOTERM_BP_5,protein tetramerization,1.60E-03,29,2.00E-02,26,1.00E-03,32,8.90E-04,27,1.20E-02,29,2.10E-03,29,8.40E-04,29GOTERM_BP_5,regulation of muscle cell differentiation,2.50E-01,22,7.00E-01,18,4.70E-01,23,1.90E-01,20,5.10E-01,22,7.60E-01,18,1.20E-01,23GOTERM_BP_5,anion transport,8.80E-01,62,7.40E-01,64,3.90E-01,81,8.30E-01,54,8.00E-01,72,6.30E-01,68,7.40E-01,63GOTERM_BP_5,generation of neurons,2.60E-01,273,2.20E-01,270,3.90E-02,326,1.00E-01,243,3.40E-01,301,2.00E-01,279,3.20E-01,262GOTERM_BP_5,B cell mediated immunity,9.10E-01,23,3.40E-01,29,5.00E-01,32,5.20E-01,24,8.60E-01,27,4.30E-01,29,8.60E-01,23GOTERM_BP_5,stem cell development,4.70E-01,14,5.90E-01,13,4.50E-01,16,6.60E-01,11,5.30E-01,15,3.40E-01,15,5.50E-01,13GOTERM_BP_5,cholesterol biosynthetic process,2.00E-02,19,1.60E-02,19,1.60E-02,21,2.50E-02,17,1.00E-02,21,8.20E-03,20,2.60E-04,22GOTERM_BP_5,coenzyme catabolic process,2.00E-02,19,4.00E-02,18,1.60E-02,21,2.50E-02,17,2.90E-03,22,5.60E-02,18,1.30E-02,19GOTERM_BP_5,positive regulation of angiogenesis,1.90E-01,16,2.90E-01,15,6.00E-01,15,1.20E-01,15,6.80E-01,14,4.90E-01,14,2.60E-01,15GOTERM_BP_5,regulation of striated muscle cell differentiation,2.00E-01,19,5.50E-01,16,4.90E-01,19,4.20E-01,15,5.50E-01,18,7.40E-01,15,2.50E-01,18GOTERM_BP_5,regulation of insulin receptor signaling pathway,2.40E-01,12,3.80E-01,11,1.60E-01,14,1.00E+00,#N/A,6.00E-01,11,1.40E-01,13,5.30E-01,10GOTERM_BP_5,regulation of endocytosis,8.00E-01,27,8.40E-01,26,4.70E-01,35,3.20E-01,28,8.30E-01,30,6.70E-01,29,9.20E-01,24GOTERM_BP_5,regulation of muscle contraction,7.20E-01,33,6.70E-01,33,8.70E-01,36,2.20E-01,34,3.60E-01,41,5.00E-01,36,8.50E-01,30GOTERM_BP_5,response to calcium ion,4.40E-01,28,8.90E-02,32,2.40E-01,34,4.80E-01,24,6.60E-01,29,1.30E-01,32,5.60E-01,26GOTERM_BP_5,"regulation of gene expression, epigenetic",3.10E-01,40,6.10E-02,44,9.90E-02,49,3.00E-01,35,1.30E-01,47,1.00E-01,44,3.80E-01,38GOTERM_BP_5,regulation of cell morphogenesis involved in differentiation,5.80E-01,37,9.40E-02,43,3.50E-03,55,4.70E-02,40,1.90E-01,46,1.50E-01,43,2.20E-01,40GOTERM_BP_5,protein polymerization,8.50E-01,21,8.60E-02,29,3.00E-01,30,3.20E-01,23,2.40E-03,37,8.00E-01,22,7.00E-01,22GOTERM_BP_5,tissue development,1.00E+00,275,1.00E+00,267,1.00E+00,#N/A,9.40E-01,252,9.50E-01,331,9.80E-01,293,1.00E+00,270GOTERM_BP_5,positive regulation of protein polymerization,8.20E-01,11,6.70E-01,12,8.00E-01,13,8.70E-02,15,6.10E-01,14,7.20E-01,12,7.80E-01,11GOTERM_BP_5,negative regulation of cell cycle process,3.00E-02,18,1.20E-01,16,2.20E-02,20,1.70E-01,14,1.50E-02,20,4.00E-03,20,5.00E-02,17GOTERM_BP_5,stem cell maintenance,5.50E-01,13,6.70E-01,12,5.20E-01,15,7.50E-01,10,6.10E-01,14,4.20E-01,14,6.40E-01,12GOTERM_BP_5,NAD metabolic process,3.00E-02,18,2.40E-02,18,2.20E-02,20,1.00E+00,#N/A,3.00E-01,16,1.60E-01,16,1.10E-01,16GOTERM_BP_5,positive regulation of adaptive immune response,7.80E-01,14,4.80E-01,16,6.90E-01,17,3.70E-01,15,7.50E-01,16,8.90E-01,13,7.20E-01,14GOTERM_BP_5,monosaccharide biosynthetic process,4.00E-04,29,2.90E-03,27,1.60E-02,28,6.60E-03,24,9.60E-03,28,5.30E-04,29,3.20E-02,24GOTERM_BP_5,lymphocyte differentiation,9.80E-01,40,8.00E-01,45,8.70E-01,52,9.50E-01,35,9.90E-01,44,9.70E-01,41,9.80E-01,38GOTERM_BP_5,neuron development,2.80E-01,167,2.20E-01,166,6.00E-02,200,2.90E-01,144,5.10E-01,180,3.30E-01,168,2.60E-01,162GOTERM_BP_5,regulation of lymphocyte mediated immunity,9.50E-01,21,1.00E+00,16,1.00E+00,#N/A,9.80E-01,16,1.00E+00,20,1.00E+00,17,1.00E+00,15GOTERM_BP_5,spermatid development,9.20E-01,22,6.60E-01,25,8.60E-01,27,9.40E-01,18,3.90E-01,31,8.80E-01,23,5.10E-01,26GOTERM_BP_5,DNA replication,1.30E-01,99,1.80E-02,104,1.90E-02,119,3.40E-02,91,8.70E-02,111,1.40E-01,100,9.90E-02,97GOTERM_BP_5,regulation of mesenchymal cell proliferation,1.00E+00,#N/A,1.00E+00,#N/A,3.70E-01,12,1.00E+00,#N/A,6.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of endothelial cell proliferation,1.70E-01,12,6.80E-02,13,3.70E-02,15,2.80E-01,10,1.70E-01,13,8.70E-02,13,1.40E-01,12GOTERM_BP_5,negative regulation of nucleocytoplasmic transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,6.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of erythrocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,3.70E-01,12,1.00E+00,#N/A,6.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,gliogenesis,6.20E-01,31,4.70E-01,32,1.50E-01,41,7.70E-01,25,5.80E-01,35,8.20E-01,29,5.20E-01,31GOTERM_BP_5,regulation of JNK cascade,1.20E-01,37,1.40E-01,36,1.50E-01,41,1.50E-01,32,2.10E-01,39,5.70E-02,39,1.70E-01,35GOTERM_BP_5,nucleoside triphosphate biosynthetic process,1.50E-01,55,4.10E-01,50,5.80E-01,56,2.10E-02,53,2.30E-01,59,2.30E-01,54,3.50E-01,50GOTERM_BP_5,regulation of neuron projection development,4.60E-01,35,1.10E-01,39,2.60E-03,51,2.50E-02,38,1.40E-01,43,1.70E-01,39,2.00E-01,37GOTERM_BP_5,cellular cation homeostasis,3.30E-01,125,4.70E-01,120,6.40E-01,137,3.30E-01,108,4.20E-01,137,5.10E-01,123,2.80E-01,122GOTERM_BP_5,response to molecule of bacterial origin,5.10E-01,42,5.00E-02,49,9.40E-03,59,1.60E-01,41,2.50E-01,50,1.80E-01,47,2.20E-02,50GOTERM_BP_5,regulation of peptidase activity,1.50E-01,47,1.90E-02,51,7.20E-02,55,1.80E-02,46,2.50E-01,50,5.60E-01,42,8.70E-02,47GOTERM_BP_5,response to starvation,3.50E-03,30,1.50E-02,28,1.30E-01,28,1.40E-01,22,2.40E-02,30,4.50E-01,22,1.50E-01,24GOTERM_BP_5,protein processing,2.50E-01,58,3.50E-02,63,1.50E-01,68,2.80E-01,50,1.10E-01,67,4.60E-02,64,1.50E-01,58GOTERM_BP_5,regulation of neurological system process,4.20E-01,75,7.20E-01,69,6.10E-01,83,4.10E-01,65,6.40E-01,80,9.00E-01,67,8.80E-01,64GOTERM_BP_5,mitotic sister chromatid segregation,9.40E-01,14,5.50E-02,23,9.40E-02,25,5.00E-02,21,3.10E-01,22,2.30E-01,21,1.50E-01,21GOTERM_BP_5,negative regulation of protein kinase cascade,1.20E-01,22,4.40E-03,26,4.80E-02,26,1.00E-02,23,6.50E-02,25,7.80E-02,23,2.10E-02,24GOTERM_BP_5,leukocyte homeostasis,8.80E-01,15,3.90E-01,19,5.10E-01,21,3.80E-01,17,5.70E-01,20,2.30E-01,21,3.60E-01,19GOTERM_BP_5,regulation of blood coagulation,6.90E-01,17,5.30E-01,18,5.10E-01,21,3.80E-01,17,9.70E-01,15,6.00E-01,18,3.60E-01,19GOTERM_BP_5,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8.40E-01,13,5.60E-01,15,7.50E-01,16,4.50E-01,14,8.00E-01,15,9.20E-01,12,7.90E-01,13GOTERM_BP_5,positive regulation of intracellular transport,4.50E-01,16,7.00E-01,14,4.80E-01,18,6.00E-01,13,9.40E-01,13,4.80E-01,16,3.80E-01,16GOTERM_BP_5,positive regulation of response to external stimulus,8.30E-01,28,5.20E-01,31,7.60E-02,42,4.90E-02,34,2.50E-01,38,7.10E-02,38,2.00E-01,34GOTERM_BP_5,regulation of vesicle-mediated transport,9.50E-01,39,9.90E-01,35,7.80E-01,50,7.00E-01,38,9.50E-01,44,9.60E-01,39,9.90E-01,33GOTERM_BP_5,purine nucleoside triphosphate metabolic process,1.10E-01,66,5.80E-01,57,6.40E-01,66,4.90E-02,60,3.50E-01,68,3.50E-01,62,4.40E-01,58GOTERM_BP_5,eye morphogenesis,9.90E-01,25,9.40E-01,27,1.00E+00,#N/A,9.80E-01,21,9.70E-01,30,9.80E-01,26,9.70E-01,25GOTERM_BP_5,response to corticosteroid stimulus,6.40E-01,40,5.00E-01,41,6.50E-01,46,1.90E-01,40,6.10E-01,45,3.50E-01,44,9.20E-01,34GOTERM_BP_5,positive regulation of cell projection organization,6.90E-01,22,3.10E-01,25,1.20E-01,31,1.50E-01,24,4.20E-01,27,3.90E-01,25,4.90E-01,23GOTERM_BP_5,"nucleobase, nucleoside and nucleotide catabolic process",3.10E-02,36,2.50E-01,31,4.00E-01,34,2.10E-01,28,5.10E-01,32,1.60E-01,33,1.40E-01,32GOTERM_BP_5,"nucleobase, nucleoside, nucleotide and nucleic acid catabolic process",3.10E-02,36,2.50E-01,31,4.00E-01,34,2.10E-01,28,5.10E-01,32,1.60E-01,33,1.40E-01,32GOTERM_BP_5,morphogenesis of embryonic epithelium,1.60E-02,37,4.10E-02,35,5.70E-02,39,3.20E-02,32,9.70E-02,37,3.80E-02,36,3.20E-02,35GOTERM_BP_5,negative regulation of protein catabolic process,1.00E+00,#N/A,2.20E-01,11,1.40E-01,13,1.00E+00,#N/A,5.90E-01,10,4.30E-01,10,3.60E-01,10GOTERM_BP_5,monoamine transport,1.00E+00,#N/A,1.00E+00,#N/A,6.40E-01,10,1.00E+00,#N/A,2.30E-01,12,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of mesenchymal cell proliferation,1.00E+00,#N/A,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,gut morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,6.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of smoothened signaling pathway,1.20E-01,12,1.00E-01,12,5.40E-02,14,1.00E+00,#N/A,1.10E-01,13,1.30E-01,12,9.10E-02,12GOTERM_BP_5,cellular protein complex disassembly,4.10E-01,10,2.20E-01,11,4.60E-01,11,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,3.60E-01,10GOTERM_BP_5,leukocyte differentiation,9.90E-01,51,7.80E-01,58,8.50E-01,67,9.60E-01,45,9.90E-01,56,9.60E-01,54,9.80E-01,50GOTERM_BP_5,stress-activated protein kinase signaling pathway,7.20E-01,29,2.80E-01,33,9.20E-02,41,3.90E-02,34,2.00E-01,38,1.40E-01,36,3.30E-01,32GOTERM_BP_5,mammary gland development,5.30E-01,31,2.80E-01,33,4.80E-01,36,1.00E-01,32,4.70E-01,35,3.70E-01,33,3.30E-01,32GOTERM_BP_5,ER-nuclear signaling pathway,4.60E-02,23,7.50E-02,22,6.40E-02,25,2.10E-01,18,8.40E-02,24,5.40E-02,23,6.20E-02,22GOTERM_BP_5,positive regulation of protein complex assembly,7.50E-01,16,7.20E-01,16,7.00E-01,19,1.30E-01,19,7.50E-01,18,7.80E-01,16,8.00E-01,15GOTERM_BP_5,negative regulation of cell differentiation,8.20E-01,97,9.30E-01,91,4.00E-01,121,4.00E-01,91,8.50E-01,108,7.10E-01,101,7.10E-01,96GOTERM_BP_5,water-soluble vitamin biosynthetic process,2.40E-03,19,2.10E-02,17,4.50E-02,18,6.30E-01,10,1.60E-01,16,7.30E-02,16,4.70E-02,16GOTERM_BP_5,regulation of epidermal growth factor receptor signaling pathway,4.00E-01,13,5.30E-01,12,6.70E-01,13,3.10E-01,12,6.00E-01,13,5.80E-01,12,2.00E-01,14GOTERM_BP_5,nucleobase metabolic process,8.80E-03,18,1.20E-01,15,1.00E-01,17,9.10E-02,14,1.60E-01,16,2.70E-01,14,1.00E-01,15GOTERM_BP_5,regulation of skeletal muscle tissue development,7.90E-02,19,3.50E-01,16,5.40E-01,17,3.90E-01,14,4.70E-01,17,5.60E-01,15,4.60E-01,15GOTERM_BP_5,microtubule-based transport,3.80E-01,16,6.40E-01,14,2.60E-01,19,1.00E+00,#N/A,4.70E-01,17,5.60E-01,15,8.50E-01,12GOTERM_BP_5,regulation of actin cytoskeleton organization,9.70E-01,35,4.80E-01,43,9.00E-01,44,7.10E-01,35,8.80E-01,43,8.10E-01,40,8.60E-01,37GOTERM_BP_5,regulation of axonogenesis,5.50E-01,28,9.00E-02,33,8.60E-04,44,4.40E-02,31,1.20E-01,36,8.40E-02,34,1.20E-01,32GOTERM_BP_5,regulation of peptide secretion,6.40E-01,22,6.00E-01,22,5.60E-01,26,4.00E-01,21,8.70E-01,22,3.30E-01,25,8.50E-01,19GOTERM_BP_5,regulation of smooth muscle cell proliferation,8.30E-01,20,4.80E-01,23,1.50E-01,30,8.30E-01,17,8.70E-01,22,5.60E-01,23,7.70E-01,20GOTERM_BP_5,ncRNA metabolic process,8.90E-03,128,3.40E-02,122,3.10E-03,147,2.10E-02,110,7.10E-06,155,5.00E-03,131,4.10E-05,136GOTERM_BP_5,regulation of ion transport,5.20E-01,48,6.90E-01,45,8.10E-01,51,3.90E-01,43,7.70E-01,50,7.20E-01,46,5.50E-01,46GOTERM_BP_5,chromatin modification,6.40E-01,128,3.90E-01,131,8.10E-02,162,5.90E-01,111,8.90E-02,157,1.90E-01,140,5.30E-01,126GOTERM_BP_5,regulation of cell development,1.40E-01,106,4.20E-01,98,1.00E-01,122,2.30E-01,90,5.40E-01,109,2.70E-01,104,3.40E-01,98GOTERM_BP_5,neural tube formation,2.10E-01,23,1.10E-01,24,1.90E-01,26,2.30E-01,20,2.20E-01,25,8.50E-02,25,8.90E-02,24GOTERM_BP_5,regulation of T cell differentiation,1.00E+00,16,8.80E-01,21,6.40E-01,28,5.20E-01,22,9.40E-01,23,8.70E-01,22,6.90E-01,23GOTERM_BP_5,epithelial tube morphogenesis,4.20E-01,34,6.50E-01,31,6.00E-01,37,8.20E-01,25,6.70E-01,35,6.50E-01,32,5.10E-01,32GOTERM_BP_5,positive regulation of lymphocyte mediated immunity,9.40E-01,13,9.30E-01,13,1.00E+00,#N/A,9.40E-01,11,9.90E-01,13,9.80E-01,12,9.60E-01,12GOTERM_BP_5,positive regulation of leukocyte mediated immunity,9.40E-01,13,9.30E-01,13,1.00E+00,#N/A,9.40E-01,11,9.90E-01,13,9.80E-01,12,9.60E-01,12GOTERM_BP_5,acyl-CoA metabolic process,5.80E-03,14,2.00E-02,13,8.50E-04,16,1.10E-03,14,5.50E-04,16,1.40E-04,16,6.70E-04,15GOTERM_BP_5,regulation of fat cell differentiation,3.20E-01,10,2.90E-01,10,5.40E-01,10,1.50E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of ATPase activity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,4.90E-01,10,3.40E-01,10,1.00E+00,#N/AGOTERM_BP_5,NADP metabolic process,1.00E-03,15,2.00E-02,13,7.80E-02,13,1.10E-03,14,1.80E-02,14,7.70E-02,12,4.00E-03,14GOTERM_BP_5,negative regulation of protein import into nucleus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,chordate embryonic development,4.50E-01,159,5.50E-01,154,1.50E-01,191,7.50E-01,130,6.30E-01,173,2.90E-01,165,5.70E-01,151GOTERM_BP_5,gene silencing,5.00E-01,28,1.70E-01,31,2.90E-01,34,2.30E-01,27,3.00E-01,33,2.40E-01,31,4.00E-01,28GOTERM_BP_5,protein stabilization,2.00E-01,17,1.80E-02,20,7.30E-03,23,4.80E-01,13,4.40E-03,23,2.10E-01,17,3.70E-02,19GOTERM_BP_5,heme metabolic process,3.90E-02,16,8.00E-02,15,1.40E-01,16,1.30E-01,13,4.60E-02,17,4.50E-02,16,9.40E-03,17GOTERM_BP_5,activation of pro-apoptotic gene products,3.20E-01,13,2.90E-01,13,2.60E-01,15,2.50E-01,12,3.50E-01,14,2.00E-01,14,1.50E-01,14GOTERM_BP_5,regulation of mitotic metaphase/anaphase transition,9.20E-02,15,1.60E-01,14,4.10E-01,14,6.20E-02,14,5.20E-01,13,3.40E-01,13,4.20E-01,12GOTERM_BP_5,vesicle targeting,9.20E-02,15,3.30E-02,16,2.60E-01,15,2.50E-02,15,2.10E-01,15,1.00E-01,15,2.70E-01,13GOTERM_BP_5,negative regulation of cell activation,8.70E-01,26,7.70E-01,27,2.80E-01,37,5.30E-01,26,8.90E-01,29,7.60E-01,28,7.30E-01,27GOTERM_BP_5,axonogenesis,1.10E-01,101,1.60E-01,98,2.40E-02,120,2.20E-01,85,3.50E-01,106,2.80E-01,98,1.70E-01,96GOTERM_BP_5,regulation of defense response,8.50E-01,63,6.20E-01,66,5.90E-01,78,2.20E-01,64,8.00E-01,72,1.60E-01,76,6.20E-01,65GOTERM_BP_5,negative regulation of DNA metabolic process,6.20E-01,19,4.50E-01,20,1.50E-01,26,4.10E-01,18,6.40E-01,21,9.10E-01,16,8.60E-01,16GOTERM_BP_5,regulation of hormone secretion,4.70E-01,33,2.40E-01,35,4.40E-01,38,1.20E-01,33,4.30E-01,37,2.40E-01,36,6.50E-01,30GOTERM_BP_5,skeletal muscle organ development,6.60E-01,31,9.40E-01,26,1.00E+00,#N/A,6.30E-01,27,5.30E-01,36,7.00E-01,31,8.20E-01,28GOTERM_BP_5,negative regulation of cell growth,2.60E-01,48,2.80E-01,47,1.40E-02,62,1.90E-01,43,2.00E-01,54,1.30E-01,51,5.80E-02,51GOTERM_BP_5,biogenic amine metabolic process,3.90E-02,56,9.30E-02,53,8.40E-02,61,3.30E-01,43,9.70E-02,59,2.70E-01,51,1.40E-01,51GOTERM_BP_5,central nervous system development,7.70E-01,195,7.50E-01,192,1.10E-01,245,7.60E-01,167,8.00E-01,217,8.20E-01,196,7.70E-01,188GOTERM_BP_5,negative regulation of cytoskeleton organization,8.30E-01,24,3.00E-01,29,4.40E-01,32,7.80E-01,21,2.50E-01,33,4.80E-01,28,4.60E-01,27GOTERM_BP_5,positive regulation of lymphocyte proliferation,9.80E-01,20,1.00E+00,17,1.00E+00,#N/A,9.90E-01,16,1.00E+00,21,7.80E-01,25,9.40E-01,21GOTERM_BP_5,B cell activation,7.10E-01,35,6.60E-01,35,5.80E-01,42,7.80E-01,29,9.60E-01,34,9.70E-01,30,9.80E-01,27GOTERM_BP_5,positive regulation of myeloid cell differentiation,9.80E-01,11,7.40E-01,15,1.90E-01,22,7.50E-01,13,4.90E-01,19,6.80E-01,16,8.10E-01,14GOTERM_BP_5,primary neural tube formation,1.60E-01,20,3.50E-02,22,1.90E-01,22,1.40E-01,18,1.40E-01,22,5.10E-02,22,6.00E-02,21GOTERM_BP_5,DNA modification,3.80E-01,18,4.70E-01,17,3.00E-01,21,3.50E-01,16,2.30E-01,21,2.80E-01,19,2.00E-01,19GOTERM_BP_5,positive regulation of B cell activation,9.80E-01,11,1.00E+00,#N/A,8.90E-01,16,1.00E+00,#N/A,1.00E+00,10,9.30E-01,13,9.90E-01,10GOTERM_BP_5,positive regulation of protein kinase cascade,5.30E-01,80,4.40E-01,80,4.00E-01,94,1.10E-01,77,6.00E-01,88,1.60E-01,88,4.80E-01,78GOTERM_BP_5,chromatin assembly or disassembly,2.10E-01,66,8.50E-04,78,8.00E-04,88,8.50E-05,74,2.60E-03,84,1.10E-04,83,1.60E-01,65GOTERM_BP_5,regulation of transmission of nerve impulse,5.00E-01,71,6.80E-01,67,6.60E-01,79,4.40E-01,62,6.90E-01,76,8.40E-01,66,8.60E-01,62GOTERM_BP_5,tube lumen formation,1.30E-01,26,1.10E-01,26,1.40E-01,29,1.30E-01,23,1.60E-01,28,5.00E-02,28,5.00E-02,27GOTERM_BP_5,isoprenoid metabolic process,4.10E-03,31,3.30E-02,28,4.50E-02,31,1.00E-02,27,2.40E-01,27,9.10E-02,27,1.50E-01,25GOTERM_BP_5,positive regulation of immune effector process,9.00E-01,18,9.60E-01,16,1.00E+00,#N/A,9.50E-01,14,9.60E-01,19,9.80E-01,16,9.60E-01,16GOTERM_BP_5,protein amino acid N-linked glycosylation,9.70E-03,30,3.30E-02,28,2.20E-02,32,1.00E-02,27,5.40E-02,30,1.20E-02,30,5.00E-02,27GOTERM_BP_5,membrane lipid metabolic process,8.30E-02,46,2.60E-01,42,4.60E-01,46,2.80E-01,37,3.50E-01,46,2.70E-01,43,2.80E-01,41GOTERM_BP_5,placenta development,8.40E-01,26,4.30E-01,30,6.30E-02,40,2.00E-01,29,7.90E-01,30,2.40E-01,33,4.90E-01,29GOTERM_BP_5,T cell proliferation,9.00E-01,11,7.80E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,9.30E-01,12,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of nitric oxide biosynthetic process,7.40E-02,18,2.20E-01,16,3.80E-01,17,5.70E-01,12,6.10E-01,15,4.10E-01,15,4.70E-01,14GOTERM_BP_5,RNA catabolic process,2.40E-01,35,2.00E-01,35,2.20E-01,40,6.20E-02,34,2.10E-01,39,3.30E-02,40,7.30E-02,37GOTERM_BP_5,establishment or maintenance of apical/basal cell polarity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,sulfur amino acid biosynthetic process,3.80E-02,12,3.30E-02,12,1.10E-01,12,1.00E+00,#N/A,8.90E-02,12,1.20E-01,11,8.40E-02,11GOTERM_BP_5,peptide hormone processing,1.00E+00,#N/A,2.10E-01,10,2.50E-01,11,1.00E+00,#N/A,2.10E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of bone remodeling,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,maternal placenta development,1.00E+00,#N/A,1.00E+00,#N/A,1.10E-01,12,1.10E-02,12,8.90E-02,12,1.20E-01,11,2.90E-02,12GOTERM_BP_5,regulation of bone resorption,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of insulin receptor signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,2.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,2.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,sterol metabolic process,8.80E-02,56,2.70E-02,58,4.30E-02,65,4.30E-02,51,2.00E-01,59,1.30E-02,61,1.90E-02,58GOTERM_BP_5,positive regulation of catabolic process,1.10E-01,29,4.10E-01,25,5.20E-01,28,2.20E-01,24,7.50E-01,25,1.90E-01,28,1.20E-01,28GOTERM_BP_5,carbohydrate homeostasis,7.80E-01,22,4.10E-01,25,6.30E-01,27,4.30E-01,22,4.30E-01,28,3.80E-01,26,2.70E-01,26GOTERM_BP_5,learning or memory,5.00E-01,54,7.80E-01,49,6.40E-01,60,5.40E-01,46,6.50E-01,58,7.00E-01,52,8.40E-01,47GOTERM_BP_5,eye photoreceptor cell differentiation,1.00E+00,#N/A,7.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,8.70E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of actin filament bundle formation,1.00E+00,#N/A,1.10E-01,14,8.00E-01,11,5.00E-01,10,8.70E-01,10,4.20E-01,12,5.10E-01,11GOTERM_BP_5,regulation of acute inflammatory response,5.70E-01,11,3.70E-01,12,1.80E-01,15,9.40E-02,13,2.70E-01,14,1.40E-01,14,1.00E+00,#N/AGOTERM_BP_5,regulation of synaptic transmission,5.50E-01,65,7.90E-01,60,7.80E-01,71,4.80E-01,57,8.20E-01,68,9.10E-01,59,8.70E-01,57GOTERM_BP_5,negative regulation of lymphocyte activation,8.00E-01,24,7.60E-01,24,2.00E-01,34,4.30E-01,24,7.90E-01,27,6.50E-01,26,6.20E-01,25GOTERM_BP_5,activation of caspase activity,2.10E-01,30,2.10E-02,34,4.60E-02,37,3.50E-02,30,2.90E-01,32,4.30E-01,28,1.50E-01,30GOTERM_BP_5,cellular amino acid derivative biosynthetic process,1.50E-02,35,6.90E-02,32,2.00E-01,34,1.00E-01,28,4.90E-02,36,1.80E-02,35,5.50E-02,32GOTERM_BP_5,JNK cascade,7.30E-01,27,3.80E-01,30,1.90E-01,37,7.10E-02,31,2.70E-01,35,1.30E-01,34,4.40E-01,29GOTERM_BP_5,cellular hormone metabolic process,1.70E-01,33,2.90E-01,31,1.20E-01,38,2.50E-01,28,4.60E-01,33,5.80E-01,29,3.40E-01,30GOTERM_BP_5,embryonic epithelial tube formation,1.70E-01,25,1.40E-01,25,1.70E-01,28,1.70E-01,22,1.90E-01,27,6.70E-02,27,6.80E-02,26GOTERM_BP_5,negative regulation of leukocyte proliferation,8.20E-01,14,8.80E-01,13,1.40E-01,22,7.00E-01,13,8.00E-01,16,7.40E-01,15,6.50E-01,15GOTERM_BP_5,cellular response to starvation,2.80E-02,22,5.00E-02,21,3.50E-01,20,2.90E-01,16,4.90E-02,23,7.40E-01,15,2.50E-01,18GOTERM_BP_5,positive regulation of T cell differentiation,9.80E-01,11,9.40E-01,12,3.50E-01,20,7.00E-01,13,9.40E-01,14,6.10E-01,16,6.50E-01,15GOTERM_BP_5,vacuolar transport,7.20E-01,15,1.70E-01,19,3.50E-01,20,4.20E-01,15,2.80E-01,20,1.30E-01,20,1.50E-01,19GOTERM_BP_5,negative regulation of mononuclear cell proliferation,8.20E-01,14,8.80E-01,13,1.40E-01,22,7.00E-01,13,8.00E-01,16,7.40E-01,15,6.50E-01,15GOTERM_BP_5,negative regulation of lymphocyte proliferation,8.20E-01,14,8.80E-01,13,1.40E-01,22,7.00E-01,13,8.00E-01,16,7.40E-01,15,6.50E-01,15GOTERM_BP_5,negative regulation of biosynthetic process,8.50E-01,260,9.10E-01,252,8.90E-02,329,4.70E-01,235,9.00E-01,289,7.80E-01,267,8.90E-01,249GOTERM_BP_5,regulation of stress-activated protein kinase signaling pathway,1.20E-01,39,2.00E-01,37,1.70E-01,43,2.00E-01,33,2.30E-01,41,6.00E-02,41,2.30E-01,36GOTERM_BP_5,phagocytosis,9.30E-01,19,7.90E-01,21,8.50E-01,24,6.10E-01,20,9.20E-01,22,8.40E-01,21,8.40E-01,20GOTERM_BP_5,negative regulation of hydrolase activity,6.30E-01,23,2.60E-01,26,3.50E-01,29,1.90E-01,24,1.80E-01,30,7.60E-01,22,2.30E-01,26GOTERM_BP_5,regulation of DNA recombination,7.60E-01,12,1.00E+00,#N/A,7.40E-01,14,1.00E+00,#N/A,9.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,insulin receptor signaling pathway,2.50E-01,21,7.70E-02,23,3.70E-02,27,4.30E-01,17,3.70E-01,22,1.10E-01,23,3.00E-01,20GOTERM_BP_5,positive regulation of cell migration,7.80E-01,40,9.40E-02,49,5.80E-01,49,3.80E-01,39,8.80E-01,43,5.10E-01,44,9.00E-01,36GOTERM_BP_5,porphyrin biosynthetic process,3.40E-02,15,9.10E-03,16,1.70E-02,17,2.60E-01,11,2.70E-03,18,3.40E-03,17,3.40E-04,18GOTERM_BP_5,negative regulation of cytokine biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,5.70E-01,12,2.60E-01,11,1.00E+00,#N/A,6.80E-01,10,1.00E+00,#N/AGOTERM_BP_5,establishment of cell polarity,4.90E-01,11,7.40E-02,14,1.70E-02,17,6.30E-02,13,9.20E-02,15,2.00E-01,13,2.70E-01,12GOTERM_BP_5,virus-host interaction,1.00E+00,#N/A,4.60E-01,11,3.90E-01,13,1.00E+00,#N/A,5.10E-01,12,2.00E-01,13,4.30E-01,11GOTERM_BP_5,regulation of RNA splicing,4.90E-01,11,6.40E-01,10,7.30E-01,11,1.00E+00,#N/A,6.80E-01,11,6.80E-01,10,4.30E-01,11GOTERM_BP_5,tetrapyrrole biosynthetic process,3.40E-02,15,9.10E-03,16,1.70E-02,17,2.60E-01,11,2.70E-03,18,3.40E-03,17,3.40E-04,18GOTERM_BP_5,negative regulation of cellular biosynthetic process,8.60E-01,254,9.00E-01,247,1.10E-01,321,5.10E-01,229,8.90E-01,283,8.10E-01,260,9.00E-01,243GOTERM_BP_5,tissue homeostasis,9.70E-01,24,8.90E-01,26,1.00E+00,#N/A,6.10E-01,26,8.80E-01,30,8.80E-01,27,9.40E-01,24GOTERM_BP_5,negative regulation of sequestering of calcium ion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,nucleobase biosynthetic process,6.10E-02,11,1.00E+00,#N/A,1.60E-01,11,6.40E-02,10,2.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pigment granule localization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cytoplasmic sequestering of protein,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of endothelial cell migration,1.60E-01,10,1.00E+00,#N/A,1.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of transcription factor import into nucleus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of sequestering of calcium ion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glycosaminoglycan catabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,2.80E-01,10,1.00E+00,#N/A,1.30E-01,10GOTERM_BP_5,purine base metabolic process,6.10E-02,11,1.00E+00,#N/A,3.20E-01,10,1.00E+00,#N/A,2.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,release of sequestered calcium ion into cytosol,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of ion transport,4.00E-02,27,6.10E-02,26,2.10E-01,27,1.00E-02,26,8.80E-02,28,3.30E-01,23,2.50E-02,27GOTERM_BP_5,regulation of microtubule cytoskeleton organization,6.60E-01,20,6.20E-01,20,3.10E-01,26,4.40E-01,19,3.40E-01,25,4.50E-01,22,4.60E-01,21GOTERM_BP_5,regulation of protein stability,4.20E-01,22,1.50E-02,28,3.90E-02,30,3.20E-01,20,4.80E-02,29,2.30E-01,24,4.90E-02,26GOTERM_BP_5,neural tube development,6.10E-02,40,7.40E-02,39,8.90E-02,44,1.70E-01,33,1.30E-01,42,2.70E-02,42,3.40E-02,40GOTERM_BP_5,negative regulation of inflammatory response,7.80E-01,14,9.20E-01,12,6.90E-01,17,3.70E-01,15,8.50E-01,15,4.10E-01,17,7.20E-01,14GOTERM_BP_5,hexose biosynthetic process,6.00E-04,25,1.60E-03,24,7.10E-03,25,2.10E-03,22,1.20E-02,24,1.90E-04,26,1.10E-02,22GOTERM_BP_5,apoptotic mitochondrial changes,8.70E-01,13,2.20E-01,18,1.70E-01,21,6.50E-01,13,4.80E-01,18,6.90E-01,15,7.20E-01,14GOTERM_BP_5,Wnt receptor signaling pathway,1.20E-01,71,2.60E-01,67,1.10E-01,81,6.00E-01,54,3.40E-01,74,3.10E-01,68,5.10E-01,62GOTERM_BP_5,inorganic anion transport,9.90E-01,34,9.20E-01,38,4.30E-01,53,9.10E-01,33,9.10E-01,44,6.70E-01,44,9.30E-01,37GOTERM_BP_5,hormone-mediated signaling,7.20E-01,24,4.60E-01,26,1.20E-01,34,2.50E-01,25,2.80E-01,31,4.30E-01,27,5.20E-01,25GOTERM_BP_5,second-messenger-mediated signaling,7.70E-01,107,7.70E-01,105,5.20E-01,129,2.50E-01,102,5.80E-01,124,9.60E-01,101,6.90E-01,105GOTERM_BP_5,negative regulation of defense response,6.90E-01,17,7.70E-01,16,6.40E-01,20,3.80E-01,17,6.90E-01,19,2.30E-01,21,7.40E-01,16GOTERM_BP_5,cellular component assembly involved in morphogenesis,1.00E+00,#N/A,9.20E-01,14,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,21,9.70E-01,13,1.00E+00,10GOTERM_BP_5,positive regulation of hormone secretion,2.00E-01,21,1.00E-01,22,1.70E-01,24,5.00E-02,21,3.10E-01,22,2.30E-01,21,3.60E-01,19GOTERM_BP_5,regulation of steroid metabolic process,3.10E-01,20,6.60E-01,17,1.70E-01,24,3.80E-01,17,9.30E-01,16,2.30E-01,21,4.90E-01,18GOTERM_BP_5,negative regulation of leukocyte activation,8.80E-01,24,8.50E-01,24,3.50E-01,34,5.70E-01,24,8.90E-01,27,7.70E-01,26,7.50E-01,25GOTERM_BP_5,cardiac muscle tissue development,9.90E-01,19,7.00E-01,26,8.90E-01,28,6.70E-01,23,1.20E-01,36,3.80E-01,30,8.30E-01,24GOTERM_BP_5,carboxylic acid transport,5.60E-01,70,5.50E-01,69,6.60E-01,79,4.40E-01,62,5.70E-01,78,5.60E-01,71,4.70E-01,69GOTERM_BP_5,regulation of monooxygenase activity,5.50E-01,13,8.90E-01,10,8.00E-01,13,1.00E+00,#N/A,7.50E-01,13,9.20E-01,10,7.80E-01,11GOTERM_BP_5,regulation of endothelial cell migration,7.00E-02,17,5.10E-01,13,1.20E-01,18,1.00E+00,#N/A,8.60E-01,12,5.70E-01,13,3.30E-01,14GOTERM_BP_5,regulation of alpha-beta T cell differentiation,8.20E-01,11,8.00E-01,11,2.20E-01,17,6.00E-01,11,8.60E-01,12,5.70E-01,13,4.80E-01,13GOTERM_BP_5,positive regulation of proteolysis,1.40E-01,16,1.20E-01,16,2.20E-01,17,1.70E-01,14,4.00E-02,19,3.40E-02,18,2.00E-02,18GOTERM_BP_5,positive regulation of axonogenesis,2.50E-01,15,2.20E-01,15,7.30E-03,21,1.70E-01,14,3.00E-01,16,1.60E-01,16,2.00E-01,15GOTERM_BP_5,regulation of skeletal muscle fiber development,1.40E-01,16,5.10E-01,13,6.70E-01,14,6.00E-01,11,6.10E-01,14,7.20E-01,12,4.80E-01,13GOTERM_BP_5,lysosomal transport,8.20E-01,11,2.20E-01,15,2.20E-01,17,2.90E-01,13,3.00E-01,16,4.20E-01,14,2.00E-01,15GOTERM_BP_5,ribonucleotide catabolic process,3.90E-01,14,5.10E-01,13,3.60E-01,16,4.40E-01,12,6.10E-01,14,4.20E-01,14,3.30E-01,14GOTERM_BP_5,cell morphogenesis involved in differentiation,5.90E-01,115,5.90E-01,113,1.60E-01,142,5.30E-01,100,8.20E-01,123,6.20E-01,116,4.90E-01,113GOTERM_BP_5,positive regulation of protein transport,7.00E-01,31,9.80E-01,24,1.00E+00,#N/A,8.80E-01,24,9.80E-01,28,9.50E-01,27,9.80E-01,24GOTERM_BP_5,maintenance of protein location in cell,9.70E-01,15,9.20E-01,16,8.10E-01,21,9.80E-01,12,7.50E-01,21,9.90E-01,14,1.00E+00,12GOTERM_BP_5,gonad development,1.90E-01,59,6.10E-01,52,6.10E-01,61,2.80E-01,50,7.50E-01,57,7.30E-01,52,9.80E-01,42GOTERM_BP_5,regulation of lipid metabolic process,1.90E-01,59,2.00E-01,58,5.10E-02,71,5.70E-01,46,7.50E-01,57,9.70E-02,62,4.70E-01,53GOTERM_BP_5,mRNA transport,6.40E-01,41,4.00E-01,43,2.30E-02,58,1.80E-01,41,5.00E-02,55,4.60E-02,51,1.50E-01,46GOTERM_BP_5,regulation of lipase activity,2.30E-01,46,8.00E-01,38,5.70E-01,48,7.30E-01,34,5.30E-01,47,6.00E-01,42,5.20E-01,41GOTERM_BP_5,pallium development,8.00E-02,28,3.70E-01,24,9.20E-02,31,7.40E-01,18,2.50E-01,28,5.60E-01,23,6.70E-01,21GOTERM_BP_5,amino acid activation,1.30E-01,27,1.70E-02,30,1.20E-02,34,7.50E-02,25,2.70E-03,35,5.30E-02,29,5.80E-03,31GOTERM_BP_5,tRNA aminoacylation for protein translation,1.30E-01,27,1.70E-02,30,1.20E-02,34,7.50E-02,25,2.70E-03,35,5.30E-02,29,5.80E-03,31GOTERM_BP_5,neuron apoptosis,1.20E-01,13,3.80E-01,11,3.00E-01,13,3.50E-01,10,4.10E-01,12,1.40E-01,13,9.60E-02,13GOTERM_BP_5,aromatic amino acid family metabolic process,2.40E-01,12,4.50E-02,14,7.10E-02,15,9.80E-02,12,1.30E-01,14,5.90E-02,14,9.60E-02,13GOTERM_BP_5,actin polymerization or depolymerization,1.00E+00,#N/A,5.60E-01,10,4.70E-01,12,1.00E+00,#N/A,4.10E-01,12,5.90E-02,14,5.30E-01,10GOTERM_BP_5,cellular amino acid derivative catabolic process,1.80E-02,15,1.50E-02,15,6.70E-03,17,4.00E-02,13,4.50E-03,17,2.10E-02,15,6.40E-04,17GOTERM_BP_5,regulation of stress fiber formation,1.00E+00,#N/A,1.10E-01,13,8.00E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,11,5.30E-01,10GOTERM_BP_5,tube closure,1.10E-01,19,2.00E-02,21,2.10E-01,20,1.10E-01,17,1.60E-01,20,6.50E-02,20,8.10E-02,19GOTERM_BP_5,positive regulation of inflammatory response,9.10E-01,12,5.60E-01,15,6.10E-02,22,1.10E-01,17,1.60E-01,20,1.30E-01,19,2.50E-01,17GOTERM_BP_5,neural tube closure,1.10E-01,19,2.00E-02,21,2.10E-01,20,1.10E-01,17,1.60E-01,20,6.50E-02,20,8.10E-02,19GOTERM_BP_5,small GTPase mediated signal transduction,1.20E-01,156,6.70E-02,156,2.00E-02,185,2.20E-01,132,1.30E-01,172,4.40E-01,149,9.40E-02,152GOTERM_BP_5,cell morphogenesis involved in neuron differentiation,1.70E-01,107,2.20E-01,104,6.60E-02,126,3.50E-01,89,5.40E-01,111,4.20E-01,103,2.80E-01,101GOTERM_BP_5,negative regulation of DNA binding,5.70E-01,25,4.10E-01,26,3.10E-01,31,2.10E-01,25,5.50E-01,28,3.80E-01,27,5.80E-01,24GOTERM_BP_5,unsaturated fatty acid metabolic process,2.50E-01,28,1.40E-01,29,4.20E-01,30,2.70E-02,29,3.10E-02,35,1.30E-01,30,4.70E-01,25GOTERM_BP_5,positive regulation of leukocyte proliferation,9.80E-01,20,1.00E+00,17,1.00E+00,#N/A,9.90E-01,16,1.00E+00,21,8.10E-01,25,9.50E-01,21GOTERM_BP_5,positive regulation of mononuclear cell proliferation,9.80E-01,20,1.00E+00,17,1.00E+00,#N/A,9.90E-01,16,1.00E+00,21,8.10E-01,25,9.50E-01,21GOTERM_BP_5,regulation of leukocyte mediated immunity,9.80E-01,22,1.00E+00,17,1.00E+00,#N/A,9.90E-01,17,1.00E+00,21,1.00E+00,18,1.00E+00,16GOTERM_BP_5,B cell proliferation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,microtubule polymerization or depolymerization,1.00E+00,#N/A,8.50E-02,10,1.00E+00,#N/A,3.50E-02,10,1.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of coagulation,9.50E-02,10,1.00E+00,#N/A,8.60E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E-01,10,7.60E-02,10GOTERM_BP_5,mitotic chromosome condensation,1.00E+00,#N/A,2.60E-02,11,8.60E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E-01,10,1.00E+00,#N/AGOTERM_BP_5,negative regulation of oxidoreductase activity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,dsRNA fragmentation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,decidualization,1.00E+00,#N/A,1.00E+00,#N/A,2.20E-01,10,3.50E-02,10,1.80E-01,10,1.00E+00,#N/A,7.60E-02,10GOTERM_BP_5,T cell activation during immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,carboxylic acid biosynthetic process,1.10E-02,89,4.40E-04,94,3.50E-02,97,2.90E-02,76,1.90E-02,96,9.10E-04,95,5.70E-02,82GOTERM_BP_5,regulation of immune effector process,9.70E-01,40,9.80E-01,38,1.00E+00,#N/A,9.60E-01,34,9.90E-01,42,1.00E+00,37,1.00E+00,33GOTERM_BP_5,positive regulation of lymphocyte differentiation,9.90E-01,11,9.80E-01,12,4.40E-01,21,7.20E-01,14,9.80E-01,14,7.80E-01,16,6.90E-01,16GOTERM_BP_5,sterol biosynthetic process,2.10E-02,24,1.70E-02,24,3.00E-02,26,3.50E-02,21,7.50E-03,27,1.10E-02,25,1.40E-04,28GOTERM_BP_5,gland development,7.20E-01,62,8.10E-01,59,7.60E-01,71,7.80E-01,52,9.30E-01,64,9.90E-01,53,8.60E-01,57GOTERM_BP_5,negative regulation of protein transport,8.60E-01,17,8.30E-01,17,8.50E-01,20,1.00E+00,#N/A,8.70E-01,19,9.30E-01,16,8.80E-01,16GOTERM_BP_5,brain development,1.40E-01,147,4.40E-01,137,5.70E-02,172,4.90E-01,119,6.40E-01,151,5.90E-01,138,4.70E-01,134GOTERM_BP_5,aspartate family amino acid metabolic process,4.40E-02,17,1.70E-01,15,2.80E-01,16,2.30E-01,13,2.30E-01,16,3.40E-01,14,1.50E-01,15GOTERM_BP_5,synaptic transmission,8.10E-01,135,7.90E-01,133,8.20E-01,156,8.20E-01,115,7.80E-01,152,9.80E-01,126,8.40E-01,129GOTERM_BP_5,nucleoside monophosphate biosynthetic process,4.80E-02,31,2.60E-01,27,6.50E-02,34,6.80E-02,27,1.90E-01,31,2.40E-01,28,1.50E-01,28GOTERM_BP_5,regulation of secretion,9.60E-01,85,9.50E-01,84,1.00E+00,#N/A,7.40E-01,79,9.60E-01,96,9.90E-01,83,9.90E-01,78GOTERM_BP_5,branching morphogenesis of a tube,5.20E-01,32,6.60E-01,30,5.90E-01,36,7.70E-01,25,7.60E-01,33,9.20E-01,27,7.80E-01,28GOTERM_BP_5,"DNA damage response, signal transduction",7.00E-01,37,5.60E-01,38,5.80E-02,52,5.90E-01,33,8.50E-01,39,9.00E-01,34,9.70E-01,30GOTERM_BP_5,"complement activation, classical pathway",7.90E-01,13,1.30E-01,18,1.60E-01,20,5.40E-01,13,2.10E-01,19,4.30E-02,20,6.10E-01,14GOTERM_BP_5,regulation of epithelial cell differentiation,9.40E-01,11,1.00E+00,#N/A,6.90E-01,16,6.80E-01,12,9.60E-01,12,8.10E-01,13,6.10E-01,14GOTERM_BP_5,regulation of myeloid cell differentiation,1.00E+00,22,9.90E-01,25,6.50E-01,38,9.30E-01,24,7.20E-01,36,7.70E-01,32,9.60E-01,26GOTERM_BP_5,gastrulation,2.80E-01,37,4.00E-01,35,2.10E-01,43,3.90E-01,31,2.00E-01,42,7.60E-02,41,4.50E-01,34GOTERM_BP_5,positive regulation of DNA binding,4.60E-01,35,2.30E-01,37,2.10E-02,48,2.30E-01,33,2.70E-01,41,4.70E-02,42,3.50E-01,35GOTERM_BP_5,sphingolipid metabolic process,1.70E-01,41,3.50E-01,38,4.40E-01,43,4.90E-01,32,3.30E-01,43,3.60E-01,39,3.80E-01,37GOTERM_BP_5,cell maturation,8.70E-01,32,8.40E-01,32,2.00E-01,46,9.20E-01,26,6.80E-01,39,8.50E-01,33,9.40E-01,29GOTERM_BP_5,negative regulation of macromolecule biosynthetic process,9.30E-01,243,9.30E-01,239,9.70E-02,314,5.20E-01,223,8.70E-01,277,8.20E-01,253,9.10E-01,236GOTERM_BP_5,ncRNA processing,1.30E-02,105,2.90E-01,92,4.10E-02,115,5.70E-02,88,3.30E-04,123,1.40E-02,106,5.40E-04,109GOTERM_BP_5,axon cargo transport,5.00E-01,10,1.00E+00,#N/A,3.70E-01,12,1.00E+00,#N/A,5.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,endoderm development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,lymphocyte activation during immune response,1.00E+00,#N/A,2.90E-01,11,3.70E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of insulin secretion,5.00E-01,10,4.70E-01,10,3.70E-01,12,1.50E-01,11,3.20E-01,12,3.40E-01,11,4.40E-01,10GOTERM_BP_5,unsaturated fatty acid biosynthetic process,8.10E-01,15,2.80E-01,19,7.60E-01,18,2.70E-01,17,1.10E-01,23,2.20E-01,20,8.50E-01,14GOTERM_BP_5,regulation of cell cycle process,6.70E-01,53,2.50E-01,58,2.00E-01,68,2.10E-01,52,5.50E-01,61,3.60E-01,58,5.40E-01,53GOTERM_BP_5,camera-type eye morphogenesis,9.00E-01,18,9.30E-01,17,1.00E+00,#N/A,9.50E-01,14,9.80E-01,18,9.80E-01,16,9.60E-01,16GOTERM_BP_5,biopolymer glycosylation,2.50E-02,73,4.90E-01,61,4.40E-01,72,1.20E-01,60,5.00E-01,69,5.10E-02,72,3.50E-01,62GOTERM_BP_5,protein amino acid glycosylation,2.50E-02,73,4.90E-01,61,4.40E-01,72,1.20E-01,60,5.00E-01,69,5.10E-02,72,3.50E-01,62GOTERM_BP_5,establishment or maintenance of cell polarity,7.80E-01,22,4.10E-01,25,2.10E-01,31,3.20E-01,23,1.50E-01,31,3.80E-01,26,4.80E-01,24GOTERM_BP_5,fatty acid biosynthetic process,1.70E-01,43,9.40E-02,44,4.60E-01,45,2.20E-01,37,1.40E-01,48,1.50E-01,44,5.50E-01,37GOTERM_BP_5,odontogenesis,3.90E-01,28,7.60E-01,24,3.80E-01,32,2.40E-01,26,6.10E-01,29,6.50E-01,26,4.10E-01,27GOTERM_BP_5,neuron migration,1.40E-01,36,4.40E-02,38,3.10E-03,47,1.30E-01,32,1.20E-01,40,1.10E-01,37,2.80E-01,33GOTERM_BP_5,regulation of mitotic cell cycle,7.10E-01,70,2.60E-01,76,3.90E-01,86,4.50E-01,64,6.70E-01,79,5.90E-01,73,4.30E-01,72GOTERM_BP_5,positive regulation of translation,8.40E-01,10,8.20E-01,10,5.10E-01,14,6.30E-01,10,8.60E-01,11,4.20E-01,13,1.00E+00,#N/AGOTERM_BP_5,actin filament-based movement,1.00E+00,#N/A,8.20E-01,10,9.00E-01,11,1.00E+00,#N/A,8.60E-01,11,8.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,vitamin A metabolic process,1.40E-01,15,5.30E-01,12,5.10E-01,14,4.70E-01,11,9.40E-01,10,8.50E-01,10,8.00E-01,10GOTERM_BP_5,regulation of heart growth,1.00E+00,#N/A,1.00E+00,#N/A,1.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.90E-02,10GOTERM_BP_5,ovulation from ovarian follicle,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of actin filament polymerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of insulin secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of vasodilation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"vesicle targeting, to, from or within Golgi",1.00E+00,#N/A,1.00E-02,11,1.30E-01,10,3.20E-03,11,1.00E-01,10,5.50E-02,10,1.00E+00,#N/AGOTERM_BP_5,nitric oxide biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"gene silencing by miRNA, production of miRNAs",1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,sarcomere organization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of peptide secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,endochondral ossification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to copper ion,1.00E+00,#N/A,4.40E-02,10,1.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to iron ion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,syncytium formation by plasma membrane fusion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cell migration,9.30E-01,120,6.70E-01,126,3.00E-01,156,5.80E-01,112,9.70E-01,132,7.60E-01,128,9.90E-01,108GOTERM_BP_5,regulation of cellular response to stress,1.20E-01,56,3.70E-01,51,1.00E-01,64,9.00E-02,50,2.60E-01,59,7.80E-02,58,3.80E-01,50GOTERM_BP_5,monovalent inorganic cation transport,7.10E-01,147,9.70E-01,132,1.00E+00,#N/A,7.00E-01,126,9.20E-01,157,9.50E-01,139,8.60E-01,137GOTERM_BP_5,negative regulation of DNA replication,8.50E-01,12,4.20E-01,15,2.00E-01,19,6.30E-01,12,6.90E-01,15,9.70E-01,10,9.50E-01,10GOTERM_BP_5,negative regulation of cell projection organization,9.70E-01,10,5.70E-01,14,5.10E-02,21,5.70E-02,17,2.60E-01,18,4.90E-01,15,3.90E-01,15GOTERM_BP_5,acute inflammatory response,4.80E-01,48,2.70E-01,50,4.10E-01,56,7.50E-01,38,6.70E-01,51,2.60E-02,58,6.00E-01,45GOTERM_BP_5,myeloid cell differentiation,9.60E-01,37,8.80E-01,39,8.60E-01,47,9.60E-01,31,9.80E-01,41,9.00E-01,40,9.80E-01,34GOTERM_BP_5,development of primary sexual characteristics,3.30E-01,64,7.90E-01,56,6.20E-01,69,3.60E-01,55,8.40E-01,63,8.70E-01,56,9.90E-01,47GOTERM_BP_5,regulation of transporter activity,5.10E-01,17,8.40E-01,14,8.10E-01,17,9.20E-01,11,7.50E-01,17,5.40E-01,17,7.10E-01,15GOTERM_BP_5,positive regulation of calcium ion transport,1.60E-01,20,3.50E-02,22,1.90E-01,22,1.60E-02,21,1.40E-01,22,2.80E-01,19,1.20E-02,23GOTERM_BP_5,positive regulation of organelle organization,9.00E-01,35,7.50E-01,37,8.90E-01,41,9.80E-02,41,9.20E-01,39,6.90E-01,39,6.20E-01,38GOTERM_BP_5,regulation of ossification,8.40E-01,34,9.00E-01,32,6.70E-01,42,2.60E-01,36,7.30E-01,40,4.00E-01,40,8.80E-01,32GOTERM_BP_5,heart morphogenesis,9.80E-01,27,8.50E-01,31,1.00E+00,#N/A,9.90E-01,22,5.00E-01,40,5.40E-01,36,8.70E-01,30GOTERM_BP_5,regulation of protein polymerization,9.70E-01,26,8.90E-01,28,1.00E+00,#N/A,5.10E-01,29,7.90E-01,34,9.30E-01,28,9.10E-01,27GOTERM_BP_5,negative regulation of cell adhesion,9.30E-01,17,4.30E-01,22,7.20E-01,23,6.10E-01,18,8.30E-01,21,9.70E-01,16,9.90E-01,14GOTERM_BP_5,regulation of actin filament length,8.60E-01,27,8.30E-01,27,8.30E-01,32,7.00E-01,25,6.70E-01,33,8.20E-01,28,8.60E-01,26GOTERM_BP_5,negative regulation of cell development,8.20E-01,21,7.00E-01,22,1.00E-01,32,3.80E-01,22,5.90E-01,26,4.40E-01,25,6.60E-01,22GOTERM_BP_5,regulation of proteolysis,2.50E-01,29,8.80E-02,31,9.80E-02,35,2.00E-01,26,3.40E-01,31,2.50E-02,34,7.10E-02,31GOTERM_BP_5,regulation of mRNA processing,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,4.00E-01,11,4.30E-01,10,2.00E-01,11GOTERM_BP_5,heme biosynthetic process,1.20E-01,12,3.90E-02,13,5.40E-02,14,2.10E-01,10,1.20E-02,15,1.60E-02,14,2.20E-03,15GOTERM_BP_5,nucleic acid transport,4.50E-01,48,3.80E-01,48,2.30E-02,64,2.00E-01,45,2.80E-02,62,3.30E-02,57,7.00E-02,53GOTERM_BP_5,RNA transport,4.50E-01,48,3.80E-01,48,2.30E-02,64,2.00E-01,45,2.80E-02,62,3.30E-02,57,7.00E-02,53GOTERM_BP_5,thymus development,6.50E-01,11,4.50E-01,12,5.80E-01,13,1.00E+00,#N/A,6.80E-01,12,5.10E-01,12,5.90E-01,11GOTERM_BP_5,initiation of viral infection,7.90E-01,10,2.90E-01,13,2.60E-01,15,1.00E+00,#N/A,5.20E-01,13,6.70E-01,11,1.00E+00,#N/AGOTERM_BP_5,oligodendrocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,2.60E-01,15,1.00E+00,#N/A,8.20E-01,11,1.00E+00,#N/A,7.40E-01,10GOTERM_BP_5,pyrimidine nucleotide biosynthetic process,9.20E-02,15,4.50E-01,12,1.40E-01,16,2.50E-01,12,5.20E-01,13,3.40E-01,13,2.70E-01,13GOTERM_BP_5,positive regulation of nucleocytoplasmic transport,1.00E+00,#N/A,7.70E-01,10,5.80E-01,13,5.70E-01,10,1.00E+00,#N/A,6.70E-01,11,4.20E-01,12GOTERM_BP_5,regulation of neurotransmitter levels,7.00E-01,31,7.40E-01,30,8.90E-01,33,6.60E-01,27,5.80E-01,36,9.20E-01,28,5.10E-01,32GOTERM_BP_5,RNA 3'-end processing,5.40E-01,14,1.30E-01,17,6.90E-02,20,8.40E-02,16,1.00E-01,19,4.10E-01,15,3.20E-01,15GOTERM_BP_5,visual learning,6.90E-01,13,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.70E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cardiac muscle tissue morphogenesis,1.00E+00,#N/A,8.80E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,6.10E-01,15,5.70E-01,14,1.00E+00,#N/AGOTERM_BP_5,muscle tissue morphogenesis,1.00E+00,#N/A,8.80E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,6.10E-01,15,5.70E-01,14,1.00E+00,#N/AGOTERM_BP_5,regulation of cell-matrix adhesion,8.10E-01,12,6.50E-01,13,8.00E-01,14,7.10E-01,11,9.30E-01,12,9.10E-01,11,1.00E+00,#N/AGOTERM_BP_5,ovulation cycle process,6.80E-01,29,5.30E-01,30,7.20E-01,33,1.30E-01,31,7.10E-01,32,7.10E-01,29,9.30E-01,24GOTERM_BP_5,centrosome organization,2.00E-01,19,3.10E-03,24,2.30E-01,21,5.30E-02,19,2.20E-02,24,7.00E-02,21,1.80E-02,22GOTERM_BP_5,DNA metabolic process,2.80E-01,247,6.00E-03,264,3.30E-02,297,1.10E-02,232,3.70E-02,288,6.00E-02,261,7.80E-02,248GOTERM_BP_5,positive regulation of cell growth,4.20E-01,22,3.80E-01,22,3.10E-01,26,3.20E-01,20,3.40E-01,25,1.50E-01,25,3.40E-01,22GOTERM_BP_5,cell cycle checkpoint,6.20E-01,43,4.80E-01,44,2.80E-02,60,5.40E-01,38,7.70E-01,46,9.00E-01,39,6.70E-01,41GOTERM_BP_5,regulation of cardiac muscle cell proliferation,1.00E+00,#N/A,1.00E+00,#N/A,6.00E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.60E-02,10GOTERM_BP_5,positive regulation of erythrocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of proteasomal ubiquitin-dependent protein catabolic process,1.00E+00,#N/A,1.90E-02,10,1.30E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,2.40E-02,10,2.50E-03,11GOTERM_BP_5,negative regulation of cell-substrate adhesion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,actin filament polymerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of cardiac muscle tissue development,1.00E+00,#N/A,1.00E+00,#N/A,6.00E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.60E-02,10GOTERM_BP_5,cytoplasmic sequestering of transcription factor,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,myoblast fusion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of myoblast differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mitochondrion morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,6.00E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,establishment of pigment granule localization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of cardiac muscle growth,1.00E+00,#N/A,1.00E+00,#N/A,6.00E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.60E-02,10GOTERM_BP_5,regulation of TOR signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,lipopolysaccharide-mediated signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of membrane potential,8.80E-01,58,6.20E-01,62,7.30E-01,71,9.60E-01,46,6.50E-01,70,9.40E-01,57,7.40E-01,59GOTERM_BP_5,regulation of epithelial cell proliferation,1.70E-01,39,6.40E-01,33,2.50E-01,43,1.90E-01,34,5.00E-01,39,4.50E-01,36,4.90E-01,34GOTERM_BP_5,positive regulation of developmental growth,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.40E-01,10,1.00E+00,#N/AGOTERM_BP_5,membrane budding,3.20E-01,10,6.10E-02,12,3.50E-01,11,2.20E-02,12,6.00E-02,13,1.80E-01,11,5.40E-02,12GOTERM_BP_5,regulation of blood vessel endothelial cell migration,3.20E-01,10,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of immune effector process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,viral genome replication,3.20E-01,10,1.00E+00,#N/A,7.80E-02,13,1.00E+00,#N/A,4.90E-01,10,3.40E-01,10,1.00E+00,#N/AGOTERM_BP_5,DNA replication initiation,1.00E+00,#N/A,6.10E-02,12,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of S phase of mitotic cell cycle,3.20E-01,10,1.50E-01,11,7.80E-02,13,1.00E+00,#N/A,6.00E-02,13,1.80E-01,11,1.00E+00,#N/AGOTERM_BP_5,response to vitamin D,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,endochondral bone morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,branched chain family amino acid metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,3.50E-01,11,1.50E-01,10,4.90E-01,10,7.70E-02,12,5.40E-02,12GOTERM_BP_5,regulation of cellular catabolic process,2.50E-01,33,6.80E-01,28,2.80E-01,37,6.30E-01,25,8.90E-01,29,6.70E-01,29,3.30E-01,31GOTERM_BP_5,regulation of actin polymerization or depolymerization,8.70E-01,26,8.40E-01,26,8.30E-01,31,7.20E-01,24,6.70E-01,32,8.30E-01,27,8.70E-01,25GOTERM_BP_5,regulation of neuron differentiation,3.90E-01,66,2.60E-01,67,5.50E-02,83,3.20E-02,66,2.80E-01,75,1.60E-01,71,1.60E-01,68GOTERM_BP_5,RNA elongation,4.00E-03,35,2.10E-01,28,2.70E-02,36,3.00E-01,24,3.30E-01,30,1.90E-01,29,4.70E-01,25GOTERM_BP_5,cAMP metabolic process,5.70E-01,11,7.10E-01,10,6.60E-01,12,1.00E+00,#N/A,8.70E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,gastrulation with mouth forming second,4.00E-01,12,2.20E-01,13,8.70E-02,16,3.30E-01,11,1.40E-01,15,6.60E-02,15,4.30E-02,15GOTERM_BP_5,G1 phase,2.50E-01,13,2.20E-01,13,3.50E-02,17,3.30E-01,11,4.30E-01,13,6.00E-01,11,5.10E-01,11GOTERM_BP_5,patterning of blood vessels,2.50E-01,13,1.80E-02,16,1.10E-02,18,9.40E-02,13,1.40E-01,15,1.40E-01,14,1.00E-01,14GOTERM_BP_5,positive regulation of leukocyte mediated cytotoxicity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,7.50E-01,10,6.80E-01,10GOTERM_BP_5,neutral amino acid transport,2.50E-01,13,3.70E-01,12,1.80E-01,15,1.90E-01,12,4.30E-01,13,4.20E-01,12,3.40E-01,12GOTERM_BP_5,negative regulation of synaptic transmission,7.30E-01,10,5.40E-01,11,8.00E-01,11,3.30E-01,11,6.00E-01,12,6.00E-01,11,6.80E-01,10GOTERM_BP_5,"retrograde vesicle-mediated transport, Golgi to ER",1.30E-01,14,1.80E-02,16,8.70E-02,16,9.40E-02,13,2.70E-01,14,6.60E-02,15,1.00E-01,14GOTERM_BP_5,positive regulation of nitric oxide biosynthetic process,1.30E-01,14,1.10E-01,14,3.20E-01,14,5.00E-01,10,6.00E-01,12,2.60E-01,13,3.40E-01,12GOTERM_BP_5,release of cytochrome c from mitochondria,1.00E+00,#N/A,5.40E-01,11,1.80E-01,15,1.00E+00,#N/A,7.50E-01,11,7.50E-01,10,6.80E-01,10GOTERM_BP_5,regulation of cell-substrate adhesion,8.30E-01,20,7.10E-01,21,8.50E-01,23,6.40E-01,19,9.20E-01,21,8.50E-01,20,9.10E-01,18GOTERM_BP_5,vasculogenesis,8.90E-01,17,5.60E-01,20,6.00E-01,23,3.90E-01,19,3.90E-01,24,6.40E-01,20,2.90E-01,22GOTERM_BP_5,regulation of production of molecular mediator of immune response,8.90E-01,17,9.90E-01,13,1.00E+00,#N/A,9.90E-01,11,9.90E-01,15,1.00E+00,11,1.00E+00,11GOTERM_BP_5,positive regulation of oxidoreductase activity,1.90E-01,16,4.30E-01,14,4.50E-01,16,3.50E-01,13,5.30E-01,15,3.40E-01,15,5.50E-01,13GOTERM_BP_5,glial cell development,6.20E-01,13,7.30E-01,12,1.80E-01,18,1.00E+00,#N/A,6.80E-01,14,8.80E-01,11,4.00E-01,14GOTERM_BP_5,nerve-nerve synaptic transmission,3.80E-01,17,9.60E-01,11,8.90E-01,15,1.00E+00,#N/A,6.20E-01,17,9.40E-01,12,9.10E-01,12GOTERM_BP_5,monosaccharide transport,8.70E-01,13,9.20E-01,12,5.60E-01,18,5.10E-01,14,8.50E-01,15,8.00E-01,14,4.50E-01,16GOTERM_BP_5,positive regulation of smooth muscle cell proliferation,9.30E-01,12,3.40E-01,17,9.40E-02,22,3.70E-01,15,7.50E-01,16,4.10E-01,17,5.90E-01,15GOTERM_BP_5,regulation of microtubule polymerization or depolymerization,7.80E-01,14,7.50E-01,14,6.90E-01,17,7.80E-01,12,4.80E-01,18,6.90E-01,15,7.20E-01,14GOTERM_BP_5,icosanoid biosynthetic process,9.30E-01,12,2.20E-01,18,6.90E-01,17,1.40E-01,17,1.30E-01,21,2.80E-01,18,8.30E-01,13GOTERM_BP_5,visual behavior,6.60E-01,15,9.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,9.60E-01,13,1.00E+00,#N/A,9.80E-01,10GOTERM_BP_5,cytokine-mediated signaling pathway,6.50E-01,33,5.00E-01,34,4.60E-01,40,7.60E-01,27,5.40E-01,38,3.20E-01,37,3.50E-01,35GOTERM_BP_5,DNA catabolic process,1.70E-02,38,1.70E-01,33,3.20E-01,36,3.10E-02,33,5.20E-01,33,1.70E-01,34,5.60E-02,35GOTERM_BP_5,secretion by cell,6.80E-01,96,6.90E-01,94,6.20E-01,112,5.30E-01,85,5.90E-01,109,7.40E-01,96,7.60E-01,91GOTERM_BP_5,negative regulation of nitrogen compound metabolic process,7.90E-01,238,9.70E-01,222,2.60E-01,291,7.20E-01,206,9.30E-01,259,9.60E-01,231,9.20E-01,223GOTERM_BP_5,monocarboxylic acid transport,8.80E-01,21,8.50E-01,21,1.00E+00,#N/A,3.60E-01,23,7.00E-01,26,9.00E-01,21,7.40E-01,22GOTERM_BP_5,negative regulation of response to external stimulus,7.30E-01,23,9.50E-01,19,6.90E-01,27,4.70E-01,22,8.60E-01,24,4.40E-01,26,8.30E-01,21GOTERM_BP_5,positive regulation of cell motion,8.80E-01,42,3.40E-01,49,7.80E-01,51,6.00E-01,40,9.70E-01,44,6.90E-01,46,9.50E-01,38GOTERM_BP_5,negative regulation of neurogenesis,8.00E-01,20,7.60E-01,20,1.80E-01,29,4.70E-01,20,6.40E-01,24,6.20E-01,22,7.30E-01,20GOTERM_BP_5,nucleosome organization,2.30E-01,49,1.40E-04,62,7.80E-04,67,4.90E-04,55,2.50E-04,67,8.30E-05,64,2.60E-01,47GOTERM_BP_5,positive regulation of epithelial cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of muscle cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,Golgi vesicle budding,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,lymphocyte apoptosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,osteoblast development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,COPI coating of Golgi vesicle,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of meiotic cell cycle,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to purine,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ectodermal gut development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of activin receptor signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ectodermal gut morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,establishment of spindle localization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of blood coagulation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of muscle adaptation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,establishment of melanosome localization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ER overload response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glucocorticoid metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pigment granule transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hemoglobin metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,Golgi transport vesicle coating,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of cell-matrix adhesion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to interferon-gamma,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of T cell receptor signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of immune response,9.90E-01,55,6.20E-01,67,1.00E+00,#N/A,9.50E-01,51,1.00E+00,62,8.80E-01,64,9.00E-01,60GOTERM_BP_5,female sex differentiation,6.90E-01,32,7.30E-01,31,7.70E-01,36,2.00E-01,33,8.80E-01,33,8.60E-01,30,9.90E-01,24GOTERM_BP_5,development of primary female sexual characteristics,6.90E-01,32,7.30E-01,31,7.70E-01,36,2.00E-01,33,8.80E-01,33,8.60E-01,30,9.90E-01,24GOTERM_BP_5,positive regulation of cell development,6.90E-01,32,7.30E-01,31,1.70E-01,43,5.50E-01,29,7.60E-01,35,6.50E-01,33,5.00E-01,33GOTERM_BP_5,regulation of fibroblast proliferation,9.20E-01,14,8.20E-01,15,4.40E-01,21,7.20E-01,14,9.10E-01,16,9.60E-01,13,9.40E-01,13GOTERM_BP_5,nucleoside metabolic process,5.80E-02,38,1.70E-01,35,4.60E-02,43,8.10E-02,33,2.50E-01,38,2.40E-02,40,5.70E-02,37GOTERM_BP_5,female gonad development,7.50E-01,29,7.10E-01,29,8.00E-01,33,2.60E-01,30,8.60E-01,31,8.50E-01,28,9.90E-01,22GOTERM_BP_5,regulation of interferon-gamma production,8.40E-01,13,9.00E-01,12,1.00E+00,#N/A,7.30E-01,12,9.90E-01,11,9.20E-01,12,1.00E+00,#N/AGOTERM_BP_5,biogenic amine biosynthetic process,5.70E-02,20,1.70E-01,18,1.20E-01,21,1.10E-01,17,1.60E-01,20,1.30E-01,19,2.50E-01,17GOTERM_BP_5,regulation of interleukin-2 production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.60E-01,11,9.40E-01,11GOTERM_BP_5,hexose transport,8.40E-01,13,9.00E-01,12,4.80E-01,18,6.00E-01,13,8.90E-01,14,7.50E-01,14,5.30E-01,15GOTERM_BP_5,cellular response to reactive oxygen species,4.50E-01,16,1.70E-01,18,8.50E-01,15,1.90E-01,16,6.90E-01,16,4.80E-01,16,6.70E-01,14GOTERM_BP_5,regulation of bone mineralization,7.30E-01,14,9.80E-01,10,6.20E-01,17,4.50E-01,14,8.90E-01,14,4.80E-01,16,6.70E-01,14GOTERM_BP_5,pyridine nucleotide biosynthetic process,3.80E-02,12,2.10E-01,10,4.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,2.00E-01,10GOTERM_BP_5,positive regulation of production of molecular mediator of immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,vesicle coating,2.30E-01,10,9.40E-02,11,2.50E-01,11,3.80E-02,11,8.90E-02,12,1.20E-01,11,8.40E-02,11GOTERM_BP_5,biogenic amine catabolic process,1.10E-01,11,9.40E-02,11,3.90E-02,13,1.00E+00,#N/A,2.90E-02,13,1.20E-01,11,7.20E-03,13GOTERM_BP_5,negative regulation of lipid biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.10E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,2.50E-01,10,2.00E-01,10GOTERM_BP_5,dicarboxylic acid transport,1.00E+00,#N/A,2.10E-01,10,2.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,2.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,mitotic spindle organization,1.00E+00,#N/A,9.40E-02,11,1.10E-01,12,1.00E-01,10,2.90E-02,13,1.20E-01,11,2.90E-02,12GOTERM_BP_5,positive regulation of endothelial cell proliferation,2.30E-01,10,9.40E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,3.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,establishment of chromosome localization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,oligodendrocyte development,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of leukocyte mediated cytotoxicity,9.10E-01,10,8.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,9.30E-01,11,8.40E-01,11,7.80E-01,11GOTERM_BP_5,regulation of steroid biosynthetic process,2.50E-01,15,5.10E-01,13,2.20E-01,17,4.40E-01,12,9.30E-01,11,2.70E-01,15,7.80E-01,11GOTERM_BP_5,terpenoid metabolic process,1.10E-02,19,1.20E-01,16,1.20E-01,18,8.70E-02,15,6.10E-01,14,4.20E-01,14,4.80E-01,13GOTERM_BP_5,negative regulation of axonogenesis,1.00E+00,#N/A,5.10E-01,13,5.70E-02,19,8.70E-02,15,1.80E-01,17,4.20E-01,14,3.30E-01,14GOTERM_BP_5,photoreceptor cell differentiation,1.00E+00,#N/A,8.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,9.70E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of S phase,4.90E-01,11,1.60E-01,13,1.20E-01,15,1.00E+00,#N/A,9.20E-02,15,2.00E-01,13,4.30E-01,11GOTERM_BP_5,blastocyst formation,6.60E-01,10,1.00E+00,#N/A,3.90E-01,13,2.60E-01,11,6.80E-01,11,5.10E-01,11,1.00E+00,#N/AGOTERM_BP_5,response to progesterone stimulus,1.00E+00,#N/A,6.40E-01,10,1.00E+00,#N/A,4.30E-01,10,8.20E-01,10,6.80E-01,10,1.00E+00,#N/AGOTERM_BP_5,bone morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glucosamine metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,6.80E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of calcium ion transport into cytosol,3.20E-01,12,2.90E-01,12,3.90E-01,13,1.40E-01,12,1.90E-01,14,5.10E-01,11,1.40E-01,13GOTERM_BP_5,isoprenoid biosynthetic process,2.90E-03,17,9.10E-03,16,5.00E-02,16,1.90E-03,16,1.10E-02,17,6.90E-04,18,7.50E-03,16GOTERM_BP_5,purine nucleoside monophosphate metabolic process,1.80E-01,13,6.40E-01,10,2.40E-01,14,4.30E-01,10,1.90E-01,14,2.00E-01,13,2.70E-01,12GOTERM_BP_5,positive regulation of neurogenesis,6.40E-01,28,6.90E-01,27,7.80E-02,39,3.40E-01,27,5.60E-01,32,4.70E-01,30,3.40E-01,30GOTERM_BP_5,positive regulation of defense response,8.30E-01,32,4.40E-01,36,3.40E-01,43,4.20E-01,32,5.00E-01,40,2.00E-01,40,3.90E-01,36GOTERM_BP_5,erythrocyte homeostasis,9.90E-01,17,9.60E-01,18,1.00E+00,#N/A,9.90E-01,14,9.90E-01,19,9.20E-01,20,1.00E+00,15GOTERM_BP_5,organic anion transport,5.30E-01,22,6.10E-01,21,6.70E-01,24,9.10E-01,15,7.00E-01,23,7.80E-01,20,5.70E-01,21GOTERM_BP_5,regulation of lymphocyte differentiation,1.00E+00,19,9.60E-01,24,8.30E-01,32,6.10E-01,26,9.90E-01,26,9.30E-01,26,7.90E-01,27GOTERM_BP_5,response to amine stimulus,8.30E-01,17,8.00E-01,17,5.90E-01,22,8.60E-01,14,8.40E-01,19,6.50E-01,19,8.60E-01,16GOTERM_BP_5,positive regulation of cell division,6.20E-01,19,5.80E-01,19,1.00E+00,#N/A,7.80E-01,15,8.40E-01,19,7.60E-01,18,6.60E-01,18GOTERM_BP_5,regulation of carbohydrate metabolic process,3.70E-01,21,8.80E-01,16,5.90E-01,22,8.60E-01,14,8.40E-01,19,8.50E-01,17,9.20E-01,15GOTERM_BP_5,odontogenesis of dentine-containing tooth,2.50E-01,22,8.00E-01,17,2.30E-01,25,5.40E-01,17,8.40E-01,19,8.50E-01,17,5.40E-01,19GOTERM_BP_5,regulation of heart contraction,7.50E-01,35,9.20E-01,31,1.00E+00,#N/A,8.10E-01,29,8.30E-01,38,6.20E-01,37,9.40E-01,30GOTERM_BP_5,post-Golgi vesicle-mediated transport,1.40E-01,33,2.30E-02,36,1.70E-02,41,8.80E-03,34,1.80E-02,40,5.10E-03,39,3.20E-02,35GOTERM_BP_5,regulation of protein secretion,9.70E-01,22,9.20E-01,23,1.00E+00,#N/A,9.70E-01,18,1.00E+00,22,9.90E-01,21,1.00E+00,18GOTERM_BP_5,catecholamine metabolic process,5.80E-01,17,5.40E-01,17,3.70E-01,21,7.90E-01,13,3.00E-01,21,2.20E-01,20,1.50E-01,20GOTERM_BP_5,neurotransmitter secretion,8.10E-01,15,7.80E-01,15,8.50E-01,17,8.80E-01,12,3.00E-01,21,8.30E-01,15,5.00E-01,17GOTERM_BP_5,catechol metabolic process,5.80E-01,17,5.40E-01,17,3.70E-01,21,7.90E-01,13,3.00E-01,21,2.20E-01,20,1.50E-01,20GOTERM_BP_5,regulation of neurogenesis,4.30E-01,81,6.60E-01,76,1.70E-01,98,2.10E-01,74,5.70E-01,88,3.80E-01,83,4.50E-01,78GOTERM_BP_5,regulation of calcium ion transport into cytosol,6.70E-01,14,6.40E-01,14,8.00E-01,15,2.60E-01,15,6.20E-01,16,8.10E-01,13,6.10E-01,14GOTERM_BP_5,positive regulation of phosphorus metabolic process,6.40E-01,47,9.20E-01,41,1.00E+00,#N/A,7.40E-01,39,9.50E-01,46,9.30E-01,42,8.90E-01,41GOTERM_BP_5,regulation of blood pressure,7.80E-01,45,5.70E-01,47,7.90E-01,52,5.90E-01,41,2.90E-01,57,3.70E-01,51,8.50E-01,42GOTERM_BP_5,positive regulation of phosphate metabolic process,6.40E-01,47,9.20E-01,41,1.00E+00,#N/A,7.40E-01,39,9.50E-01,46,9.30E-01,42,8.90E-01,41GOTERM_BP_5,vesicle docking during exocytosis,7.70E-01,11,4.40E-01,13,5.90E-01,14,5.40E-01,11,6.80E-01,13,7.90E-01,11,7.20E-01,11GOTERM_BP_5,nucleoside triphosphate catabolic process,4.70E-01,13,6.00E-01,12,4.30E-01,15,2.30E-01,13,6.80E-01,13,3.40E-01,14,2.60E-01,14GOTERM_BP_5,photoreceptor cell development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of synapse structure and activity,6.30E-01,12,7.50E-01,11,5.90E-01,14,3.70E-01,12,6.80E-01,13,5.00E-01,13,7.20E-01,11GOTERM_BP_5,amine biosynthetic process,2.00E-02,49,7.40E-03,50,7.50E-02,52,2.60E-02,43,6.40E-02,51,1.50E-02,50,4.60E-02,46GOTERM_BP_5,"negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process",8.30E-01,233,9.70E-01,219,3.00E-01,286,7.20E-01,203,9.30E-01,255,9.60E-01,228,9.30E-01,219GOTERM_BP_5,DNA fragmentation involved in apoptosis,5.20E-02,14,4.00E-03,16,2.50E-02,16,4.00E-02,13,5.30E-02,15,5.80E-03,16,1.30E-02,15GOTERM_BP_5,centrosome cycle,4.00E-01,11,4.50E-02,14,4.70E-01,12,2.00E-01,11,1.30E-01,14,2.60E-01,12,9.60E-02,13GOTERM_BP_5,positive regulation of biomineral formation,2.40E-01,12,1.00E+00,#N/A,6.50E-01,11,3.50E-01,10,7.60E-01,10,6.10E-01,10,5.30E-01,10GOTERM_BP_5,bile acid metabolic process,1.20E-01,13,1.50E-02,15,6.70E-03,17,4.00E-02,13,4.50E-03,17,5.80E-03,16,3.90E-02,14GOTERM_BP_5,cartilage condensation,1.00E+00,#N/A,1.00E+00,#N/A,3.00E-01,13,2.00E-01,11,4.10E-01,12,4.30E-01,11,1.00E+00,#N/AGOTERM_BP_5,smoothened signaling pathway,5.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,5.30E-01,10GOTERM_BP_5,intra-Golgi vesicle-mediated transport,1.20E-01,13,1.10E-01,13,4.70E-01,12,2.00E-01,11,5.30E-02,15,4.30E-01,11,2.00E-01,12GOTERM_BP_5,determination of bilateral symmetry,6.00E-01,21,8.60E-01,18,6.10E-01,24,8.90E-01,15,1.90E-01,27,5.10E-01,22,3.90E-01,22GOTERM_BP_5,regulation of osteoblast differentiation,6.00E-01,21,7.70E-01,19,1.70E-01,28,6.00E-02,24,4.00E-01,25,1.20E-01,26,5.10E-01,21GOTERM_BP_5,erythrocyte differentiation,9.80E-01,15,9.50E-01,16,8.80E-01,21,9.70E-01,13,9.90E-01,17,9.40E-01,17,1.00E+00,12GOTERM_BP_5,regulation of polysaccharide biosynthetic process,6.10E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of glucan biosynthetic process,6.10E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of chondrocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,3.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of smooth muscle cell proliferation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,muscle maintenance,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,syncytium formation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of actin filament bundle formation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of ossification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,synaptic vesicle endocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mRNA splice site selection,6.10E-02,11,1.40E-01,10,3.20E-01,10,1.00E+00,#N/A,2.80E-01,10,1.70E-01,10,1.00E+00,#N/AGOTERM_BP_5,endosome to lysosome transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of glycogen biosynthetic process,6.10E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,nitric oxide mediated signal transduction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,6.40E-02,10,1.30E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of epidermal cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of interleukin-1 beta production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ovulation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,amino acid transport,2.60E-01,47,2.10E-01,47,3.00E-01,53,5.00E-01,38,5.80E-01,48,2.40E-01,48,3.80E-01,44GOTERM_BP_5,regulation of smooth muscle contraction,6.80E-01,18,7.60E-01,17,8.50E-01,19,3.60E-01,18,5.70E-01,21,8.10E-01,17,9.00E-01,15GOTERM_BP_5,regulation of cellular carbohydrate metabolic process,4.30E-01,20,9.10E-01,15,6.50E-01,21,9.10E-01,13,8.80E-01,18,8.90E-01,16,9.40E-01,14GOTERM_BP_5,DNA integrity checkpoint,6.20E-01,25,6.70E-01,24,1.20E-01,34,6.70E-01,21,9.10E-01,24,9.90E-01,18,9.30E-01,20GOTERM_BP_5,glutamine family amino acid metabolic process,5.00E-02,32,1.10E-01,30,1.90E-01,33,3.60E-02,29,2.80E-01,31,1.60E-01,30,1.50E-01,29GOTERM_BP_5,male gonad development,3.00E-01,28,7.70E-01,23,6.90E-01,28,7.70E-01,20,7.90E-01,26,7.50E-01,24,8.80E-01,21GOTERM_BP_5,smooth muscle contraction,6.50E-01,16,6.10E-01,16,7.00E-01,18,7.50E-01,13,3.50E-01,20,1.70E-01,20,7.10E-01,15GOTERM_BP_5,antigen receptor-mediated signaling pathway,9.20E-01,13,4.70E-01,17,7.00E-01,18,8.50E-01,12,9.60E-01,14,8.80E-01,14,5.80E-01,16GOTERM_BP_5,phospholipid transport,9.20E-01,13,8.40E-01,14,8.10E-01,17,3.50E-01,16,9.10E-01,15,9.30E-01,13,8.10E-01,14GOTERM_BP_5,mRNA export from nucleus,6.50E-01,16,7.40E-01,15,1.90E-01,22,4.80E-01,15,4.90E-01,19,1.70E-01,20,5.80E-01,16GOTERM_BP_5,activation of immune response,9.30E-01,39,3.50E-01,47,7.10E-01,50,9.50E-01,32,9.70E-01,42,6.20E-01,45,8.70E-01,39GOTERM_BP_5,negative regulation of neurological system process,6.10E-01,14,5.70E-01,14,7.50E-01,15,4.80E-01,13,5.40E-01,16,4.90E-01,15,6.80E-01,13GOTERM_BP_5,fatty acid transport,1.00E+00,#N/A,8.30E-01,12,1.00E+00,#N/A,6.30E-01,12,8.90E-01,13,8.70E-01,12,9.50E-01,10GOTERM_BP_5,positive regulation of DNA replication,4.60E-01,15,1.70E-01,17,3.20E-01,18,3.30E-01,14,5.40E-01,16,7.70E-01,13,5.40E-01,14GOTERM_BP_5,regulation of fatty acid oxidation,3.20E-01,16,2.80E-01,16,2.00E-01,19,6.30E-01,12,6.90E-01,15,2.10E-01,17,3.90E-01,15GOTERM_BP_5,proton transport,1.20E-01,35,5.80E-01,29,7.60E-01,32,1.10E-01,31,4.70E-01,34,5.70E-01,30,5.30E-01,29GOTERM_BP_5,regulation of transcription factor activity,8.50E-01,45,5.20E-01,49,2.50E-01,61,4.40E-01,44,5.70E-01,55,3.30E-01,53,7.60E-01,45GOTERM_BP_5,intracellular receptor-mediated signaling pathway,1.70E-01,41,3.30E-03,48,1.10E-02,52,7.80E-02,38,1.30E-01,46,2.00E-01,41,7.30E-02,42GOTERM_BP_5,negative regulation of gene expression,8.10E-01,230,8.90E-01,222,3.20E-01,281,5.40E-01,205,8.70E-01,255,7.90E-01,234,8.30E-01,221GOTERM_BP_5,response to vitamin A,7.70E-01,19,7.30E-01,19,8.50E-01,21,6.80E-01,17,9.80E-01,17,9.60E-01,16,8.70E-01,17GOTERM_BP_5,determination of left/right symmetry,6.60E-01,20,8.90E-01,17,6.60E-01,23,9.30E-01,14,2.30E-01,26,5.80E-01,21,4.60E-01,21GOTERM_BP_5,heart contraction,1.00E+00,#N/A,5.30E-01,12,9.00E-01,11,1.80E-01,13,1.60E-01,16,1.50E-01,15,6.60E-01,11GOTERM_BP_5,negative regulation of angiogenesis,7.20E-01,11,8.20E-01,10,6.70E-01,13,1.00E+00,#N/A,8.60E-01,11,8.50E-01,10,8.00E-01,10GOTERM_BP_5,sulfur amino acid metabolic process,6.40E-02,16,5.50E-02,16,2.00E-01,16,3.10E-01,12,1.60E-01,16,2.70E-01,14,1.00E-01,15GOTERM_BP_5,retinoid metabolic process,2.60E-02,17,2.20E-01,14,2.00E-01,16,1.80E-01,13,7.50E-01,12,5.80E-01,12,6.60E-01,11GOTERM_BP_5,cell structure disassembly during apoptosis,2.50E-01,14,2.10E-02,17,1.00E-01,17,9.10E-02,14,1.60E-01,16,7.30E-02,16,4.70E-02,16GOTERM_BP_5,negative regulation of blood coagulation,8.40E-01,10,3.60E-01,13,5.10E-01,14,4.70E-01,11,9.40E-01,10,5.80E-01,12,3.40E-01,13GOTERM_BP_5,positive regulation of peptide secretion,5.60E-01,12,6.90E-01,11,6.70E-01,13,3.10E-01,12,7.50E-01,12,5.80E-01,12,8.00E-01,10GOTERM_BP_5,positive regulation of cytokine secretion,7.20E-01,11,8.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,8.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of DNA metabolic process,5.00E-01,28,7.50E-01,25,3.90E-01,33,6.30E-01,23,7.10E-01,29,9.20E-01,23,9.50E-01,21GOTERM_BP_5,negative regulation of catabolic process,3.70E-01,20,2.20E-01,21,2.20E-01,24,8.00E-01,14,8.40E-01,18,5.30E-01,19,5.50E-01,18GOTERM_BP_5,sterol transport,5.00E-01,19,7.10E-01,17,5.90E-01,21,1.00E+00,#N/A,9.50E-01,16,8.60E-01,16,8.70E-01,15GOTERM_BP_5,cholesterol transport,5.00E-01,19,7.10E-01,17,5.90E-01,21,1.00E+00,#N/A,9.50E-01,16,8.60E-01,16,8.70E-01,15GOTERM_BP_5,biomineral formation,7.40E-01,17,8.90E-01,15,7.10E-01,20,3.10E-01,18,7.50E-01,19,6.60E-01,18,3.00E-01,20GOTERM_BP_5,regulation of G-protein coupled receptor protein signaling pathway,7.70E-01,23,9.30E-01,20,1.00E+00,#N/A,5.20E-01,22,6.50E-01,27,9.80E-01,19,6.90E-01,23GOTERM_BP_5,development of primary male sexual characteristics,4.20E-01,33,8.80E-01,27,6.80E-01,35,8.40E-01,24,8.30E-01,32,8.80E-01,28,9.00E-01,26GOTERM_BP_5,neuron maturation,3.20E-01,11,2.90E-01,11,2.10E-01,13,1.00E+00,#N/A,5.00E-01,11,3.40E-01,11,2.70E-01,11GOTERM_BP_5,glycoprotein catabolic process,2.90E-02,14,2.90E-01,11,3.70E-01,12,1.00E+00,#N/A,7.60E-02,14,5.20E-01,10,2.70E-01,11GOTERM_BP_5,G1 phase of mitotic cell cycle,3.20E-01,11,1.60E-01,12,9.90E-02,14,2.80E-01,10,6.80E-01,10,5.20E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of cytokine production during immune response,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,chondrocyte differentiation,5.00E-01,10,1.00E+00,#N/A,2.10E-01,13,2.80E-01,10,1.00E+00,#N/A,5.20E-01,10,1.00E+00,#N/AGOTERM_BP_5,positive regulation of bone mineralization,3.20E-01,11,1.00E+00,#N/A,5.60E-01,11,2.80E-01,10,6.80E-01,10,5.20E-01,10,4.40E-01,10GOTERM_BP_5,regulation of cytokine biosynthetic process,9.90E-01,27,9.70E-01,28,8.70E-01,37,9.40E-01,25,1.00E+00,28,9.50E-01,30,9.60E-01,28GOTERM_BP_5,tissue regeneration,9.50E-01,12,9.70E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,9.70E-01,13,9.60E-01,12,8.70E-01,13GOTERM_BP_5,regulation of Wnt receptor signaling pathway,2.10E-01,26,3.70E-01,24,9.20E-02,31,4.00E-01,21,1.70E-01,29,1.50E-01,27,1.50E-01,26GOTERM_BP_5,cellular respiration,3.20E-04,64,1.50E-03,61,4.20E-03,67,2.20E-04,58,3.50E-04,69,2.40E-04,65,4.00E-05,65GOTERM_BP_5,cellular response to heat,1.00E+00,#N/A,8.50E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,7.60E-02,10GOTERM_BP_5,regulation of microtubule polymerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of microtubule polymerization or depolymerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of transforming growth factor beta receptor signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,methionine metabolic process,9.50E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of histone modification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of lyase activity,7.50E-01,25,7.90E-01,24,8.90E-01,27,9.10E-01,19,9.30E-01,25,1.00E+00,17,9.60E-01,20GOTERM_BP_5,negative regulation of cyclase activity,7.50E-01,25,7.90E-01,24,8.90E-01,27,9.10E-01,19,9.30E-01,25,1.00E+00,17,9.60E-01,20GOTERM_BP_5,positive regulation of protein secretion,8.90E-01,17,9.60E-01,15,1.00E+00,#N/A,8.40E-01,15,9.50E-01,18,9.70E-01,15,9.90E-01,13GOTERM_BP_5,positive regulation of epithelial cell proliferation,2.50E-01,23,6.80E-01,19,6.00E-01,23,2.80E-01,20,5.20E-01,23,5.20E-01,21,4.00E-01,21GOTERM_BP_5,regulation of transmembrane transport,6.90E-01,13,8.80E-01,11,8.00E-01,14,1.00E+00,#N/A,9.30E-01,12,7.10E-01,13,8.60E-01,11GOTERM_BP_5,male sex differentiation,4.10E-01,37,9.30E-01,29,6.20E-01,40,8.90E-01,26,8.80E-01,35,7.90E-01,33,8.20E-01,31GOTERM_BP_5,positive regulation of cellular catabolic process,3.10E-01,20,6.60E-01,17,7.60E-01,19,6.40E-01,15,8.80E-01,17,6.00E-01,18,4.90E-01,18GOTERM_BP_5,hippocampus development,9.20E-02,15,4.50E-01,12,5.80E-01,13,1.00E+00,#N/A,3.50E-01,14,1.00E+00,#N/A,7.40E-01,10GOTERM_BP_5,regulation of cell-cell adhesion,7.90E-01,10,7.70E-01,10,5.80E-01,13,5.70E-01,10,9.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of striated muscle contraction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,heart looping,7.90E-01,10,7.70E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,5.20E-01,13,8.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,endothelial cell migration,1.00E+00,#N/A,6.20E-01,11,7.40E-01,12,1.00E+00,#N/A,8.20E-01,11,8.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,hormone secretion,5.90E-01,22,9.70E-01,16,5.00E-01,26,7.00E-01,18,8.30E-01,22,8.20E-01,20,9.90E-01,14GOTERM_BP_5,protein-DNA complex assembly,1.70E-01,49,1.30E-04,61,2.70E-03,64,4.90E-04,54,9.70E-04,64,3.00E-05,64,3.40E-01,45GOTERM_BP_5,glycolipid metabolic process,2.50E-01,18,4.80E-01,16,6.90E-01,17,1.40E-01,17,6.20E-01,17,5.50E-01,16,2.00E-01,18GOTERM_BP_5,regulation of chemotaxis,8.70E-01,13,8.50E-01,13,8.00E-01,16,5.10E-01,14,9.20E-01,14,5.50E-01,16,9.10E-01,12GOTERM_BP_5,regulation of action potential in neuron,8.60E-01,23,5.60E-01,26,6.00E-01,30,9.40E-01,18,7.10E-01,28,9.30E-01,22,6.20E-01,25GOTERM_BP_5,regulation of actin filament polymerization,9.20E-01,22,8.90E-01,22,1.00E+00,#N/A,5.40E-01,23,7.10E-01,28,9.30E-01,22,8.70E-01,22GOTERM_BP_5,eye development,1.00E+00,41,1.00E+00,46,1.00E+00,#N/A,9.90E-01,43,1.00E+00,54,9.90E-01,51,1.00E+00,47GOTERM_BP_5,spindle assembly,2.40E-01,11,1.00E-01,12,2.70E-01,12,2.10E-01,10,2.30E-01,12,4.30E-01,10,3.60E-01,10GOTERM_BP_5,negative regulation of microtubule polymerization or depolymerization,1.00E+00,#N/A,3.80E-01,10,4.60E-01,11,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of interleukin-1 production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of calcium-mediated signaling,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,membrane lipid catabolic process,4.10E-01,10,3.80E-01,10,4.60E-01,11,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of protein import into nucleus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,gene silencing by miRNA,1.00E+00,#N/A,1.00E+00,#N/A,6.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/AGOTERM_BP_5,homeostasis of number of cells within a tissue,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of interleukin-12 production,1.00E+00,#N/A,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/AGOTERM_BP_5,fructose metabolic process,2.40E-01,11,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/AGOTERM_BP_5,"nucleotide-excision repair, DNA gap filling",1.00E+00,#N/A,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of small GTPase mediated signal transduction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to amino acid stimulus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,vesicle docking,8.60E-01,11,4.30E-01,14,6.00E-01,15,5.00E-01,12,6.80E-01,14,7.80E-01,12,8.20E-01,11GOTERM_BP_5,serine family amino acid metabolic process,4.90E-02,18,1.60E-02,19,4.10E-02,20,5.90E-02,16,1.40E-01,18,8.20E-03,20,3.40E-02,18GOTERM_BP_5,regulation of immunoglobulin production,7.60E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,apoptotic nuclear changes,3.20E-01,15,1.60E-02,19,9.20E-02,19,5.90E-02,16,6.70E-02,19,2.30E-02,19,1.30E-02,19GOTERM_BP_5,negative regulation of hormone secretion,7.60E-01,12,5.90E-01,13,7.40E-01,14,3.50E-01,13,8.10E-01,13,4.90E-01,14,8.20E-01,11GOTERM_BP_5,cellular polysaccharide biosynthetic process,1.00E-01,17,4.30E-01,14,4.50E-01,16,6.60E-01,11,2.40E-01,17,3.40E-01,15,5.50E-01,13GOTERM_BP_5,negative regulation of coagulation,8.60E-01,11,4.30E-01,14,6.00E-01,15,5.00E-01,12,9.50E-01,11,6.50E-01,13,4.00E-01,14GOTERM_BP_5,positive regulation of fibroblast proliferation,1.00E+00,#N/A,1.00E+00,#N/A,7.40E-01,14,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of transmembrane transporter activity,7.60E-01,12,9.20E-01,10,8.50E-01,13,1.00E+00,#N/A,9.50E-01,11,7.80E-01,12,9.10E-01,10GOTERM_BP_5,limb morphogenesis,3.60E-01,50,6.90E-01,45,2.30E-01,59,5.60E-01,41,6.40E-01,52,3.40E-01,51,7.10E-01,44GOTERM_BP_5,microtubule organizing center organization,2.50E-01,20,6.70E-03,25,3.10E-01,22,1.30E-01,19,4.20E-02,25,1.80E-01,21,6.20E-02,22GOTERM_BP_5,regulation of glucose metabolic process,3.70E-01,19,8.20E-01,15,5.80E-01,20,8.20E-01,13,8.40E-01,17,7.80E-01,16,8.80E-01,14GOTERM_BP_5,metanephros development,9.50E-01,17,9.90E-01,14,1.00E+00,#N/A,1.00E+00,11,1.00E+00,16,1.00E+00,13,9.80E-01,15GOTERM_BP_5,glycoprotein biosynthetic process,4.10E-02,87,7.80E-01,70,7.10E-01,84,2.90E-01,69,8.30E-01,79,2.20E-01,82,7.20E-01,70GOTERM_BP_5,germ cell migration,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic gut development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,C21-steroid hormone metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,erythrocyte development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of phagocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of calcium ion transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of nuclear division,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,vesicle fusion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of smooth muscle cell migration,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,aromatic amino acid family catabolic process,1.00E+00,#N/A,4.40E-02,10,3.90E-02,11,1.00E+00,#N/A,1.00E+00,#N/A,5.50E-02,10,3.90E-02,10GOTERM_BP_5,positive regulation of stress fiber formation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of collagen metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,spindle checkpoint,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"retrograde transport, endosome to Golgi",1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of acute inflammatory response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of mitosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,long-term memory,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,histidine family amino acid metabolic process,5.00E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,oligosaccharide biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of humoral immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of antigen receptor-mediated signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of microtubule polymerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,steroid biosynthetic process,4.70E-01,42,3.30E-01,43,3.90E-01,49,5.00E-01,36,2.10E-01,50,1.50E-01,47,4.60E-02,48GOTERM_BP_5,positive regulation of biosynthetic process,9.70E-01,305,8.50E-01,311,4.30E-01,382,9.50E-01,263,1.00E+00,329,9.80E-01,309,9.20E-01,301GOTERM_BP_5,positive regulation of macromolecule biosynthetic process,9.90E-01,282,8.70E-01,291,4.80E-01,358,9.80E-01,243,1.00E+00,311,9.90E-01,287,9.50E-01,280GOTERM_BP_5,cellular polysaccharide metabolic process,4.50E-01,27,3.00E-01,28,4.30E-01,31,7.10E-01,21,3.40E-01,31,4.90E-01,27,3.60E-01,27GOTERM_BP_5,regulation of carbohydrate biosynthetic process,1.30E-01,14,5.40E-01,11,6.60E-01,12,1.00E+00,#N/A,7.50E-01,11,4.20E-01,12,6.80E-01,10GOTERM_BP_5,aminoglycan catabolic process,1.00E+00,#N/A,7.10E-01,10,1.00E+00,#N/A,5.00E-01,10,4.30E-01,13,6.00E-01,11,2.00E-01,13GOTERM_BP_5,long-chain fatty acid transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,epithelial cell development,1.00E+00,#N/A,1.00E+00,#N/A,8.00E-01,11,5.00E-01,10,4.30E-01,13,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"negative regulation of gene expression, epigenetic",1.00E+00,#N/A,7.10E-01,10,8.00E-01,11,1.00E+00,#N/A,2.70E-01,14,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,skeletal system morphogenesis,1.00E+00,37,9.80E-01,43,5.40E-01,62,7.20E-01,44,8.10E-01,56,8.40E-01,50,9.30E-01,45GOTERM_BP_5,negative regulation of myeloid cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,8.40E-01,11,8.90E-01,14,9.20E-01,12,9.40E-01,11GOTERM_BP_5,regulation of chromosome organization,6.00E-01,15,4.20E-01,16,1.20E-01,21,2.50E-02,19,8.80E-02,21,2.20E-01,18,1.50E-01,18GOTERM_BP_5,regulation of generation of precursor metabolites and energy,2.00E-01,18,5.60E-01,15,4.80E-01,18,9.20E-01,10,6.90E-01,16,4.80E-01,16,5.30E-01,15GOTERM_BP_5,regulation of cytokine secretion,9.60E-01,11,9.00E-01,12,1.00E+00,#N/A,9.20E-01,10,9.70E-01,12,1.00E+00,#N/A,9.70E-01,10GOTERM_BP_5,peptide hormone secretion,7.30E-01,18,9.70E-01,14,3.40E-01,24,6.70E-01,16,7.50E-01,20,7.60E-01,18,9.90E-01,12GOTERM_BP_5,meiosis,8.40E-01,43,8.90E-01,41,7.20E-01,52,6.80E-01,39,9.30E-01,46,9.90E-01,37,9.90E-01,35GOTERM_BP_5,M phase of meiotic cell cycle,8.40E-01,43,8.90E-01,41,7.20E-01,52,6.80E-01,39,9.30E-01,46,9.90E-01,37,9.90E-01,35GOTERM_BP_5,RNA modification,4.60E-02,30,4.70E-01,24,2.50E-01,30,3.80E-01,22,1.80E-01,30,5.60E-01,24,2.30E-01,26GOTERM_BP_5,B cell differentiation,7.40E-01,22,5.90E-01,23,8.50E-01,24,8.80E-01,17,9.80E-01,20,9.90E-01,16,9.90E-01,15GOTERM_BP_5,regulation of nucleotide metabolic process,9.10E-01,49,8.40E-01,50,8.10E-01,60,6.90E-01,46,8.90E-01,56,9.80E-01,46,8.90E-01,48GOTERM_BP_5,regulation of cellular ketone metabolic process,2.50E-01,31,4.90E-01,28,3.50E-01,34,3.50E-01,26,7.50E-01,29,2.80E-01,31,5.50E-01,27GOTERM_BP_5,ear morphogenesis,1.40E-01,37,6.10E-01,31,4.40E-01,38,5.30E-01,28,5.30E-01,36,6.10E-01,32,8.20E-01,28GOTERM_BP_5,nucleosome assembly,2.00E-01,45,1.40E-04,57,2.20E-03,60,1.50E-04,52,7.90E-04,60,6.90E-05,59,2.40E-01,43GOTERM_BP_5,forebrain development,2.20E-01,78,8.00E-01,67,5.80E-01,83,7.00E-01,60,7.30E-01,78,8.10E-01,69,8.30E-01,65GOTERM_BP_5,negative regulation of immune response,1.00E+00,#N/A,8.90E-01,10,6.70E-01,14,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic digit morphogenesis,2.50E-01,15,5.10E-01,13,2.20E-01,17,2.90E-01,13,3.00E-01,16,2.70E-01,15,3.30E-01,14GOTERM_BP_5,negative regulation of epithelial cell proliferation,5.50E-01,13,8.90E-01,10,3.60E-01,16,7.50E-01,10,8.60E-01,12,5.70E-01,13,8.80E-01,10GOTERM_BP_5,regulation of ion transmembrane transport,7.00E-01,12,8.90E-01,10,8.00E-01,13,1.00E+00,#N/A,8.60E-01,12,7.20E-01,12,7.80E-01,11GOTERM_BP_5,negative regulation of transmission of nerve impulse,8.20E-01,11,6.70E-01,12,8.00E-01,13,4.40E-01,12,6.10E-01,14,5.70E-01,13,6.40E-01,12GOTERM_BP_5,positive regulation of osteoblast differentiation,3.90E-01,14,8.90E-01,10,1.20E-01,18,3.90E-02,16,6.10E-01,14,7.90E-02,17,3.30E-01,14GOTERM_BP_5,sperm motility,8.20E-01,11,3.60E-01,14,8.00E-01,13,7.50E-01,10,7.50E-01,13,8.40E-01,11,6.40E-01,12GOTERM_BP_5,amino sugar metabolic process,9.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.30E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of cytokine-mediated signaling pathway,1.00E+00,#N/A,1.50E-01,11,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of muscle cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pyrimidine ribonucleotide metabolic process,3.20E-01,10,1.00E+00,#N/A,3.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of phagocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,signal complex assembly,3.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,myotube differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of natural killer cell mediated cytotoxicity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of receptor-mediated endocytosis,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of natural killer cell mediated immunity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of microtubule depolymerization,1.00E+00,#N/A,2.90E-01,10,5.40E-01,10,1.00E+00,#N/A,3.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,midbrain development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,gland morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,trophectodermal cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.40E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of microtubule depolymerization,1.00E+00,#N/A,2.90E-01,10,5.40E-01,10,1.00E+00,#N/A,3.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of protein complex assembly,9.40E-01,13,8.70E-01,14,7.60E-01,18,7.90E-01,13,8.00E-01,17,8.30E-01,15,9.20E-01,13GOTERM_BP_5,ethanolamine and derivative metabolic process,4.40E-01,18,7.80E-01,15,8.50E-01,17,8.80E-01,12,8.00E-01,17,9.50E-01,13,9.20E-01,13GOTERM_BP_5,membrane lipid biosynthetic process,2.00E-01,20,6.70E-01,16,1.00E+00,#N/A,5.40E-01,15,8.00E-01,17,7.30E-01,16,5.00E-01,17GOTERM_BP_5,myeloid leukocyte differentiation,8.10E-01,15,4.00E-01,18,7.60E-01,18,7.90E-01,13,9.40E-01,15,7.30E-01,16,8.50E-01,14GOTERM_BP_5,negative regulation of translation,7.00E-01,16,4.00E-01,18,4.10E-02,25,5.40E-01,15,1.10E-01,23,7.40E-02,22,2.50E-01,19GOTERM_BP_5,mitotic cell cycle checkpoint,6.00E-01,21,5.50E-01,21,1.70E-01,28,4.90E-01,19,6.40E-01,23,6.30E-01,21,2.80E-01,23GOTERM_BP_5,energy reserve metabolic process,8.10E-01,19,3.20E-01,23,6.10E-01,24,7.30E-01,17,8.30E-01,21,7.40E-01,20,7.40E-01,19GOTERM_BP_5,Notch signaling pathway,4.00E-01,27,5.70E-01,25,5.90E-01,29,4.50E-01,23,7.90E-01,26,7.50E-01,24,4.10E-01,26GOTERM_BP_5,immune response-activating signal transduction,8.70E-01,22,6.70E-01,24,7.80E-01,27,9.50E-01,17,9.90E-01,21,9.30E-01,21,8.20E-01,22GOTERM_BP_5,cartilage development,6.30E-01,35,9.70E-01,28,1.60E-01,46,3.60E-01,33,8.00E-01,37,6.80E-01,35,8.90E-01,30GOTERM_BP_5,immune response-regulating signal transduction,9.10E-01,23,8.30E-01,24,7.90E-01,29,9.60E-01,18,9.90E-01,22,9.20E-01,23,9.10E-01,22GOTERM_BP_5,regulation of nucleotide biosynthetic process,8.90E-01,47,8.10E-01,48,8.00E-01,57,5.90E-01,45,8.90E-01,53,9.80E-01,43,8.60E-01,46GOTERM_BP_5,negative regulation of cytokine production,9.90E-01,12,8.50E-01,16,8.50E-01,19,7.40E-01,15,9.60E-01,16,8.10E-01,17,8.20E-01,16GOTERM_BP_5,positive regulation of cellular biosynthetic process,9.90E-01,297,8.70E-01,305,4.50E-01,376,9.60E-01,258,1.00E+00,325,9.90E-01,302,9.20E-01,296GOTERM_BP_5,positive regulation of chemotaxis,8.80E-01,12,7.70E-01,13,6.90E-01,16,3.90E-01,14,8.50E-01,14,4.10E-01,16,8.50E-01,12GOTERM_BP_5,negative regulation of protein polymerization,9.40E-01,11,9.30E-01,11,8.90E-01,14,8.00E-01,11,7.50E-01,15,9.50E-01,11,9.20E-01,11GOTERM_BP_5,collagen catabolic process,1.00E+00,#N/A,6.40E-01,10,7.30E-01,11,1.00E+00,#N/A,5.10E-01,12,5.10E-01,11,4.30E-01,11GOTERM_BP_5,regulation of interleukin-1 beta production,1.00E+00,#N/A,6.40E-01,10,8.60E-01,10,4.30E-01,10,6.80E-01,11,1.00E+00,#N/A,6.10E-01,10GOTERM_BP_5,negative regulation of cellular catabolic process,3.20E-01,12,4.60E-01,11,5.00E-02,16,4.30E-01,10,1.00E+00,#N/A,5.10E-01,11,2.70E-01,12GOTERM_BP_5,regulation of calcium-mediated signaling,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of vasodilation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of adenylate cyclase activity,9.50E-01,39,8.00E-01,42,7.80E-01,50,7.00E-01,38,9.30E-01,45,9.90E-01,36,9.30E-01,38GOTERM_BP_5,embryonic limb morphogenesis,6.40E-01,41,5.70E-01,41,3.20E-01,51,5.70E-01,36,5.30E-01,47,3.50E-01,45,5.20E-01,41GOTERM_BP_5,embryonic appendage morphogenesis,6.40E-01,41,5.70E-01,41,3.20E-01,51,5.70E-01,36,5.30E-01,47,3.50E-01,45,5.20E-01,41GOTERM_BP_5,regulation of B cell activation,1.00E+00,16,1.00E+00,11,1.00E+00,#N/A,1.00E+00,13,1.00E+00,17,9.50E-01,20,9.90E-01,16GOTERM_BP_5,male sex determination,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of macrophage differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of collagen biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of epidermal growth factor receptor signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of oxygen and reactive oxygen species metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,amyloid precursor protein metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of mitochondrial membrane permeability,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to oxygen radical,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,entry into host cell,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pentose metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cerebral cortex neuron differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of systemic arterial blood pressure by renin-angiotensin,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,sphingomyelin metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of mitotic metaphase/anaphase transition,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,polyamine metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of cyclin-dependent protein kinase activity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of glycoprotein biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,post-embryonic organ development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,movement in host environment,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,head morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of T cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of adaptive immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,metaphase plate congression,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of Notch signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of interferon-gamma production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,entry into host,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,entry of virus into host cell,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hemopoietic progenitor cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of keratinocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to cadmium ion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,entry into other organism during symbiotic interaction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mitotic cell cycle spindle assembly checkpoint,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ensheathment of neurons,9.90E-01,14,7.30E-01,19,6.60E-01,23,9.80E-01,12,8.70E-01,20,9.80E-01,15,8.70E-01,17GOTERM_BP_5,complement activation,9.10E-01,17,2.70E-01,23,6.60E-01,23,8.70E-01,15,7.90E-01,21,2.30E-01,24,8.70E-01,17GOTERM_BP_5,hair follicle development,9.10E-01,17,7.30E-01,19,3.10E-01,26,6.80E-01,17,8.70E-01,20,6.90E-01,20,4.60E-01,21GOTERM_BP_5,cell fate determination,5.10E-01,17,3.40E-01,18,4.30E-01,20,6.20E-01,14,4.90E-01,19,4.00E-01,18,3.10E-01,18GOTERM_BP_5,synaptic vesicle transport,9.60E-01,12,8.40E-01,14,8.90E-01,16,9.20E-01,11,9.10E-01,15,9.70E-01,12,9.90E-01,10GOTERM_BP_5,cerebral cortex development,1.60E-01,20,2.20E-01,19,1.10E-01,23,7.50E-01,13,2.30E-01,21,5.40E-01,17,7.10E-01,15GOTERM_BP_5,cilium morphogenesis,6.50E-01,16,4.70E-01,17,8.90E-01,16,6.20E-01,14,4.90E-01,19,5.40E-01,17,5.80E-01,16GOTERM_BP_5,embryonic organ development,8.10E-01,77,9.00E-01,73,5.70E-01,94,7.00E-01,68,9.20E-01,83,7.70E-01,79,9.20E-01,71GOTERM_BP_5,phospholipid metabolic process,2.00E-01,97,8.00E-01,84,5.50E-01,104,8.00E-01,73,8.40E-01,95,8.30E-01,86,8.90E-01,80GOTERM_BP_5,glycerophospholipid metabolic process,2.40E-01,61,5.90E-01,55,4.80E-01,66,6.00E-01,48,6.90E-01,61,7.10E-01,55,8.40E-01,50GOTERM_BP_5,positive regulation of ossification,4.70E-01,13,1.00E+00,#N/A,7.40E-01,13,3.70E-01,12,6.80E-01,13,6.60E-01,12,5.70E-01,12GOTERM_BP_5,regulation of ion transmembrane transporter activity,7.70E-01,11,1.00E+00,#N/A,8.50E-01,12,1.00E+00,#N/A,9.00E-01,11,7.90E-01,11,8.40E-01,10GOTERM_BP_5,embryonic placenta development,6.30E-01,12,6.00E-01,12,2.80E-01,16,1.00E+00,#N/A,9.60E-01,10,6.60E-01,12,1.00E+00,#N/AGOTERM_BP_5,regulation of RNA stability,1.00E+00,#N/A,2.90E-01,14,4.30E-01,15,6.90E-01,10,5.30E-01,14,2.10E-01,15,2.60E-01,14GOTERM_BP_5,negative regulation of secretion,9.80E-01,20,9.10E-01,22,8.90E-01,27,5.90E-01,23,9.80E-01,23,9.10E-01,23,9.60E-01,20GOTERM_BP_5,ameboidal cell migration,8.40E-01,16,9.70E-01,13,5.90E-01,21,8.80E-01,13,7.50E-01,19,8.60E-01,16,9.30E-01,14GOTERM_BP_5,peroxisomal transport,1.00E+00,#N/A,1.00E+00,#N/A,1.10E-01,12,1.00E+00,#N/A,3.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,synaptic vesicle exocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of interleukin-1 secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of polysaccharide metabolic process,1.10E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,detection of visible light,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of type I interferon production,1.00E+00,#N/A,2.10E-01,10,1.10E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,1.20E-01,11,1.00E+00,#N/AGOTERM_BP_5,filopodium assembly,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of dendrite development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,microtubule bundle formation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glycerolipid metabolic process,3.80E-01,80,6.70E-01,74,6.10E-01,88,7.50E-01,63,9.20E-01,78,8.70E-01,72,9.10E-01,67GOTERM_BP_5,negative regulation of transcription,9.30E-01,203,9.80E-01,194,4.00E-01,254,7.50E-01,181,9.30E-01,228,9.30E-01,206,9.40E-01,195GOTERM_BP_5,"positive regulation of transcription, DNA-dependent",9.90E-01,200,7.40E-01,216,4.30E-01,263,9.30E-01,180,9.60E-01,234,9.30E-01,214,7.80E-01,211GOTERM_BP_5,positive regulation of nitrogen compound metabolic process,9.70E-01,282,7.00E-01,294,2.30E-01,361,9.20E-01,246,9.90E-01,313,9.70E-01,286,8.40E-01,283GOTERM_BP_5,negative regulation of lipid metabolic process,3.20E-01,16,2.80E-01,16,2.00E-01,19,6.30E-01,12,8.00E-01,14,2.10E-01,17,3.90E-01,15GOTERM_BP_5,polysaccharide catabolic process,9.20E-01,11,5.70E-01,14,8.50E-01,14,3.30E-01,14,3.90E-01,17,4.90E-01,15,1.50E-01,17GOTERM_BP_5,negative regulation of actin filament polymerization,9.20E-01,11,9.10E-01,11,1.00E+00,#N/A,7.60E-01,11,6.90E-01,15,9.30E-01,11,8.90E-01,11GOTERM_BP_5,positive regulation of cytokine production,8.60E-01,39,6.80E-01,41,8.80E-01,45,5.90E-01,37,9.30E-01,42,6.30E-01,43,7.80E-01,39GOTERM_BP_5,positive regulation of RNA metabolic process,9.90E-01,202,7.00E-01,219,4.00E-01,266,9.20E-01,182,9.60E-01,236,9.30E-01,216,7.70E-01,213GOTERM_BP_5,ovarian follicle development,8.90E-01,17,8.70E-01,17,8.80E-01,20,5.20E-01,18,8.40E-01,20,9.70E-01,15,9.90E-01,13GOTERM_BP_5,RNA export from nucleus,4.80E-01,21,6.80E-01,19,2.50E-01,26,3.90E-01,19,3.90E-01,24,1.90E-01,24,4.00E-01,21GOTERM_BP_5,regulation of myeloid leukocyte differentiation,1.00E+00,12,9.80E-01,14,8.10E-01,21,9.10E-01,14,9.00E-01,19,9.00E-01,17,9.90E-01,13GOTERM_BP_5,peptide secretion,8.20E-01,18,9.80E-01,14,4.80E-01,24,7.50E-01,16,8.40E-01,20,7.50E-01,19,1.00E+00,12GOTERM_BP_5,regulation of positive chemotaxis,1.00E+00,#N/A,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,7.60E-01,10,6.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,cell-cell signaling involved in cell fate specification,4.00E-01,11,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of positive chemotaxis,1.00E+00,#N/A,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,7.60E-01,10,6.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,myoblast differentiation,1.00E+00,#N/A,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,developmental induction,4.00E-01,11,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,leukotriene biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.50E-01,10,6.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,synaptogenesis,8.20E-01,14,4.10E-01,17,4.90E-01,19,8.20E-01,12,6.90E-01,17,6.10E-01,16,8.70E-01,13GOTERM_BP_5,spliceosome assembly,6.00E-02,21,9.80E-02,20,2.30E-01,21,9.50E-01,10,2.80E-01,20,1.30E-01,20,3.70E-01,17GOTERM_BP_5,translational initiation,3.60E-01,24,3.10E-01,24,6.50E-02,31,3.50E-01,21,7.60E-02,30,3.80E-02,29,3.70E-02,28GOTERM_BP_5,regulation of lipid biosynthetic process,1.00E-01,27,4.30E-01,23,1.10E-01,30,3.50E-01,21,9.40E-01,20,1.20E-01,27,6.20E-01,21GOTERM_BP_5,regulation of postsynaptic membrane potential,1.00E+00,#N/A,1.00E+00,#N/A,9.00E-01,11,1.00E+00,#N/A,7.50E-01,12,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cardiac muscle cell differentiation,1.00E+00,#N/A,5.30E-01,12,9.00E-01,11,1.00E+00,#N/A,2.80E-01,15,8.50E-01,10,8.00E-01,10GOTERM_BP_5,regulation of interleukin-1 production,1.00E+00,#N/A,8.20E-01,10,1.00E+00,#N/A,4.70E-01,11,7.50E-01,12,1.00E+00,#N/A,8.00E-01,10GOTERM_BP_5,blood vessel remodeling,8.40E-01,10,1.00E+00,#N/A,9.00E-01,11,1.00E+00,#N/A,8.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of ion transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,organic cation transport,7.20E-01,11,3.60E-01,13,6.70E-01,13,4.70E-01,11,6.00E-01,13,7.40E-01,11,6.60E-01,11GOTERM_BP_5,calcium ion-dependent exocytosis,7.20E-01,11,8.20E-01,10,8.00E-01,12,1.00E+00,#N/A,6.00E-01,13,8.50E-01,10,6.60E-01,11GOTERM_BP_5,glucan metabolic process,6.90E-01,17,2.70E-01,20,5.10E-01,21,6.40E-01,15,6.90E-01,19,7.20E-01,17,3.60E-01,19GOTERM_BP_5,cellular glucan metabolic process,6.90E-01,17,2.70E-01,20,5.10E-01,21,6.40E-01,15,6.90E-01,19,7.20E-01,17,3.60E-01,19GOTERM_BP_5,mesoderm formation,5.70E-01,18,9.60E-01,13,7.60E-01,19,9.20E-01,12,8.80E-01,17,6.00E-01,18,9.50E-01,13GOTERM_BP_5,regulation of fatty acid metabolic process,3.50E-01,26,5.30E-01,24,4.10E-01,29,4.30E-01,22,8.30E-01,24,1.90E-01,28,6.00E-01,23GOTERM_BP_5,ion transmembrane transport,3.50E-01,26,3.10E-01,26,7.30E-01,26,2.20E-01,24,5.40E-01,27,8.00E-01,22,7.00E-01,22GOTERM_BP_5,exocytosis,7.00E-01,53,7.70E-01,51,8.70E-01,58,7.90E-01,44,7.80E-01,58,8.90E-01,50,6.40E-01,52GOTERM_BP_5,insulin secretion,8.10E-01,12,1.00E+00,#N/A,5.30E-01,16,8.30E-01,10,6.10E-01,15,9.10E-01,11,1.00E+00,#N/AGOTERM_BP_5,formation of primary germ layer,6.70E-01,19,9.50E-01,15,7.70E-01,21,8.90E-01,14,8.70E-01,19,5.80E-01,20,9.40E-01,15GOTERM_BP_5,DNA repair,3.50E-01,139,1.80E-01,141,9.40E-02,167,1.10E-01,127,7.90E-02,163,1.30E-01,147,4.60E-01,132GOTERM_BP_5,positive regulation of interleukin-1 secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,protein targeting to peroxisome,1.00E+00,#N/A,1.00E+00,#N/A,1.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pyrimidine nucleoside triphosphate metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,3.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cell volume homeostasis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of osteoblast differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,indolalkylamine metabolic process,1.00E+00,#N/A,5.30E-02,11,5.80E-02,12,1.00E+00,#N/A,1.30E-01,11,1.70E-01,10,1.00E+00,#N/AGOTERM_BP_5,indole derivative metabolic process,1.00E+00,#N/A,5.30E-02,11,5.80E-02,12,1.00E+00,#N/A,1.30E-01,11,1.70E-01,10,1.00E+00,#N/AGOTERM_BP_5,artery morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,melanocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"synaptic transmission, cholinergic",1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,deoxyribonucleotide catabolic process,1.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of transporter activity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of steroid metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glycolipid biosynthetic process,1.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.30E-01,10GOTERM_BP_5,pteridine and derivative biosynthetic process,1.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,sphingolipid biosynthetic process,3.80E-01,17,8.50E-01,13,1.00E+00,#N/A,7.80E-01,12,8.50E-01,15,8.90E-01,13,7.20E-01,14GOTERM_BP_5,"transcription, DNA-dependent",4.80E-01,140,6.80E-01,133,1.80E-01,168,8.60E-01,111,7.80E-01,149,7.80E-01,135,7.50E-01,129GOTERM_BP_5,regulation of cell projection assembly,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,epithelial to mesenchymal transition,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of synaptogenesis,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of smooth muscle contraction,3.20E-01,11,2.90E-01,11,3.70E-01,12,6.40E-02,12,3.20E-01,12,5.20E-01,10,4.40E-01,10GOTERM_BP_5,DNA geometric change,1.00E+00,#N/A,1.60E-01,12,3.70E-01,12,1.00E+00,#N/A,5.00E-01,11,5.20E-01,10,4.40E-01,10GOTERM_BP_5,alpha-beta T cell activation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of myeloid leukocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pancreas development,8.50E-01,15,4.60E-01,18,1.20E-01,24,5.90E-01,15,5.00E-01,20,2.80E-01,20,3.00E-01,19GOTERM_BP_5,positive regulation of secretion,8.30E-01,48,8.80E-01,46,1.00E+00,#N/A,5.60E-01,45,8.80E-01,53,9.70E-01,44,9.20E-01,44GOTERM_BP_5,positive regulation of glucose transport,4.80E-01,12,7.70E-01,10,8.60E-01,11,5.70E-01,10,5.20E-01,13,8.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,oocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,7.40E-01,12,1.00E+00,#N/A,6.80E-01,12,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of proteolysis,6.50E-01,11,2.90E-01,13,1.40E-01,16,4.00E-01,11,1.00E+00,#N/A,2.00E-01,14,5.90E-01,11GOTERM_BP_5,branching involved in ureteric bud morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of glucose import,4.80E-01,12,7.70E-01,10,8.60E-01,11,5.70E-01,10,5.20E-01,13,8.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,mesenchyme development,8.00E-01,23,1.00E+00,16,7.80E-01,27,9.10E-01,18,9.90E-01,21,9.80E-01,19,9.60E-01,19GOTERM_BP_5,regulation of transforming growth factor beta receptor signaling pathway,6.20E-01,19,3.30E-01,21,3.40E-01,24,4.10E-01,18,5.10E-01,22,2.80E-01,22,2.90E-01,21GOTERM_BP_5,positive regulation of neurological system process,4.90E-01,20,3.30E-01,21,5.90E-01,22,1.20E-01,21,3.80E-01,23,6.50E-01,19,5.40E-01,19GOTERM_BP_5,vasodilation,4.70E-01,14,2.90E-01,15,3.00E-01,17,1.20E-01,15,2.40E-01,17,4.90E-01,14,2.60E-01,15GOTERM_BP_5,regulation of nuclear division,5.00E-01,28,4.40E-01,28,8.60E-01,28,2.30E-01,27,8.60E-01,27,4.30E-01,29,6.10E-01,26GOTERM_BP_5,regulation of mitosis,5.00E-01,28,4.40E-01,28,8.60E-01,28,2.30E-01,27,8.60E-01,27,4.30E-01,29,6.10E-01,26GOTERM_BP_5,ribonucleoprotein complex assembly,7.70E-02,40,1.10E-02,43,7.30E-03,49,4.50E-01,30,2.40E-02,46,1.30E-03,47,2.60E-02,41GOTERM_BP_5,positive regulation of cell adhesion,9.90E-01,21,9.50E-01,23,8.60E-01,30,3.80E-01,27,9.70E-01,26,7.20E-01,28,9.60E-01,22GOTERM_BP_5,immunoglobulin production,9.10E-01,12,9.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,10,9.60E-01,11,1.00E+00,#N/AGOTERM_BP_5,regulation of lipid transport,6.00E-01,15,4.20E-01,16,3.40E-01,19,8.40E-01,11,6.90E-01,16,9.20E-01,12,7.90E-01,13GOTERM_BP_5,regulation of glucose transport,5.80E-01,17,7.80E-01,15,1.00E+00,#N/A,6.70E-01,14,8.00E-01,17,7.30E-01,16,9.60E-01,12GOTERM_BP_5,positive regulation of behavior,8.10E-01,15,6.70E-01,16,6.40E-01,19,2.70E-01,17,8.00E-01,17,3.40E-01,19,7.60E-01,15GOTERM_BP_5,regulation of exocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.90E-01,12,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of vasoconstriction,7.00E-01,16,9.70E-01,12,1.00E+00,#N/A,7.90E-01,13,8.80E-01,16,9.50E-01,13,9.60E-01,12GOTERM_BP_5,lipid homeostasis,4.50E-01,26,8.80E-01,21,8.80E-01,25,9.80E-01,15,9.80E-01,21,9.20E-01,21,9.10E-01,20GOTERM_BP_5,cellular amino acid biosynthetic process,1.10E-01,30,2.70E-02,32,3.10E-01,31,8.70E-02,27,3.30E-01,30,7.70E-02,31,1.20E-01,29GOTERM_BP_5,mesenchymal cell development,8.40E-01,22,1.00E+00,16,8.20E-01,26,8.90E-01,18,9.90E-01,20,9.80E-01,19,9.50E-01,19GOTERM_BP_5,mesenchymal cell differentiation,8.40E-01,22,1.00E+00,16,8.20E-01,26,8.90E-01,18,9.90E-01,20,9.80E-01,19,9.50E-01,19GOTERM_BP_5,positive regulation of transcription,9.90E-01,239,7.90E-01,254,4.50E-01,310,9.80E-01,208,1.00E+00,269,9.80E-01,247,8.70E-01,246GOTERM_BP_5,mesoderm morphogenesis,5.60E-01,19,9.80E-01,13,8.50E-01,19,9.50E-01,12,9.30E-01,17,7.10E-01,18,9.70E-01,13GOTERM_BP_5,regulation of interferon-gamma biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of response to nutrient levels,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,brain morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of cellular amine metabolic process,9.50E-02,10,1.00E+00,#N/A,8.60E-02,11,1.00E+00,#N/A,1.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,oocyte maturation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of endothelial cell migration,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of response to extracellular stimulus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of interferon-beta production,1.00E+00,#N/A,1.00E+00,#N/A,2.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E-01,10,1.00E+00,#N/AGOTERM_BP_5,immunoglobulin production during immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of multicellular organismal metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,forebrain neuron differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hair follicle maturation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,motor axon guidance,1.00E+00,#N/A,1.00E+00,#N/A,2.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cortical actin cytoskeleton organization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of heart contraction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of transcription factor import into nucleus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,middle ear morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of interleukin-2 biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,superoxide anion generation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of natural killer cell mediated cytotoxicity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"protein import into nucleus, docking",1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,5.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hydrogen peroxide catabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of myeloid leukocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to zinc ion,1.00E+00,#N/A,3.80E-01,10,6.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of JNK cascade,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,vasoconstriction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,4.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,preassembly of GPI anchor in ER membrane,1.00E+00,#N/A,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pattern recognition receptor signaling pathway,4.10E-01,10,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of natural killer cell mediated immunity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,RNA biosynthetic process,4.70E-01,142,7.20E-01,134,2.30E-01,169,9.00E-01,111,7.80E-01,151,7.70E-01,137,7.80E-01,130GOTERM_BP_5,meiosis I,9.10E-01,17,8.90E-01,17,6.60E-01,23,8.70E-01,15,7.90E-01,21,9.60E-01,16,9.60E-01,15GOTERM_BP_5,immune response-regulating cell surface receptor signaling pathway,9.90E-01,14,8.90E-01,17,1.00E+00,#N/A,9.60E-01,13,1.00E+00,15,9.80E-01,15,8.70E-01,17GOTERM_BP_5,positive regulation of lyase activity,9.20E-01,24,6.90E-01,27,5.70E-01,33,4.40E-01,26,9.30E-01,27,8.40E-01,26,7.40E-01,26GOTERM_BP_5,regulation of neurotransmitter secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of homeostatic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.90E-01,12,7.50E-01,11,1.00E+00,#N/A,5.10E-01,11GOTERM_BP_5,G2/M transition of mitotic cell cycle,1.00E+00,#N/A,5.40E-01,11,4.90E-01,13,1.00E+00,#N/A,7.50E-01,11,6.00E-01,11,6.80E-01,10GOTERM_BP_5,oocyte development,1.00E+00,#N/A,1.00E+00,#N/A,8.00E-01,11,1.00E+00,#N/A,7.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of muscle contraction,4.00E-01,12,3.70E-01,12,3.20E-01,14,9.40E-02,13,4.30E-01,13,4.20E-01,12,5.10E-01,11GOTERM_BP_5,phosphatidylcholine metabolic process,5.70E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of survival gene product expression,4.00E-01,12,3.70E-01,12,6.60E-01,12,1.00E+00,#N/A,8.70E-01,10,6.00E-01,11,5.10E-01,11GOTERM_BP_5,translation,2.70E-04,189,2.90E-04,186,1.30E-04,214,2.30E-04,167,9.90E-06,214,4.90E-05,195,1.90E-07,198GOTERM_BP_5,sensory organ development,9.90E-01,92,9.90E-01,90,1.00E+00,#N/A,9.00E-01,85,9.90E-01,103,9.90E-01,93,9.80E-01,90GOTERM_BP_5,protein amino acid O-linked glycosylation,2.50E-01,15,2.20E-01,15,2.20E-01,17,1.70E-01,14,4.50E-01,15,7.90E-02,17,1.10E-01,16GOTERM_BP_5,positive regulation of innate immune response,8.30E-01,20,8.00E-01,20,1.00E+00,#N/A,9.70E-01,14,9.60E-01,20,5.60E-01,23,6.70E-01,21GOTERM_BP_5,"positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process",9.90E-01,268,8.20E-01,280,3.70E-01,345,9.50E-01,235,1.00E+00,299,9.90E-01,273,9.20E-01,269GOTERM_BP_5,neutral lipid metabolic process,8.80E-01,21,9.70E-01,18,1.00E+00,#N/A,9.90E-01,14,1.00E+00,18,9.80E-01,18,9.80E-01,17GOTERM_BP_5,regulation of glucose import,5.10E-01,17,7.40E-01,15,8.90E-01,16,6.20E-01,14,7.50E-01,17,6.80E-01,16,9.50E-01,12GOTERM_BP_5,regulation of innate immune response,8.00E-01,24,7.60E-01,24,1.00E+00,#N/A,9.70E-01,17,9.50E-01,24,4.30E-01,28,8.10E-01,23GOTERM_BP_5,positive regulation of transmission of nerve impulse,5.00E-01,19,4.60E-01,19,7.10E-01,20,1.20E-01,20,5.00E-01,21,6.60E-01,18,5.50E-01,18GOTERM_BP_5,lipoprotein biosynthetic process,3.90E-01,30,5.40E-01,28,2.20E-01,36,7.90E-01,22,7.10E-01,30,7.30E-01,27,7.80E-01,25GOTERM_BP_5,DNA recombination,8.40E-01,46,6.00E-01,49,1.00E+00,#N/A,7.30E-01,41,6.40E-01,55,9.40E-01,44,9.00E-01,43GOTERM_BP_5,positive regulation of gene expression,1.00E+00,243,8.10E-01,261,4.60E-01,319,9.60E-01,217,9.90E-01,278,9.80E-01,255,8.40E-01,255GOTERM_BP_5,acylglycerol metabolic process,8.50E-01,21,9.60E-01,18,1.00E+00,#N/A,9.90E-01,14,1.00E+00,17,9.80E-01,18,9.80E-01,17GOTERM_BP_5,regulation of sterol transport,6.60E-01,10,4.60E-01,11,3.90E-01,13,1.00E+00,#N/A,6.80E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of leukocyte migration,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,11,4.30E-01,10,1.00E+00,#N/A,5.10E-01,11,1.00E+00,#N/AGOTERM_BP_5,negative regulation of lymphocyte differentiation,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of the force of heart contraction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,focal adhesion formation,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to morphine,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of carbohydrate catabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of cellular carbohydrate catabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,lipid phosphorylation,1.00E+00,#N/A,2.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,4.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,actin cytoskeleton reorganization,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,bone mineralization,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.50E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to isoquinoline alkaloid,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of blood vessel size,6.60E-01,25,5.10E-01,26,8.20E-01,27,5.00E-01,23,4.40E-01,30,4.90E-01,27,5.70E-01,25GOTERM_BP_5,negative regulation of RNA metabolic process,9.40E-01,158,9.90E-01,149,6.90E-01,194,9.40E-01,134,9.90E-01,171,9.80E-01,156,9.90E-01,145GOTERM_BP_5,cardiac cell differentiation,9.20E-01,11,5.70E-01,14,8.50E-01,14,7.60E-01,11,5.40E-01,16,8.70E-01,12,8.90E-01,11GOTERM_BP_5,pituitary gland development,2.00E-01,17,4.20E-01,15,3.20E-01,18,4.80E-01,13,8.00E-01,14,8.70E-01,12,5.40E-01,14GOTERM_BP_5,positive regulation of cell-substrate adhesion,9.70E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,7.60E-01,11,9.80E-01,11,8.70E-01,12,9.50E-01,10GOTERM_BP_5,acrosome reaction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neuron projection regeneration,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,plasma lipoprotein particle assembly,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,isotype switching,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of muscle contraction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of glycolysis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,somatic diversification of immunoglobulins during immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of dendrite morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,fibrinolysis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,quaternary ammonium group transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,pyrimidine deoxyribonucleotide metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neutral lipid biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic eye morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mitochondrial respiratory chain complex assembly,1.00E+00,#N/A,1.00E+00,#N/A,1.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,5.50E-02,10,1.00E+00,#N/AGOTERM_BP_5,positive regulation of mitotic cell cycle,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,acylglycerol biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,somatic recombination of immunoglobulin genes during immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mesoderm development,8.50E-01,32,9.70E-01,28,5.70E-01,41,9.40E-01,25,9.00E-01,35,8.20E-01,33,9.60E-01,28GOTERM_BP_5,positive regulation of cell cycle,4.40E-01,29,9.40E-01,22,8.90E-01,28,9.70E-01,18,1.00E+00,20,5.80E-01,28,8.30E-01,24GOTERM_BP_5,leukocyte migration,1.00E+00,14,9.90E-01,19,1.00E+00,#N/A,9.80E-01,17,1.00E+00,18,1.00E+00,18,1.00E+00,16GOTERM_BP_5,positive regulation of cyclase activity,9.60E-01,22,7.80E-01,25,6.60E-01,31,4.60E-01,25,9.30E-01,26,9.00E-01,24,8.30E-01,24GOTERM_BP_5,central nervous system neuron development,5.90E-01,16,4.10E-01,17,3.50E-01,20,1.80E-01,17,2.80E-01,20,6.10E-01,16,5.10E-01,16GOTERM_BP_5,platelet activation,9.80E-01,11,9.70E-01,11,1.00E+00,#N/A,9.50E-01,10,1.00E+00,10,9.90E-01,10,1.00E+00,#N/AGOTERM_BP_5,"negative regulation of transcription, DNA-dependent",9.60E-01,154,9.80E-01,148,6.40E-01,192,9.20E-01,133,9.90E-01,169,9.70E-01,154,9.90E-01,142GOTERM_BP_5,positive regulation of cytokine biosynthetic process,1.00E+00,15,1.00E+00,12,1.00E+00,#N/A,1.00E+00,11,1.00E+00,15,1.00E+00,15,1.00E+00,14GOTERM_BP_5,phosphoinositide metabolic process,5.90E-01,35,7.10E-01,33,6.20E-01,40,6.10E-01,30,6.80E-01,38,5.40E-01,36,8.20E-01,31GOTERM_BP_5,inner ear morphogenesis,3.90E-01,29,7.50E-01,25,7.00E-01,30,6.30E-01,23,7.90E-01,28,8.10E-01,25,9.10E-01,22GOTERM_BP_5,dorsal/ventral pattern formation,7.70E-01,27,9.20E-01,24,8.60E-01,30,9.40E-01,20,9.70E-01,26,8.60E-01,26,6.90E-01,27GOTERM_BP_5,regulation of systemic arterial blood pressure mediated by a chemical signal,9.00E-01,11,6.50E-01,13,1.00E+00,#N/A,7.10E-01,11,8.50E-01,13,5.70E-01,14,1.00E+00,#N/AGOTERM_BP_5,somatic diversification of immune receptors,9.50E-01,10,7.80E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,9.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,genitalia development,1.00E+00,#N/A,1.00E+00,#N/A,3.40E-01,15,6.30E-01,10,7.50E-01,12,8.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of tumor necrosis factor production,1.00E+00,#N/A,9.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,9.60E-01,13,9.70E-01,11,9.80E-01,10GOTERM_BP_5,activation of innate immune response,5.90E-01,10,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,spleen development,1.00E+00,#N/A,5.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to amphetamine,1.00E+00,#N/A,1.00E+00,#N/A,6.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of interleukin-2 biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of catecholamine secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,detection of light stimulus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,triglyceride metabolic process,8.10E-01,19,9.80E-01,15,1.00E+00,#N/A,9.70E-01,13,1.00E+00,14,9.90E-01,15,9.70E-01,15GOTERM_BP_5,positive regulation of tumor necrosis factor production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to X-ray,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of endocytosis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of release of sequestered calcium ion into cytosol,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E-01,10,1.00E+00,#N/A,2.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,positive regulation of leukocyte migration,1.00E+00,#N/A,1.00E+00,#N/A,4.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,2.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,"complement activation, alternative pathway",1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cell fate specification,6.70E-01,24,9.60E-01,19,7.40E-01,27,8.20E-01,19,9.60E-01,22,7.90E-01,23,7.80E-01,22GOTERM_BP_5,glycerolipid biosynthetic process,3.50E-01,41,4.70E-01,39,1.90E-01,49,8.20E-01,30,5.60E-01,43,7.40E-01,37,7.50E-01,35GOTERM_BP_5,positive regulation of synaptic transmission,5.80E-01,17,6.70E-01,16,8.50E-01,17,2.70E-01,17,6.90E-01,18,8.30E-01,15,6.40E-01,16GOTERM_BP_5,oogenesis,9.80E-01,13,9.10E-01,15,7.60E-01,20,9.50E-01,12,8.00E-01,19,8.90E-01,16,9.40E-01,14GOTERM_BP_5,negative regulation of Wnt receptor signaling pathway,4.50E-01,16,2.80E-01,17,3.40E-01,19,3.10E-01,15,4.00E-01,18,3.40E-01,17,2.50E-01,17GOTERM_BP_5,cerebellum development,6.00E-01,15,8.10E-01,13,2.10E-01,20,9.20E-01,10,5.50E-01,17,7.50E-01,14,6.70E-01,14GOTERM_BP_5,regulation of neurotransmitter transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of lipid metabolic process,6.40E-01,22,8.70E-01,19,7.70E-01,24,8.30E-01,17,1.00E+00,17,7.70E-01,21,9.70E-01,16GOTERM_BP_5,adult walking behavior,6.50E-01,11,1.00E+00,#N/A,8.60E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of heart rate,6.50E-01,11,7.70E-01,10,8.60E-01,11,1.00E+00,#N/A,5.20E-01,13,5.10E-01,12,7.40E-01,10GOTERM_BP_5,excretion,1.00E+00,19,9.90E-01,20,1.00E+00,#N/A,9.90E-01,17,9.90E-01,23,1.00E+00,17,1.00E+00,17GOTERM_BP_5,regulated secretory pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,somatic recombination of immunoglobulin gene segments,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic cranial skeleton morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,7.30E-01,10,1.00E+00,#N/A,6.80E-01,10,5.20E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of phosphatase activity,5.00E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,5.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cerebellar cortex development,5.00E-01,10,1.00E+00,#N/A,3.70E-01,12,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,acid secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,fucose metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic organ morphogenesis,8.30E-01,59,8.20E-01,58,7.50E-01,70,6.00E-01,54,8.40E-01,66,8.60E-01,59,9.00E-01,55GOTERM_BP_5,ear development,1.20E-01,52,5.50E-01,45,6.00E-01,52,4.20E-01,41,5.50E-01,51,7.30E-01,44,7.20E-01,42GOTERM_BP_5,positive regulation of amine transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,phosphatidylcholine biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,dorsal/ventral neural tube patterning,1.00E+00,#N/A,1.00E+00,#N/A,3.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,macroautophagy,1.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,2.80E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cGMP metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.60E-01,11,1.00E+00,#N/A,2.80E-01,10,1.70E-01,10,1.30E-01,10GOTERM_BP_5,polysaccharide biosynthetic process,1.70E-01,26,5.40E-01,22,6.20E-01,25,8.00E-01,17,5.30E-01,25,5.10E-01,23,6.20E-01,21GOTERM_BP_5,receptor-mediated endocytosis,9.70E-01,20,8.70E-01,22,7.40E-01,28,5.00E-01,23,6.60E-01,28,7.90E-01,24,8.50E-01,22GOTERM_BP_5,neural crest cell differentiation,7.70E-01,15,1.00E+00,#N/A,8.90E-01,16,8.50E-01,12,9.60E-01,14,9.70E-01,12,9.50E-01,12GOTERM_BP_5,neural crest cell development,7.70E-01,15,1.00E+00,#N/A,8.90E-01,16,8.50E-01,12,9.60E-01,14,9.70E-01,12,9.50E-01,12GOTERM_BP_5,phototransduction,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,skin development,8.80E-01,12,9.70E-01,10,2.60E-01,19,8.00E-01,11,9.60E-01,12,9.80E-01,10,9.20E-01,11GOTERM_BP_5,epidermis morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,6.70E-01,14,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,8.80E-01,10GOTERM_BP_5,positive regulation of multicellular organism growth,7.00E-01,12,6.70E-01,12,5.20E-01,15,2.90E-01,13,8.60E-01,12,2.70E-01,15,4.80E-01,13GOTERM_BP_5,positive regulation of stress-activated protein kinase signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,7.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of gliogenesis,7.30E-01,10,1.00E+00,#N/A,8.00E-01,11,1.00E+00,#N/A,7.50E-01,11,7.50E-01,10,5.10E-01,11GOTERM_BP_5,male meiosis,1.00E+00,#N/A,1.00E+00,#N/A,8.00E-01,11,1.00E+00,#N/A,7.50E-01,11,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hindbrain development,9.00E-01,25,9.20E-01,24,2.30E-01,37,9.40E-01,20,8.60E-01,29,8.60E-01,26,6.90E-01,27GOTERM_BP_5,sperm-egg recognition,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to nicotine,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of organic acid transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,binding of sperm to zona pellucida,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of homeostatic process,5.50E-01,20,7.40E-01,18,7.70E-01,21,4.60E-01,18,6.90E-01,21,7.00E-01,19,4.70E-01,20GOTERM_BP_5,central nervous system neuron differentiation,6.70E-01,19,6.30E-01,19,4.10E-01,24,2.30E-01,20,4.50E-01,23,7.00E-01,19,5.90E-01,19GOTERM_BP_5,ATP synthesis coupled proton transport,5.50E-01,20,6.30E-01,19,1.00E+00,#N/A,3.40E-01,19,5.80E-01,22,8.80E-01,17,8.10E-01,17GOTERM_BP_5,"energy coupled proton transport, down electrochemical gradient",5.50E-01,20,6.30E-01,19,1.00E+00,#N/A,3.40E-01,19,5.80E-01,22,8.80E-01,17,8.10E-01,17GOTERM_BP_5,glycerophospholipid biosynthetic process,3.70E-01,35,6.00E-01,32,3.60E-01,40,8.50E-01,25,7.20E-01,35,7.70E-01,31,8.10E-01,29GOTERM_BP_5,telomere maintenance,9.20E-01,11,8.30E-01,12,7.50E-01,15,4.80E-01,13,2.60E-01,18,4.90E-01,15,3.90E-01,15GOTERM_BP_5,glutathione metabolic process,5.30E-02,19,2.80E-01,16,7.50E-01,15,1.10E-01,16,3.90E-01,17,1.20E-01,18,1.50E-01,17GOTERM_BP_5,reciprocal meiotic recombination,8.80E-01,10,8.60E-01,10,8.50E-01,12,6.90E-01,10,5.30E-01,14,1.00E+00,#N/A,8.40E-01,10GOTERM_BP_5,positive regulation of neuron differentiation,1.00E+00,#N/A,7.50E-01,11,7.40E-01,13,5.40E-01,11,9.00E-01,11,6.60E-01,12,5.70E-01,12GOTERM_BP_5,detection of mechanical stimulus involved in sensory perception,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.50E-02,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of lipid catabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,protein trimerization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to dietary excess,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glycosaminoglycan metabolic process,8.90E-01,23,7.90E-01,24,8.90E-01,27,7.80E-01,21,7.50E-01,28,6.90E-01,26,5.60E-01,26GOTERM_BP_5,transcription initiation,6.50E-01,39,6.70E-01,38,6.50E-01,45,9.20E-01,29,9.20E-01,39,9.50E-01,34,8.80E-01,34GOTERM_BP_5,plasma lipoprotein particle remodeling,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of carbohydrate metabolic process,4.90E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,defense response to Gram-positive bacterium,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of cellular carbohydrate metabolic process,4.90E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,hormone biosynthetic process,9.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,10,9.90E-01,10,1.00E+00,#N/AGOTERM_BP_5,body fluid secretion,9.50E-01,10,7.80E-01,12,8.90E-01,13,8.30E-01,10,9.30E-01,12,9.10E-01,11,8.60E-01,11GOTERM_BP_5,anterior/posterior axis specification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,acidic amino acid transport,1.00E+00,#N/A,2.90E-01,10,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,water homeostasis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,male genitalia development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cerebellar cortex morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,5.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,telencephalon cell migration,1.00E+00,#N/A,1.00E+00,#N/A,3.50E-01,11,1.00E+00,#N/A,4.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,startle response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,phospholipid biosynthetic process,4.00E-01,51,8.30E-01,44,5.80E-01,56,9.50E-01,35,8.90E-01,49,9.00E-01,44,8.40E-01,43GOTERM_BP_5,response to gamma radiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neural crest cell migration,8.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,9.40E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,epithelium development,9.80E-01,93,9.80E-01,91,1.00E+00,#N/A,9.10E-01,84,9.60E-01,108,1.00E+00,87,1.00E+00,86GOTERM_BP_5,aminoglycan metabolic process,7.90E-01,29,8.20E-01,28,1.00E+00,#N/A,7.70E-01,25,7.60E-01,33,7.40E-01,30,6.10E-01,30GOTERM_BP_5,cerebellum morphogenesis,5.90E-01,10,1.00E+00,#N/A,4.70E-01,12,1.00E+00,#N/A,7.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to cocaine,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,autonomic nervous system development,5.90E-01,10,1.00E+00,#N/A,4.70E-01,12,1.00E+00,#N/A,7.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,response to tropane,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of defense response to virus,1.00E+00,#N/A,1.00E+00,#N/A,6.50E-01,11,3.50E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of glucose metabolic process,5.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of lipid catabolic process,4.70E-01,14,7.30E-01,12,7.40E-01,14,1.00E+00,#N/A,9.80E-01,10,6.50E-01,13,9.10E-01,10GOTERM_BP_5,respiratory electron transport chain,1.00E-02,41,6.90E-03,41,1.20E-01,41,7.90E-04,40,2.50E-02,43,3.20E-03,43,4.00E-04,44GOTERM_BP_5,positive regulation of DNA repair,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,behavioral fear response,2.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,3.80E-01,10,2.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,macrophage activation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic axis specification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of lipid transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,regulation of chemokine production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of neuron differentiation,5.10E-01,17,4.70E-01,17,4.30E-01,20,3.50E-01,16,4.90E-01,19,2.80E-01,19,2.00E-01,19GOTERM_BP_5,regulation of amine transport,9.20E-01,13,9.60E-01,12,1.00E+00,#N/A,6.20E-01,14,9.10E-01,15,9.90E-01,11,8.90E-01,13GOTERM_BP_5,somatic diversification of immunoglobulins,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of B cell activation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,peripheral nervous system development,8.00E-01,16,7.70E-01,16,5.10E-01,21,3.80E-01,17,1.20E-01,24,7.20E-01,17,4.90E-01,18GOTERM_BP_5,glutamate signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,steroid catabolic process,7.30E-01,10,5.40E-01,11,4.90E-01,13,3.30E-01,11,6.00E-01,12,6.00E-01,11,6.80E-01,10GOTERM_BP_5,natural killer cell activation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neural tube patterning,5.70E-01,11,7.10E-01,10,3.20E-01,14,1.00E+00,#N/A,6.00E-01,12,4.20E-01,12,3.40E-01,12GOTERM_BP_5,cell chemotaxis,1.00E+00,#N/A,1.00E+00,10,1.00E+00,#N/A,9.80E-01,11,1.00E+00,11,1.00E+00,11,1.00E+00,#N/AGOTERM_BP_5,regulation of interleukin-6 biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,L-glutamate transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,ciliary or flagellar motility,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of G-protein coupled receptor protein signaling pathway,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cerebral cortex cell migration,1.00E+00,#N/A,1.00E+00,#N/A,3.20E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,embryonic skeletal system development,9.40E-01,31,8.30E-01,33,8.90E-01,38,9.10E-01,27,9.80E-01,33,9.30E-01,32,9.60E-01,29GOTERM_BP_5,brown fat cell differentiation,1.00E+00,#N/A,8.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,9.60E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neuron fate commitment,5.40E-01,21,8.20E-01,18,7.70E-01,22,6.80E-01,17,9.30E-01,19,7.90E-01,19,5.80E-01,20GOTERM_BP_5,protein secretion,9.30E-01,12,3.40E-01,17,6.90E-01,17,3.70E-01,15,8.50E-01,15,5.50E-01,16,8.30E-01,13GOTERM_BP_5,endocrine pancreas development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,forebrain cell migration,1.00E+00,#N/A,1.00E+00,#N/A,4.60E-01,11,1.00E+00,#N/A,5.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neuromuscular synaptic transmission,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of transforming growth factor beta receptor signaling pathway,1.00E+00,#N/A,3.80E-01,10,6.40E-01,10,1.00E+00,#N/A,5.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,DNA integration,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,somitogenesis,7.00E-01,16,9.90E-01,11,1.00E+00,#N/A,9.40E-01,11,8.80E-01,16,9.90E-01,11,9.80E-01,11GOTERM_BP_5,ATP synthesis coupled electron transport,3.00E-02,35,4.00E-02,34,2.10E-01,35,4.20E-03,34,5.40E-02,37,9.90E-03,37,1.60E-03,38GOTERM_BP_5,proximal/distal pattern formation,7.20E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,L-amino acid transport,1.00E+00,#N/A,6.90E-01,11,9.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,8.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,segmentation,7.40E-01,22,9.90E-01,16,1.00E+00,#N/A,9.30E-01,16,9.50E-01,21,9.70E-01,18,9.90E-01,16GOTERM_BP_5,leukocyte chemotaxis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,10,1.00E+00,#N/AGOTERM_BP_5,regulation of B cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,negative regulation of protein secretion,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,cytokine biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,translational elongation,8.80E-02,56,3.00E-01,51,5.40E-01,56,2.40E-01,46,2.60E-01,58,2.10E-01,54,6.90E-02,55GOTERM_BP_5,hair follicle morphogenesis,1.00E+00,#N/A,1.00E+00,#N/A,8.00E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,mechanoreceptor differentiation,1.50E-01,18,3.50E-01,16,6.90E-01,16,5.40E-01,13,6.20E-01,16,4.10E-01,16,3.20E-01,16GOTERM_BP_5,regulation of DNA repair,7.90E-01,10,1.00E+00,#N/A,7.40E-01,12,5.70E-01,10,9.10E-01,10,8.10E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of osteoclast differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,alditol metabolic process,2.50E-01,15,6.70E-01,12,6.70E-01,14,7.50E-01,10,7.50E-01,13,5.70E-01,13,7.80E-01,11GOTERM_BP_5,embryonic skeletal system morphogenesis,9.90E-01,19,9.70E-01,21,1.00E+00,#N/A,9.00E-01,20,9.80E-01,24,9.70E-01,22,9.60E-01,21GOTERM_BP_5,regulation of interleukin-8 production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of nucleotide metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of nucleotide biosynthetic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,myeloid leukocyte mediated immunity,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neuron fate specification,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,myeloid cell activation during immune response,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neutrophil chemotaxis,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of lipid biosynthetic process,1.30E-01,14,1.00E+00,#N/A,8.00E-01,11,1.00E+00,#N/A,1.00E+00,#N/A,4.20E-01,12,1.00E+00,#N/AGOTERM_BP_5,defense response to virus,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,glycerol metabolic process,4.00E-01,13,8.20E-01,10,8.00E-01,12,1.00E+00,#N/A,8.60E-01,11,5.80E-01,12,1.00E+00,#N/AGOTERM_BP_5,aminoglycan biosynthetic process,7.20E-01,11,8.20E-01,10,9.00E-01,11,1.00E+00,#N/A,8.60E-01,11,8.50E-01,10,1.00E+00,#N/AGOTERM_BP_5,regulation of interleukin-6 production,9.90E-01,12,9.60E-01,13,1.00E+00,#N/A,9.60E-01,11,9.90E-01,13,9.70E-01,13,9.80E-01,12GOTERM_BP_5,hindlimb morphogenesis,9.30E-01,10,8.40E-01,11,8.50E-01,13,1.00E+00,#N/A,9.50E-01,11,7.80E-01,12,9.10E-01,10GOTERM_BP_5,ectoderm development,1.00E+00,62,1.00E+00,66,1.00E+00,#N/A,1.00E+00,57,1.00E+00,71,1.00E+00,68,1.00E+00,61GOTERM_BP_5,spinal cord development,1.00E+00,12,9.80E-01,13,1.00E+00,#N/A,9.20E-01,13,1.00E+00,14,9.90E-01,13,9.20E-01,15GOTERM_BP_5,"mitochondrial electron transport, NADH to ubiquinone",1.30E-01,25,1.80E-01,24,4.20E-01,25,4.40E-02,24,2.30E-01,26,4.80E-02,27,2.50E-02,27GOTERM_BP_5,water transport,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,forelimb morphogenesis,7.90E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,nerve development,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,epidermis development,1.00E+00,57,1.00E+00,61,1.00E+00,#N/A,1.00E+00,53,1.00E+00,67,1.00E+00,63,1.00E+00,57GOTERM_BP_5,glycosaminoglycan biosynthetic process,7.30E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of fatty acid metabolic process,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,auditory receptor cell differentiation,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,proteoglycan metabolic process,8.80E-01,18,1.00E+00,11,1.00E+00,#N/A,9.70E-01,13,1.00E+00,14,9.90E-01,14,1.00E+00,10GOTERM_BP_5,chemotaxis,1.00E+00,56,1.00E+00,54,1.00E+00,#N/A,9.90E-01,51,1.00E+00,63,1.00E+00,56,1.00E+00,52GOTERM_BP_5,associative learning,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,neuromuscular process controlling balance,9.60E-01,13,9.50E-01,13,1.00E+00,#N/A,9.50E-01,11,9.80E-01,14,9.30E-01,14,9.40E-01,13GOTERM_BP_5,epithelial cell differentiation,1.00E+00,41,1.00E+00,47,1.00E+00,#N/A,9.80E-01,45,1.00E+00,58,1.00E+00,43,1.00E+00,41GOTERM_BP_5,positive regulation of mitosis,9.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of nuclear division,9.10E-01,10,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,positive regulation of interleukin-6 production,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,photoreceptor cell maintenance,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,defense response to bacterium,1.00E+00,27,1.00E+00,28,1.00E+00,#N/A,1.00E+00,29,1.00E+00,36,1.00E+00,32,1.00E+00,28GOTERM_BP_5,anterior/posterior pattern formation,9.70E-01,57,1.00E+00,46,1.00E+00,#N/A,1.00E+00,43,1.00E+00,54,1.00E+00,52,1.00E+00,49GOTERM_BP_5,regulation of gene expression,1.00E+00,1282,1.00E+00,1266,1.00E+00,#N/A,1.00E+00,1069,1.00E+00,1419,1.00E+00,1299,1.00E+00,1217GOTERM_BP_5,regulation of cellular biosynthetic process,1.00E+00,1304,1.00E+00,1283,1.00E+00,#N/A,1.00E+00,1090,1.00E+00,1439,1.00E+00,1305,1.00E+00,1231GOTERM_BP_5,regulation of macromolecule biosynthetic process,1.00E+00,1247,1.00E+00,1229,1.00E+00,#N/A,1.00E+00,1041,1.00E+00,1380,1.00E+00,1256,1.00E+00,1179GOTERM_BP_5,epidermal cell differentiation,1.00E+00,19,1.00E+00,20,1.00E+00,#N/A,1.00E+00,15,1.00E+00,24,1.00E+00,17,1.00E+00,16GOTERM_BP_5,"regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process",1.00E+00,1232,1.00E+00,1219,1.00E+00,#N/A,1.00E+00,1038,1.00E+00,1375,1.00E+00,1235,1.00E+00,1167GOTERM_BP_5,regulation of transcription,1.00E+00,1130,1.00E+00,1111,1.00E+00,#N/A,1.00E+00,942,1.00E+00,1258,1.00E+00,1134,1.00E+00,1067GOTERM_BP_5,regulation of RNA metabolic process,1.00E+00,747,1.00E+00,738,1.00E+00,#N/A,1.00E+00,619,1.00E+00,829,1.00E+00,741,1.00E+00,696GOTERM_BP_5,keratinization,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,#N/A,1.00E+00,10,1.00E+00,#N/A,1.00E+00,#N/AGOTERM_BP_5,"regulation of transcription, DNA-dependent",1.00E+00,727,1.00E+00,716,1.00E+00,#N/A,1.00E+00,601,1.00E+00,805,1.00E+00,717,1.00E+00,672GOTERM_BP_5,sensory perception,1.00E+00,187,1.00E+00,177,1.00E+00,#N/A,1.00E+00,150,1.00E+00,199,1.00E+00,179,1.00E+00,174GOTERM_BP_5,G-protein coupled receptor protein signaling pathway,1.00E+00,303,1.00E+00,288,1.00E+00,#N/A,1.00E+00,242,1.00E+00,326,1.00E+00,283,1.00E+00,283GOTERM_BP_5,cell surface receptor linked signal transduction,1.00E+00,647,1.00E+00,619,1.00E+00,#N/A,1.00E+00,526,1.00E+00,704,1.00E+00,635,1.00E+00,619